0001213900-23-039367.txt : 20230515 0001213900-23-039367.hdr.sgml : 20230515 20230515091642 ACCESSION NUMBER: 0001213900-23-039367 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 80 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Payment Solutions, Inc. CENTRAL INDEX KEY: 0001591913 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55648 FILM NUMBER: 23918953 BUSINESS ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 BUSINESS PHONE: (866) 477-4729 MAIL ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 FORMER COMPANY: FORMER CONFORMED NAME: QPAGOS DATE OF NAME CHANGE: 20160615 FORMER COMPANY: FORMER CONFORMED NAME: Asiya Pearls, Inc. DATE OF NAME CHANGE: 20131113 10-Q 1 f10q0323_innovativepay.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

  

Commission file number 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #ATCarmel By The SeaCA 93921
(Address of Principal Executive Offices, including zip code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer   Accelerated Filer
Non-accelerated Filer   Smaller Reporting Company
Emerging growth company      

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

As of May 10, 2023, there were 376,901,679 shares of the Company’s common stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

 

Form 10-Q

For the Quarter Ended March 31, 2023

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022 1
     
  Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31,  2023 and 2022 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (Unaudited) 4
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 25
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 30
     
Item 4. Controls and Procedures 30
     
Part II. Other Information 31
     
Item 1. Legal Proceedings 31
     
Item 1A. Risk Factors 32
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 32
     
Item 3. Defaults Upon Senior Securities 32
     
Item 4. Mine Safety Disclosures 32
     
Item 5. Other Information 32
     
Item 6. Exhibits 33
     
Signatures 34

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

  

  our ability to implement our business plan, including our ability to launch, achieve customer downloads of and generate revenue from our IPSIPay or other digital payment solutions;

 

acceptance by the marketplace of our products and services, notably IPSIPay;

 

our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

 

the viability of our current intellectual property and intellectual property created in the future;

 

our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

 

our ability to retain key employees and third-party service providers;

 

adverse changes in general market conditions for payment solutions such as IPSIPay and other products and services we offer;

 

our ability to generate cash flow and profitability and continue as a going concern;

 

our future financing plans and ability to repay outstanding indebtedness; and

 

our ability to adapt to changes in market conditions (including as a result of the COVID-19 pandemic) which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this report and in the “Business,” “Risk Factors” and other sections of the 2022 Form 10-K. You should thoroughly read this report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this report relate only to events or information as of the date of this report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this report completely and with the understanding that our actual future results may be materially different from what we expect

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   March 31,   December 31, 
   2023   2022 
  (Unaudited)     
Assets        
         
Current Assets        
Cash  $155,868   $374,765 
Other current assets   75,085    97,042 
Total Current Assets   230,953    471,807 
           
Non-current assets          
Plant and equipment   25,528    40,362 
Intangible assets   1,631,739    1,692,811 
Security deposit   47,592    47,592 
Investment   500,000    500,000 
Total Non-Current Assets   2,204,859    2,280,765 
Total Assets  $2,435,812   $2,752,572 
           
Liabilities and Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $889,042   $761,732 
Federal relief loans – current portion   3,217    
-
 
Notes payable   988,368    964,268 
Convertible debt, net of unamortized discount of $228,888 and $0, respectively   2,632,451    2,266,602 
Derivative liability   1,609,892    2,550,642 
Total Current Liabilities   6,122,970    6,543,244 
           
Non-Current Liabilities          
Federal relief loans   159,952    163,978 
Total Non-Current Liabilities   159,952    163,978 
           
Total Liabilities   6,282,922    6,707,222 
           
Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 shares authorized, 376,901,679 shares issued and outstanding as of March 31, 2023 and December 31, 2022.   37,690    37,690 
Additional paid-in-capital   48,788,448    48,405,921 
Accumulated deficit   (52,673,248)   (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders   (3,847,110)   (3,956,247)
Non-controlling interest   
-
    1,597 
Total Equity (Deficit)   (3,847,110)   (3,954,650)
Total Liabilities and Equity (Deficit)  $2,435,812   $2,752,572 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months
ended
   Three months
ended
 
   March 31,   March 31, 
   2023   2022 
         
Net Revenue  $433   $
-
 
           
Cost of Goods Sold   2,085    
-
 
           
Gross loss   (1,652)   
-
 
           
General and administrative   965,207    869,387 
Depreciation and amortization   140,690    4,496 
Total Expense   1,105,897    873,883 
           
Loss from Operations   (1,107,549)   (873,883)
           
Penalty on convertible notes   
-
    (719,558)
Interest expense   (85,221)   (45,766)
Amortization of debt discount   (22,967)   (263,200)
Derivative liability movements   940,750    92,161 
Loss before Income Taxes   (274,987)   (1,810,246)
           
Income Taxes   
-
    
-
 
Net Loss   (274,987)   (1,810,246)
Net loss attributable to non-controlling interest   1,597    8,752 
Net loss attributable to Innovative Payment Solutions, Inc. stockholders  $(273,390)  $(1,801,494)
           
Basic and diluted loss per share
  $(0.00)  $(0.00)
           
Weighted Average Number of Shares Outstanding – Basic and diluted
   376,901,679    367,901,679 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

    Preferred
Stock
Shares
    Amount     Common Stock
Shares*
    Amount     Additional
Paid-in
Capital
    Accumulated
Deficit
    Non-
controlling
shareholders
interest
    Total
Stockholders’
Equity
(Deficit)
 
                                                 
Balance at December 31, 2022            -     $         -       376,901,679     $ 37,690     $ 48,405,921     $ (52,399,858 )   $ 1,597     $ (3,954,650 )
Fair value of warrants issued     -       -       -       -       251,856       -       -       251,856  
Stock based option expense     -       -       -       -       130,671       -       -       130,671  
Net loss     -       -       -       -       -       (273,390 )     (1,597 )     (274,987 )
Balance at March 31, 2023     -     $ -       376,901,679     $ 37,690     $ 48,788,448     $ (52,673,248 )   $ -     $ (3,847,110 )

 

   Preferred
Stock
Shares
   Amount   Common Stock
Shares*
   Amount   Additional
Paid-in
Capital
   Accumulated
Deficit
   Non-
controlling
shareholders
interest
   Total
Stockholders’
Equity
(Deficit)
 
                                 
Balance at December 31, 2021   
          -
   $
       -
    367,901,679   $36,790   $45,771,012   $(42,111,701)  $35,211   $3,731,312 
Stock based option expense   -    
-
    -    
-
    94,466    
-
    
-
    94,466 
Restricted stock awards   -    
-
    -    
-
    62,766    
-
    
-
    62,766 
Net loss   -    
-
    -    
-
    
-
    (1,801,494)   (8,752)   (1,810,246)
Balance at March 31, 2022   
-
   $
-
    367,901,679   $36,790   $45,928,244   $(43,913,195)  $26,459   $2,078,298 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Three months
ended
   Three months
ended
 
   March 31,   March 31, 
   2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(274,987)  $(1,810,246)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   (940,750)   (92,161)
Depreciation   140,690    4,496 
Amortization of debt discount   22,967    263,200 
Penalty on convertible debt   
-
    719,558 
Stock based compensation   130,671    157,232 
Changes in Assets and Liabilities          
Other current assets   21,957    45,708 
Accounts payable and accrued expenses   127,311    (6,221)
Interest accruals   83,837    (42,484)
CASH USED IN OPERATING ACTIVITIES   (688,304)   (760,918)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in intangibles   (64,783)   (179,030)
NET CASH USED IN INVESTING ACTIVITIES   (64,783)   (179,030)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from convertible notes   535,000    
-
 
Repayment of convertible notes   
-
    (1,147,063)
Repayment of federal relief loans   (809)   
-
 
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES   534,191    (1,147,063)
           
NET DECREASE IN CASH   (218,896)   (2,087,011)
CASH AT BEGINNING OF PERIOD   374,765    5,449,751 
CASH AT END OF PERIOD  $155,869   $3,362,740 
           
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $1,384   $88,250 
NON CASH INVESTING AND FINANCING ACTIVITIES          
Fair value of warrants issued with convertible notes  $251,856   $
-
 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

b)Description of current business

 

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was fully launched in July 2022 after a soft launch in December 2021. Previously the Company intended to invest in physical kiosks where any payment processing could be undertaken by customers in person. The Company has shifted its business to focus solely on downloadable apps used via smartphones and other online payment processing solutions..

 

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

 

2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

h)Reporting by Segment

 

No segmental information is required as the Company only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

i.identify the contract with a customer;

 

ii.identify the performance obligations in the contract;

 

iii.determine the transaction price;

 

iv.allocate the transaction price to performance obligations in the contract; and

 

v.recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. 

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2023 and the year ended December 31, 2022, the Company had a net loss of $274,987 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the three months ended March 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

  

4INTANGIBLES

 

On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $41,320  and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $1,127,400 and $28,893, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.

 

    March 31,
2023
    December 31, 
2022
 
     Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchase Technology – Beyond Wallet   $ 327,211     $
-
    $ 327,211     $ 291,320  
Purchased Technology - IPSIPay     1,531,293       (226,765 )     1,304,528       1,401,491  
    $ 1,858,504     $ (226,765 )   $ 1,631,739     $ 1,692,811  

 

Amortization expense was $125,856 and $0 for the three months ended March 31, 2023 and 2022, respectively.

 

5INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

 

The shares in Frictionless are unlisted as of March 31, 2023.

 

   

March 31,

2023

    December 31,
2022
 
Investment in Frictionless Financial Technologies, Inc.   $ 500,000     $ 500,000  
    $ 500,000     $ 500,000  

 

6LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Operating lease expense  $15,264   $14,400 

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

6LEASES (continued)

 

Other lease information:

 

   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(15,264)  $(14,400)
           
Remaining lease term – operating lease   Monthly    Monthly 

 

 

7FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company.

 

The Company has repaid an aggregate principal amount of $809 and interest of $1,384 as of March 31, 2023. The loan balance outstanding as of March 31, 2023, consists of principal of $149,191 and accrued interest thereon of $13,978, of which $3,217 is disclosed as current.

 

8NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    March 31, 2023
Amount, net
    December 31, 2022
Amount, net
 
Cavalry Fund I LP     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Total convertible notes payable               $ 964,000     $ 24,368     $ 988,368     $ 964,268  

  

Interest expense totaled $24,100 and $0 for the three months ended March 31, 2023 and 2022, respectively.

 

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

9CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

On February 16, 2021, we entered into separate SPAs with each of Cavalry and Mercer, pursuant to which we received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.24 per share. Cavalry and Mercer are Selling Stockholders listed in this prospectus.

 

The Original Warrants are discussed in note 8 above.

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under their respective Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Notes). As a result of this change in conversion price, under the existing terms of the Notes, the 3,000,000 shares of common stock underlying the Extension Warrants was increased to 39,130,435 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

  

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Notes until after March 30, 2023 and (ii) waive any events of default under the Notes and the SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the common stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and

 

(5)The company was obligated to register the shares of common stock underlying the Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our common stock underlying the Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to the filed registration statement.

 

The amendments to the convertible debt were evaluated in terms of ASC470, Debt, to determine if the amendments to the convertible debt were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the convertible notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the convertible note holders valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (Note 8 above) and the value of full rachet provisions of certain of the warrants issued to the convertible note holders amounting to $841,003, see note 12 below, the amendment of the convertible notes was determined to be a debt extinguishment.

 

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

9CONVERTIBLE NOTES PAYABLE (continued)

 

Convertible notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    March 31, 2023 Amount, net     December 31, 2022 Amount, net  
Cavalry Fund I LP     10 %   December 30, 
2023
    1,091,754       68,841      
          -
      1,160,595       1,133,301  
                                                     
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 
2023
    1,091,754       68,841      
-
      1,160,595       1,133,301  
                                                     
February 2023 convertible notes     8 %   February 13, 2024
to February 23, 2024
    535,000       5,149       (228,888 )     311,261      
-
 
                                                     
Total convertible notes payable               $ 2,718,508     $ 142,831     $ (228,888 )   $ 2,632,451     $ 2,266,602  

 

Interest expense totaled $59,737 and $44,379 for the three months ended March 31, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $22,967 and $263,200 for the three months ended March 31, 2023 and 2022, respectively.

 

The Cavalry and Mercer convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the common stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

The balance of the Cavalry Note plus accrued interest at March 31, 2023 was $1,160,595.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

9CONVERTIBLE NOTES PAYABLE (continued)

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

The balance of the Mercer Note plus accrued interest at March 31, 2023 was $1,160,595.

  

February 2023 convertible notes

 

Between February 13, 2023 and February 23, 2023, the Company, entered into Securities Purchase Agreements (the “Securities Purchase Agreement”) with 11 accredited investors, pursuant to which the Company received an aggregate of $535,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

Convertible Notes Promissory (the “Notes” and each a “Note”); and

 

five-year warrants (the “Warrants”) to purchase an aggregate 46,521,739 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

The Notes and the Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

The balance of the February 2023 Notes plus accrued interest at March 31, 2023 was $311,261, net of unamortized debt discount of $228,888.

 

10DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 9 above and certain warrants disclosed in note 11 below, have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

16

 

 

 INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

10DERIVATIVE LIABILITY (continued)

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 9 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

The net movement on the derivative liability for the three months ended March 31, 2023 was a net mark-to-market release of derivative liability of $940,750, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Three months ended March 31, 2023       Year ended December 31, 2022 
Conversion price  $0.0115   $0.0115 to $0.15  
Risk free interest rate   3.60 to 4.79%   0.79 to 4.73 %
Expected life of derivative liability   9 to 53 months    1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 192.53%    120.49 to 258.3 %
Expected dividend rate   0%   0%

 

The movement in derivative liability is as follows:

 

  

March 31,
2023

  

December 31,
2022

 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   
-
    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (940,750)   (411,752)
   $1,609,892   $2,550,642 

 

11STOCKHOLDERS’ EQUITY

 

a.Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 shares of Common Stock issued and outstanding as of March 31, 2023 and December 31, 2022, respectively.

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11STOCKHOLDERS’ EQUITY (continued)

   

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2022   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding December 31, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2023   23,495,000   $0.050    -   $0.049    23,495,000   $0.050 

 

The restricted stock granted, issued and exercisable at March 31, 2023 is as follows:

 

   Restricted Stock Granted and Vested 
Grant date Price  Number Granted   Weighted Average Fair Value per Share 
$ 0.049   20,495,000   $0.049 
$ 0.050   1,000,000    0.050 
$ 0.055   2,000,000    0.055 
    23,495,000   $0.050 

 

The Company has recorded an expense of $0 and $62,766 for the three months March 31, 2023 and 2022, respectively. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2023 and December 31, 2022.

 

d.Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

    

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of common stock in the Company at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. Subsequent to March 31, 2023, the Company entered into an agreement to cancel this warrant (see Note 15).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:

 

  The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;

 

  The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

  An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

Between February 13, 2023 and February 23, 2023, the Company entered into Securities Purchase Agreements with 11 accredited investors, as disclosed in Note 9 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 46,521,739 shares of the Company’s common stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

The Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11STOCKHOLDERS’ EQUITY (continued)

 

d.Warrants (continued)

    

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

    Three months
ended
March 31,
2023
 
Exercise price   $ 0.0115  
Risk free interest rate     3.93 to 4.16 %
Expected life     5 years   
Expected volatility of underlying stock     189.15 to 189.37 %
Expected dividend rate     0 %

 

A summary of warrant activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

    Shares
Underlying
Warrants
    Exercise
price per
share
    Weighted
average
exercise price
 
Outstanding January 1, 2022     37,304,105     $ 0.05 – 0.1875     $ 0.12  
Granted     51,000,000        0.0115 – 0.0345       0.01826  
Increase in warrants due to debt amendment full rachet trigger     72,260,870       0.0115       0.0115  
Cancelled on debt amendment     (4,973,914 )     0.15       0.1500  
Exercised     -       -       -  
Outstanding December 31, 2022     155,591,061     $  0.0115 – 0.1875     $ 0.0300  
Granted     46,521,739        0.0115       0.0115  
Forfeited     (1,000,000 )     0.05       0.05  
Cancelled on debt amendment     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     201,112,800     $  0.0115 – 0.1875     $ 0.0256  

 

The warrants outstanding and exercisable at March 31, 2023 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0115    168,519,466    4.48         168,519,466         4.48 
$0.0345    15,000,000    2.27         10,312,500         2.27 
$0.15    15,166,667    2.96         15,166,667         2.96 
$0.1875    2,426,667    2.96         2,426,667         2.96 
      201,112,800    4.18   $0.0256    196,425,300   $0.0256    4.23 

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

A summary of option activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

    Shares
Underlying
options
    Exercise
price per
share
    Weighted
average
exercise
price
 
Outstanding January 1, 2022     30,516,666     $ 0.15 to 0.40     $ 0.15  
Granted     15,800,000        0.04 – 0.15       0.14  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding December 31, 2022     46,316,666     0.04 to 0.40     $ 0.15  
Granted     -       -       -  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     46,316,666     0.04 to 0.40     $ 0.15  

 

21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

11STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

The options outstanding and exercisable at March 31, 2023 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise  Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.04    800,000    9.46         800,000         9.46 
$0.15    45,208,333    8.69         38,125,000         8.74 
$0.24    208,333    7.90         208,333         7.90 
$0.40    100,000    5.75         100,000         5.75 
      46,316,666    8.69   $0.15    39,233,333   $0.15    8.75 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.

 

The option expense was $94,464 and $94,466 for the three months ended March 31, 2023 and 2022, respectively. 

 

12NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2023 and 2022 are as follows:

 

   Three months ended
March 31,
2023
(Shares)
   Three months ended
March 31,
2022
(Shares)
 
Convertible debt   248,812,128    11,687,855 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   201,112,800    37,304,104 
    496,241,594    79,508,625 

 

22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

 

The option expense for Mr. Corbett was $66,587 and $1,090,201  for the three months ended March 31, 2023 and the year ended December 31, 20221, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

Madisson Corbett

 

On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Corbett was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

  

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

13RELATED PARTY TRANSACTIONS (continued)

 

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $27,879 and $111,514 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

14COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under note 8 and 9 above, which mature between December 30, 2023 and February 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

 

15SUBSEQUENT EVENTS

 

On April 28, 2023, the Company formed a new Delaware limited liability company called IPSIPay Express LLC. This entity was formed as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. As of the date of issuance of these financial statements, definitive documentation memorializing the joint venture are being finalized.

 

On May 10, 2023, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which the Company issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to the Company of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. The Company is required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

24

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a provider of digital payment solutions and services to businesses and consumers. We are focused on operating and developing “e-wallets” that enable consumers to deposit cash, convert it into a digital form, and remit the funds to Mexico and other countries quickly and securely. Our flagship e-wallet, IPSIPay®, is focused on the consumer market and was fully launched in July 2022 after a soft launch in December 2021.

 

Our platform (which can be used both business-to-business and business-to-consumer) facilitates the transfer of funds in digital form to other countries, initially Mexico but also, India and the Philippines, primarily from hand-held devices as well as on desktop or laptop computers.

 

In October 2022, we announced that since the commencement of our new IPSIPay marketing campaign featuring Mr. Lopez in August 2022, we achieved 10,000 downloads of IPSIPay, and of the 10,000 downloads, 1,200 have been converted to active users with wallets, meaning the users have initiated at least one transaction via IPSIPay. As of May 10, 2023, we had achieved approximately 56,600 downloads and over 5,400 active users with wallets.

 

Our launch plan for IPSIPay is to target lower income, migrant communities in California (notably in the agriculture industry), and expanding to other states with large migrant populations such as Texas and Florida. We not only believe the addressable market for our products and services is large and growing, but that servicing this market is socially responsible. We believe our digital payment facilitation platform and related apps will empower and enable the unbanked and under-served and payment providers who service these users, acting as a bridge to provide access to comprehensive and easy to use payment solutions. Given the large size of our addressable market, our ability to capture even a very small share of the market represents a significant revenue opportunity for our company.

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

Launch and Scaling of E-Wallets; IPSIPay Express

 

Having achieved full commercial integration and launch of the IPSIPay app during the third quarter of 2022, the key for our business for the foreseeable future is to scale the number of IPSIPay downloads achieved and revenue generated from transactions process by customers via IPSIPay. Presently, our ability to generate meaningful revenue from customer use of IPSIPay is limited, given the relatively recent commencement of launch activities, the relatively limited app downloads and active users achieved to date and our launch promotional activities. While we see great potential for our product offerings in our initial target markets as described above, both the near- and long-term viability of our business is dependent in large part on our ability to scale our IPSIPay business and add complimentary offerings (such as our telemedicine collaboration with MeMD (also known as Walmart Health Virtual Care), which we announced in October 2022), all with the goal of increasing app downloads and active users who would generate transaction processing and other fees for our company.

 

We generated nominal IPSIPay-related revenue during the first quarter of 2023, with the goal of increasing revenues over time. In the current environment, it has proven to take longer to win a customer’s trust and resulting fee generating usage of our apps.  This is especially true when it relates to the unbanked and underserved sending money abroad.  We initiated an aggressive digital marketing campaign late in the third quarter of 2022, and have since achieved over 50,000 downloads of IPSIPay and seen a steady growth of the issuance of debit Visa cards via IPSIPay.  While we have not seen any significant revenue from these endeavors, we believe the brand we are building and the impressions we have recorded should help us grow the awareness and use of our apps during 2023. Our ability to reach sufficient scale of our business and generate sufficient revenue is, however, unproven and speculative at this time, so we remain faced with all of the risks associated with launching and seeking to scale a new business. If we are unable to grow our IPSIPay business, our company could be severely harmed or could fail.

 

In May 2023, we publicly announced a new line of business called IPSIPay Express, a three-way joint venture with payment industry veterans OpenPath and eFinityPay to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. As of the date of this Report, the definitive documentation memorializing this joint venture remains in the process of being finalized. While we believe the IPSIPay Express opportunity has great promise, no assurances can be given that IPSIPay Express will be successfully launched or will generate revenues or otherwise have a positive impact on our results of operations.

 

Also, May 12, 2023, we entered into an agreement with one of our technology partners, Frictionless Financial Technologies, Inc. (“Frictionless”), to, among other things, divest ourselves of our interest in Frictionless and in Beyond Fintech, Inc., a joint venture entity we owned with Frictionless which has been developing an application called Beyond Wallet. See Note 15 to the accompanying financial statements for further information.

 

25

 

 

COVID-19

 

The novel coronavirus (“COVID-19”) pandemic has resulted in government authorities and businesses throughout the world implementing numerous measures intended to contain and limit the spread of COVID-19, including travel restrictions, border closures, quarantines, shelter-in-place and lock-down orders, mask and social distancing requirements, and business limitations and shutdowns. The spread of COVID-19 and increased variants has caused, and may continue to cause us to make significant modifications to our business practices, including enabling most of our workforce to work from home, establishing strict health and safety protocols for our offices, restricting physical participation in meetings, events, and conferences, and imposing restrictions on employee travel. We will continue to actively monitor the situation and may take further actions that alter our business practices as may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, or business partners.

 

The rapidly changing global market and economic conditions as a result of the COVID-19 pandemic have impacted, and are expected to continue to impact, our operations and business. For example, COVID-19 related issues has caused a delay in our ability to launch our products and services. The broader implications of the COVID-19 pandemic and related global economic unpredictability on our business, financial condition, and results of operations remain uncertain.

 

Russia’s Invasion of Ukraine

 

In February 2022, Russia invaded Ukraine, with Belarus complicit in the invasion. As of the date of this report, the conflict between these two countries is ongoing. We do not have any direct or indirect exposure to Ukraine, Belarus or Russia, through our operations, employee base or any investments in any of these countries. In addition, our securities are not traded on any stock exchanges in these three countries. We do not believe that the sanction levied against Russia or Belarus or individuals and entities associated with these two countries will have a material impact on our operations or business, if any. Further, we do not believe that we have any direct or indirect reliance on goods sourced from Russia, Ukraine or Belarus or countries that are supportive of Russia.

 

We have commercially launched our e-wallet platforms which provide online money transfer and payment services to our customers which may expose us to cybersecurity risks. We employ the latest encryption techniques and firewall practices and constantly monitor the usage of our software, however, this may not be sufficient to prevent the heightened risk of cybersecurity attacks emanating from Russia, Ukraine, Belarus, or any other country.

 

The impact of the invasion by Russia of Ukraine has increased volatility in stock trading prices and commodities throughout the world. To date, we have not seen a material impact on our operations; however, a prolonged conflict may impact on consumer spending, in general, which could have an adverse impact on the payment services industry as a whole and our business.

 

Inflation

 

Macro-economic conditions could affect consumer spending adversely and consequently our future operations when we fully launch our e-wallet products commercially. The U.S. has entered a period of significant inflation, and this may impact consumer’s desire to adopt our products and services and may increase our costs overall. However, as of the date of this report, we do not expect there to be any material impact on our liquidity as forecast in our business plan due to recent inflationary concerns in the U.S.

 

Foreign Exchange Risks

 

We intend to operate in several foreign countries, including Mexico. Changes and fluctuations in the foreign exchange rate between the US Dollar and other foreign currencies, including the Mexican Peso, may in future have an effect our results of operations.

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

 

26

 

 

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

  Conversion prices;

 

  Current market prices of our equity

  

  Risk free interest rates;

 

  Expected remaining life of the derivative liability;

 

  Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

 

Impairment of Investments and Intangible assets

 

We carried investments of $500,000 and Intangible assets of $1,631,739 as more fully described in Notes 4 and 5 to the accompanying condensed consolidated financial statements. The Company tests its investments and intangible assets with an indefinite useful life annually for impairment or more frequently if indicators for impairment exist. The value of our Investments and intangibles is based upon our mutual goal of providing payment services to an underserved market. Currently our investments or our intangible assets have not produced any revenues on which to assess whether the income generated from these assets can support the carrying value of these assets. For impairment testing of investments and intangibles we determine the fair value of the underlying assets using an income-based approach which estimates the fair value using a discounted cash flow model. Key assumptions in estimating fair values include projected revenue growth and the weighted average cost of capital. In addition, management recently reviewed the future revenue and profit projections of our e-wallet services based on management forecasts of the size of the market and expected customer growth and retention, we determined that no impairment charges were necessary, however if we are unable to achieve our forecasts once operations begin, we may need to re-evaluate our forecasts which could result in an impairment charge. Since performing this analysis we have no reason to believe that further impairment is necessary as of March 31, 2023.

 

Results of Operations

 

Results of Operations for the Three Months Ended March 31, 2023 and 2022

 

Net revenue

 

We recorded minimal revenues of $433 during the three months ended March 31, 2023 and we did not have revenues during the three months ended March 31, 2022. Our goal is to increase revenue as our product becomes more widely used and we are exploring different market segments to increase our revenue from our e-wallets. We have utilized financial promotional strategies to encourage downloads and use of IPSIPay, which has reduced our ability to generate revenues in the near term while such strategies are in effect.

 

Cost of goods sold

 

Cost of goods sold was $2,085 for the three months ended March 31, 2023 and consists primarily of bank and merchant related fees and chargebacks. We had no cost of goods sold, as we did not have revenues during the three months ended March 31, 2022.

 

General and administrative expenses

 

General and administrative expenses were $965,207 and $869,387 for the three months ended March 31, 2023 and 2022, respectively, an increase of $95,820 or 11.0%. The increase is primarily due to the following:

 

  (i)

Professional fees was $240,136 and $63,966 for the three months ended March 31, 2023 and 2022, respectively, an increase of $176,170 or 275.4%. The increase is primarily due to the increase in fees from Frictionless related to operating the payment platform which was launched in the second quarter of the prior year.

 

27

 

 

  (ii)

Legal fees was $135,523 and $35,369 for the three months ended March 31, 2023 and 2022, respectively, an increase of $100,154 or 283.2%. The increase is primarily due to a lawsuit filed against the company at the end of the first quarter in the prior year and other general corporate legal fees related to financing and corporate structure.

     
  (iii)

Selling and marketing expenses was $169,958 and $118,677 for the three months ended March 31, 2023 and 2022, respectively, an increase of $51,281 or 43.2%. The increase is primarily related to the Lopez endorsement agreement entered into during the third quarter of the prior year to facilitate the launch of the IPSIPay wallet, this was offset by a reduction in social media activity during the current period.

     
  (iv) Payroll expenses was $279,764 and $377,596 for the three months ended March 31, 2023 and 2022, respectively, a decrease of $97,832 or  25.9%. The decrease is primarily due to the reduction in head count of 2 over the prior period and the amortization of restricted stock in the prior year of $62,766, which was fully vested on January 1, 2023.
     
  (v) Other general and administrative expenses was $25,942 and $174,294 for the three months ended March 31, 2023 and 2022, respectively, a decrease of $148,352 or 85.1%. The decrease includes a decrease in audit fees of $105,000 due to the timing of billing, a reduction in directors fees of $16,500 due to the resignation of a director in the fourth quarter of the prior year and the reduction in directors fees by $3,000 per quarter per director and a reduction in investor relations expense of $22,500, no investor relations expenditure was incurred during the current period. 
     
  (iv) The balance of the general and administrative expenses decreased by $14,399, which is made up of several individually insignificant expenses.

 

Depreciation

 

Depreciation was $140,690 and $4,496 for the three months ended March 31, 2023 and 2022, respectively, an increase of $136,194 or 3,029.2%, primarily due to the amortization of the IPSIPay platform which commenced during the third quarter of the prior year.

 

Penalty on convertible notes

 

Penalty on convertible notes was $0 and $719,558 for the three months ended March 31, 2023 and 2022, a decrease of $719,558 or 100.0%. The decrease is due to the repayment of one convertible note and the modification of the maturity date of two convertible notes in the prior period, resulting in the triggering of the repayment penalty per the convertible note agreements as well as an additional 10% penalty for the extension of the maturity date.

 

Interest expense, net

 

Interest expense was $85,221 and $45,766 for the three months ended March 31, 2023 and 2022, respectively, an increase of $39,455 or 86.2%. The increase is due to: (i) the issuance of promissory notes in the aggregate principal amount of $964,000 in exchange for certain warrants on December 30, 2022, which promissory notes bear interest at 10% per annum; (ii) the issuance of convertible debt with an aggregate principal amount of $535,000 during February 2023, bearing interest at 8% per annum; and (iii) the penalty and capitalization of interest on the extension of the maturity of certain convertible notes during 2022, resulting in an increase in the interest charge during the current period.

 

Amortization of debt discount

 

Amortization of debt discount was $22,967 and $263,200 for the three months ended March 31, 2023 and 2022, respectively, a decrease of $240,233 or 91.3%. The decrease is primarily due to the complete amortization of debt discount on convertible notes issued on February 2021, offset by amortization of debt discount on the convertible notes issued during February of the current period.

 

Derivative liability movements

 

Derivative liability movements were $(940,750) and $(92,161) for the three months ended March 31, 2023 and 2022, respectively, an increase of $(848,589) or 920.8%. The derivative liability arose due to the issuance of convertible securities with a fundamental transaction clause allowing for a cash settlement of the convertible note and the associated warrants at the option of the holder. The charge during the current period represents the reduction in the mark -to -market value of the derivative liability outstanding as of March 31, 2023.

 

Net loss

 

Net loss was $274,987 and $1,810,246 for the three months ended March 31, 2023 and 2022, respectively, a decrease in loss of $1,535,259 or 84.8%. The decrease is primarily due to the increase in the derivative liability movements, the decrease in the penalty on convertible debt and the decrease in the amortization of debt discount, offset by an increase in general and administrative expenses, depreciation expense and interest expense, as discussed above.

 

28

 

 

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of $52,673,248 through March 31, 2023 and incurred negative cash flow from operations of $688,304 for the three months ended March 31, 2023. Our primary focus is on launching and operating e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely, which will require us to spend, substantial amounts in connection with implementing our business strategy.

 

At March 31, 2023, we had cash of $155,868 and working capital deficit of $5,892,017 including a derivative liability of $1,609,892. After eliminating the derivative liability our working capital deficit is $4,282,125. Subsequent to March 31, 2023, on May 10, 2023 we raised $104,750 through the issuance of a promissory note to an institutional investor.

 

We utilized cash of $688,304 and $760,918 in operations for the three months ended March 31, 2023 and 2022, respectively. Overall cash utilized in operations decreased by $72,614, due to cost containment to preserve cash balances.

 

We invested a further $64,783 in our e-wallet platforms to enhance the product offering and to further develop the Beyond Wallet application. As of the date of this Report, we have entered into an agreement to divest ourselves of our interest in Beyond Fintech and the Beyond Wallet application (see Note 15 to the accompanying financial statements for further information).

 

We generated cash of $534,191 during the current period primarily $535,000 from convertible notes issued to investors to bridge our working capital needs and minor repayments of $809 on federal relief loans during the current period. Cash utilized in financing activities for the three months ended March 31, 2022 was the repayment of a convertible note of $1,147,063.

 

At March 31, 2023, we had outstanding notes in the principal amount of $2,861,339 ($2,632,451 net of debt discount of $228,888). The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rates of 8% to 10% per annum. and are convertible into our common stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

We expect to restrict our investment in our e-wallet products, capital expenditure is expected to be less than $100,000 during the next twelve month period.

 

However, given our losses and negative cash flows, we will be required to raise significant additional funds to progress our business as planned by issuing equity or equity-linked securities. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off balance sheet financing arrangements as of the date of this report.

 

29

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures

 

Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (“Exchange Act”), our management carried out an evaluation, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures as of March 31, 2023 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

 

(b) Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended March 31, 2023.

 

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

 

30

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of our outstanding pending litigation matters. Litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business.

 

Voloshin v. Innovative Payment Solutions, Inc.

 

On October 20, 2021, a complaint was filed against our company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees of our company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

 

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez; they appealed that decision. We moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion.

 

On May 25, 2022, the parties held a mediation in an attempt to resolve the matters. The mediation was unsuccessful.

 

On October 26, 2022, OSHA scheduled a hearing on Ms. Rey’s and Mr. Perez’s appeal for April 5, 2023. On November 8, 2022, the claimants’ counsel informed us that all five claimants intended to exercise their right to file a lawsuit in federal court and asked if we would stipulate to dismissal of Rey’s and Perez’s OSHA claims without prejudice. We agreed and a stipulation of dismissal without prejudice was filed on November 10, 2022.

 

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against IPSI and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, inter alia, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and IPSI. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802

 

Defendants moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings are stayed until the motion to compel arbitration is heard and decided. The hearing for the motion to compel arbitration was scheduled for May 4, 2023. The court held its ruling in abeyance to allow limited discovery and additional briefing. Another hearing is expected to be held in mid-June 2023.

 

We may engage in alternative dispute resolution with the plaintiffs but there can be no assurance that these efforts will be successful. While the outcome of the anticipated civil action is uncertain at this point, we intend to vigorously defend against the action.

 

31

 

 

Minkovich v. Corbett, et al.

 

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (I) breach of contract; (II) nonpayment of wages; (III) waiting time penalties; (IV) failure to indemnify for alleged employee business expenses; (V) violation of Section 17200 of the California Business and Professional Code; and (VI) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our company.

 

We are vigorously defending these claims, which are premised upon a putative three-year employment agreement that is not signed by our company or Mr. Corbett, and which Minkovich admits in his complaint that we expressly refused to sign.

 

We and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett have appealed that decision to the California Court of Appeal. As a result of the appeal, the court case is stayed until the appeal is decided, which we expect to take at least six months. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we and Mr. Corbett filed has yet to be decided and will not be decided unless the court’s decision is sustained on appeal. Otherwise, the case shall proceed to arbitration. Our opening brief in the appeal is due on May 19, 2023.

 

Other than as set forth above, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Item 1A. Risk Factors.

 

Not applicable to smaller reporting companies.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

(a) Between February 13, 2023 and February 17, 2023, we entered into Securities Purchase Agreements with 7 accredited investors, pursuant to which we received an aggregate of $535,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

Convertible Notes Promissory (the “Notes” and each a “Note”); and

 

five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 36,956,521 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

(b) On May 10, 2023, we entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which we issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to us of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. We are required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion.

 

The securities described above were sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Rule 506(b) of Regulation D promulgated thereunder. The Investors are accredited investors who have purchased the securities as an investment in a private placement that did not involve a general solicitation.  The Common Stock to be issued upon conversion of the Notes or the 1800 Note and the exercise of the Warrants have not been registered under the Securities Act and may not be offered or sold in the United States in the absence of an effective registration statement or exemption from the registration requirements.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None. 

 

32

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
10.1*   Agreement, dated May 12, 2023, by and between Frictionless Financial Technologies, Inc. and the Company
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

* Filed herewith

 

33

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
   

Date: May 15, 2023

By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: May 15, 2023

By: /s/ Richard Rosenblum
    Richard Rosenblum
    President & Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

 

34

 

 

Innovative Payment Solutions, Inc. 0.00 0.00 376901679 376901679 false --12-31 Q1 0001591913 0001591913 2023-01-01 2023-03-31 0001591913 2023-05-10 0001591913 2023-03-31 0001591913 2022-12-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 qpag:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 qpag:QpagosCorporationsCapitalStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2019-11-01 0001591913 2019-11-01 0001591913 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 qpag:GastonPereiraMember 2019-12-31 0001591913 qpag:AndreyNovikovMember 2019-12-31 0001591913 qpag:JosephAbramsMember 2019-12-31 0001591913 qpag:FrictionlessMember 2021-06-22 0001591913 qpag:FrictionlessMember 2023-03-31 0001591913 qpag:FrictionlessMember 2023-01-01 2023-03-31 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2023-03-31 0001591913 qpag:BeyondFintechMember 2021-08-01 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:BeyondFintechIncMember 2023-03-31 0001591913 qpag:KiosksMember 2023-03-31 0001591913 us-gaap:ComputerEquipmentMember 2023-03-31 0001591913 us-gaap:OfficeEquipmentMember 2023-03-31 0001591913 2022-01-01 2022-12-31 0001591913 2021-01-01 2021-12-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2023-01-01 2023-03-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2023-03-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2022-12-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2023-01-01 2023-03-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2023-03-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2022-12-31 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2023-01-01 2023-03-31 0001591913 qpag:InvestmentInFrictionlessFinancialTechnologiesIncMember 2023-03-31 0001591913 qpag:InvestmentInFrictionlessFinancialTechnologiesIncMember 2022-12-31 0001591913 2023-01-01 2023-01-01 0001591913 2020-07-01 2020-07-07 0001591913 2021-02-10 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:December302022NoteMember 2021-02-16 0001591913 qpag:December302022NoteMember 2021-02-10 2021-02-16 0001591913 qpag:CavalryFundILPMember 2023-03-31 0001591913 qpag:CavalryFundILPMember 2023-01-01 2023-03-31 0001591913 qpag:CavalryFundILPMember 2022-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 2021-02-01 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-01 2021-02-16 0001591913 2022-02-01 2022-02-03 0001591913 qpag:CavalryAndMercerMember 2022-02-03 0001591913 2022-02-03 0001591913 qpag:CavalryAndMercerMember 2022-02-01 2022-02-03 0001591913 srt:MinimumMember qpag:CavalryAndMercerMember 2023-03-31 0001591913 srt:MaximumMember qpag:CavalryAndMercerMember 2023-03-31 0001591913 qpag:CavalryAndMercerMember 2023-01-01 2023-03-31 0001591913 2022-12-01 2022-12-28 0001591913 qpag:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 srt:MinimumMember 2023-03-31 0001591913 srt:MaximumMember 2023-03-31 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-11-16 0001591913 qpag:CavalryFundILPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember qpag:CavalryFundILPMember 2022-11-16 0001591913 srt:MaximumMember qpag:CavalryFundILPMember 2022-11-16 0001591913 qpag:CavalryFundILPMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 srt:MaximumMember qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-03-31 0001591913 2023-02-01 2023-02-23 0001591913 2023-02-01 2023-02-13 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:CavalryAndMercerMember 2023-03-31 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember 2023-01-01 2023-03-31 0001591913 2022-10-01 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 us-gaap:CommonStockMember 2022-08-01 2022-08-30 0001591913 2022-08-02 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 2022-12-01 2022-12-30 0001591913 qpag:DebtConversionNoticesMember 2021-02-01 2021-02-23 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember 2023-03-31 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember 2023-01-01 2023-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember srt:MaximumMember 2023-03-31 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-01 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-01 2022-09-13 0001591913 2022-09-13 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalRestrictedSharesMember 2023-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2023-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:ExercisePrice0049Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePriceRange5Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice0055Member 2023-01-01 2023-03-31 0001591913 qpag:WarrantsMember 2023-03-31 0001591913 srt:MinimumMember qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2023-03-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-03-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-03-31 0001591913 qpag:ExercisePrice00115Member 2023-03-31 0001591913 qpag:ExercisePrice00115Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice00345Member 2023-03-31 0001591913 qpag:ExercisePrice00345Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice015Member 2023-03-31 0001591913 qpag:ExercisePrice015Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice0187Member 2023-03-31 0001591913 qpag:ExercisePrice0187Member 2023-01-01 2023-03-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 us-gaap:StockOptionMember 2023-03-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice004Member 2023-03-31 0001591913 qpag:ExercisePrice004Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice024Member 2023-03-31 0001591913 qpag:ExercisePrice024Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice040Member 2023-03-31 0001591913 qpag:ExercisePrice040Member 2023-01-01 2023-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-03-31 0001591913 qpag:StockOptionsMember 2023-01-01 2023-03-31 0001591913 qpag:StockOptionsMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 qpag:JamesFullerMember 2022-09-01 2022-09-13 0001591913 qpag:JamesFullerMember 2023-01-01 2023-03-31 0001591913 qpag:JamesFullerMember 2022-01-01 2022-12-31 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 qpag:WilliamCorbettMember 2023-01-01 2023-03-31 0001591913 qpag:WilliamCorbettMember 2022-01-01 2022-12-31 0001591913 qpag:CliffordHenryMember 2023-01-01 2023-03-31 0001591913 qpag:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-01-01 2022-12-31 0001591913 qpag:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-09-13 0001591913 qpag:MadissonCorbettMember 2023-01-01 2023-03-31 0001591913 qpag:MadissonCorbettMember 2022-01-01 2022-12-31 0001591913 qpag:DavidRiosMember 2022-09-01 2022-09-13 0001591913 qpag:DavidRiosMember 2022-09-13 0001591913 qpag:DavidRiosMember 2023-01-01 2023-03-31 0001591913 qpag:DavidRiosMember 2022-01-01 2022-12-31 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-07-11 0001591913 qpag:RichardRosenblumMember 2022-07-11 0001591913 qpag:RichardRosenblumMember 2023-01-01 2023-03-31 0001591913 qpag:RichardRosenblumMember 2022-01-01 2022-12-31 0001591913 us-gaap:SubsequentEventMember 2023-05-10 0001591913 srt:ScenarioForecastMember 2023-06-01 2023-06-15 0001591913 srt:ScenarioForecastMember 2023-06-15 0001591913 us-gaap:SubsequentEventMember 2023-05-01 2023-05-11 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-10.1 2 f10q0323ex10-1_innovativepay.htm AGREEMENT, DATED MAY 12, 2023, BY AND BETWEEN FRICTIONLESS FINANCIAL TECHNOLOGIES, INC. AND THE COMPANY

Exhibit 10.1

 

AGREEMENT

 

This Agreement (the “Agreement”) is made and entered into as of this 12th day of May, 2023 by and between FRICTIONLESS FINANCIAL TECHNOLOGIES, INC., a Delaware corporation (“FFT”) and INNOVATIVE PAYMENT SOLUTIONS, INC., a Nevada corporation (“IPSI”).

 

RECITALS

 

WHEREAS, FFT and IPSI entered into that certain Stock Purchase Agreement dated as of June 22, 2021 (the “SPA”); and

 

WHEREAS, pursuant to the provisions of the SPA, IPSI purchased 150 shares of common stock of FTT (the “FFT Shares”) for $500,000 (the “FFT Shares Purchase Price”), representing ten percent (10%) of the outstanding shares of common stock of FFT; and

 

WHEREAS, pursuant to the provisions of Section 7.4 of the SPA, IPSI is obligated to issue to FFT a non-restricted non-dilutable 5 year warrant to purchase 30,000,000 shares of IPSI common stock (the “Warrant”); and

 

WHEREAS, pursuant to Section 7.6 of the SPA, IPSI has been granted the right to acquire an additional 41% of the issued and outstanding shares of common stock of FFT at $300,000 for each 1% of the outstanding FFT Shares issued (the “IPSI Option”); and

 

WHEREAS, IPSI is the record owner of 765 shares of capital stock of Beyond Fintech, Inc., a Delaware corporation (“Fintech”), constituting 51% of the issued and outstanding shares of capital stock of Fintech (the “Fintech Shares”); and

 

WHEREAS, FFT and IPSI are parties to that certain SaaS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (including its exhibits and attachments, the “SAAS Agreement”), pursuant to which FFT has provided certain information technology, supplier access, billing and rating technology, mobile wallet/debit card enablement, back-office support services, customer service, and consulting services to IPSI (as further defined in the SAAS Agreement, the “Services”) related to IPSI’s IPSIPay® mobile application (“IPSIPay”); and

 

WHEREAS, as a result of extensive discussions and negotiations between FFT and IPSI, it has been decided that it is in the mutual best interests of both parties to disengage their various ownership interests and designated other rights, with the result that, from and after the Closing Date, the sole relationship between FFT and IPSI, and their respective Affiliates, shall be one where FFT and its Affiliates are strictly providers of Services to IPSI under the SAAS Agreement.

 

NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows.

 

 

 

 

ARTICLE I

RECITALS AND DEFINITIONS

 

1.1Recitals. The Recitals set forth above are incorporated herein in their entirety by this reference, and this Agreement shall be interpreted in light thereof.

 

1.2Definitions. Each initially-capitalized term used but not defined has the meaning set forth below in this Section 1.2.

 

Affiliate” means, with respect to any specified Person, any Person that directly or indirectly controls, is directly or indirectly controlled by or is directly or indirectly under common control with such specified Person. As used in this definition, “control” (including “controlled by’ and “under common control with” ) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise and shall be construed as such term is used in the rules promulgated under the Securities Act of 1933.

 

Business Day” means any day other than a Saturday or Sunday or any other day on which banks in Boston, Massachusetts or San Francisco, California are permitted or required to be closed.

 

Closing Date” means the date on which the Closing actually takes place, but in no event later than May 15, 2023.

 

Governmental Entity” means any federal, state or local department, agency or governing or regulatory body or self-regulatory organization (including any stock exchange) in the United States or any foreign country which has jurisdiction over a party hereto or its Affiliate.

 

Person” means an individual, partnership, corporation, business trust, limited liability company, limited liability partnership, joint stock company, trust, estate, unincorporated association, joint venture or other entity or Governmental Entity.

 

ARTICLE II

FFT SHARES, THE WARRANT AND THE IPSI OPTION

 

2.1 Assignment and Transfer of FFT Shares. At the Closing on the Closing Date, and in consideration of the benefits received or to be received by IPSI pursuant to this Agreement, IPSI shall assign and transfer to FFT the FFT Shares free and clear of any and all taxes, charges, impositions, purchase rights, liens, claims, equities, security interests or encumbrances. Such transfer and assignment shall be effectuated by IPSI’s execution and delivery to FFT of an Assignment in the form of Exhibit 1 attached hereto.

 

2

 

 

2.2 Cancellation of the Warrant. At the Closing on the Closing Date, without the requirement of any action by FFT or any other person or entity, and subject to the performance of the transfer obligation of IPSI set forth in Section 2.1 above, the Warrant and all rights of FTT under the SPA to any warrant or other securities of IPSI or its Affiliates or subsidiaries as provided for in the SPA or otherwise shall be deemed automatically cancelled and terminated in its entirety and of no further force or effect, and such cancellation shall be deemed to be in full payment and consideration for the transfer to FFT of the FFT Shares and further in consideration of the benefits received or to be received by FFT pursuant to this Agreement.

 

2.3 The IPSI Option. In addition to the cancellation of the Warrant constituting payment and consideration for the FFT Shares, the cancellation of the Warrant is also deemed to constitute full and complete payment and consideration for the cancellation of the IPSI Option. At the Closing on the Closing Date, without the requirement of any action by IPSI or any other person or entity, the IPSI Option shall be deemed automatically cancelled in its entirety and of no further force or effect.

 

ARTICLE III

THE FINTECH SHARES

 

3.1 The Fintech Shares. At the Closing on the Closing Date IPSI shall transfer and assign to FFT the Fintech Shares free and clear of any and all taxes, charges, impositions, purchase rights, liens, claims, security interests, equities and encumbrances. The transfer and assignment of the Fintech Shares shall be effectuated by the execution and delivery by IPSI to FFT of an Assignment in the form of Exhibit 1 attached hereto.

 

3.2 Purchase Price and Method of Payment for the Fintech Shares. The purchase price for the Fintech Shares is $250,000 United States Dollars (the “Fintech Shares Purchase Price”). The Fintech Shares Purchase Price shall not bear interest and shall be paid in the form of a 20% credit against invoices issued by FFT or its Affiliates to IPSI or its Affiliates for work done under the SAAS Agreement between the Closing Date and the 18 month anniversary of the Closing Date (the “Anniversary Date”) until the Fintech Shares Purchase Price is paid in full; provided, however, that FFT may, at any time and in its sole discretion accelerate payment of all or any portion of the Fintech Shares Purchase Price with payments to IPSI in cash. Anything herein to the contrary notwithstanding, if the 20% credits contemplated in this Section 3.2 shall be insufficient to pay the Fintech Shares Purchase Price in full on or before the Anniversary Date, then any unpaid balance of the Fintech Shares Purchase Price as of the Anniversary Date shall be deemed immediately and irrevocably cancelled and forgiven and neither FFT nor any of its Affiliates shall be deemed to have any further obligation with respect thereto.

 

3

 

 

ARTICLE IV

ADDITIONAL COVENANTS AND AGREEMENTS

 

4.1 Right to Provide Financing. Effective with the consummation of the Closing on the Closing Date, and without the requirement of any action by FFT, IPSI, or any other Person, Section 7.6.1 of the SPA shall be deemed immediately and irrevocably deleted and of no further force or effect, so that IPSI shall no longer have the right to participate in any future financing activity of FFT.

 

4.2 Appointment of Director. IPSI acknowledges that, upon the consummation of the Closing on the Closing Date, IPSI shall no longer be the record or beneficial owner of shares of FFT and, as a result thereof, IPSI shall no longer have any right to appoint any individual to serve as its representative on the Board of Directors of FFT pursuant to Section 7.5 of the SPA.

 

4.3 No Continuing Interest by IPSI or its Affiliates. IPSI, on its own behalf and on behalf of each of its Affiliates and as it relates to any of FFT, Fintech or any of their respective Affiliates, acknowledges and agrees that, upon the consummation of the Closing on the Closing Date, it shall have no claim to, or interest in, any portion of FFT’s, Fintech’s or any of their respective Affiliate’s assets (whether tangible, intangible or mixed), rights, privileges, options, proceeds, or business opportunities in development or operation, and whether currently existing or hereafter arising. IPSI further acknowledges and agrees that, except for FFT’s obligation to pay the purchase price for shares hereunder, or FFT’s obligations to provide Services under the SAAS Agreement, neither FFT nor Fintech, nor any of their respective Affiliates, is obligated to IPSI or any of its Affiliates for any amount, performance or other obligation of any type or description.

 

4.4 No Continuing Interest by FFT or its Affiliates. FFT, on its own behalf and on behalf of each of its Affiliates and as it relates to any of IPSI or any of its Affiliates, acknowledges and agrees that, upon the consummation of the Closing on the Closing Date, it shall have no claim to, or interest in, any portion of IPSI or its Affiliate’s assets (whether tangible, intangible or mixed), rights, privileges, options, proceeds, or business opportunities in development or operation, and whether currently existing or hereafter arising.

 

4.5 Release by IPSI and its Affiliates. Except with respect to (a) the payment and performance obligations of FFT set forth in this Agreement or (b) the payment or performance obligations of FFT under the SAAS Agreement or (c) the right to enforce this Agreement or the SAAS Agreement, all of which are expressly not waived or released by this Section 4.5, IPSI, on its own behalf and on behalf of each of its Affiliates, fully and forever waives, releases and discharges FFT and its past and current officers, directors, employees, shareholders, agents and attorneys, from any and all claims, demands, actions, causes of action, obligations, judgments, rights, fees, damages, debts, obligations, liabilities, and expenses (inclusive of attorneys’ fees) of any kind whatsoever, whether known or unknown, from the beginning of time to the Closing Date.

 

4.6 Release by FFT and its Affiliates. Except with respect to (a) the payment and performance obligations of IPSI set forth in this Agreement or (b) the payment or performance obligations of IPSI under the SAAS Agreement or (c) the right to enforce this Agreement or the SAAS Agreement, all of which are expressly not waived or released by this Section 4.6, FFT, on its own behalf and on behalf of its Affiliates, fully and forever waives, releases and discharges IPSI and its past and current officers, directors, employees, agents and attorneys from any and all claims, demands, actions, causes of actions, obligations, judgments, rights, fees, damages, debts, obligations, liabilities and expenses (inclusive of attorneys’ fees) of any kind whatsoever, whether known or unknown, from the beginning of time to the Closing Date.

 

4

 

 

ARTICLE V

REPRESENTATIONS AND WARRANTIES BY IPSI

 

5.1 Representations and Warranties of IPSI. IPSI hereby makes the following representations and warranties to FFT as of the date hereof and as of the Closing Date as though made at the Closing Date:

 

5.1.1 Organization. IPSI is a corporation duly organized, validly existing and in good standing under the laws of the State of Nevada, and has the requisite corporate power and authority to own, lease and operate its assets and properties, and to carry on its business as it is now being conducted.

 

5.1.2 Power and Authority. IPSI has all necessary corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by IPSI and the consummation by IPSI of the transactions contemplated hereby that are applicable to IPSI have been duly and validly authorized and approved by all necessary corporate action on the part of IPSI, and no other corporate proceedings on the part of IPSI are necessary to authorize and approve this Agreement or to consummate the transactions contemplated hereby. This Agreement has been duly and validly executed by IPSI and, assuming the execution and delivery of this Agreement by FFT, constitutes legal and binding obligations of IPSI, enforceable against IPSI in accordance with its terms.

 

5.1.3 No Conflict; Required Filings and Consents. The execution and delivery of this Agreement by IPSI does not, and the performance of IPSI’s obligations hereunder will not, (i) conflict with or violate the Articles of Incorporation or Bylaws or equivalent organizational documents of IPSI, or (ii) require any consent, approval, authorization or permit of, or registration, filing with or notification to, any Governmental Entity, except for applicable requirements, if any, of the Securities Act of 1933 , as amended, the Securities Exchange Act of 1934, as amended, state securities laws, and the rules and regulations promulgated under each such act or state law.

 

5.1.4 Ownership of FFT Shares and Fintech Shares. IPSI is the record and beneficial owner of the FFT Shares and the Fintech Shares free and clear of any and all taxes, charges, impositions, purchase rights, liens, claims, security interests, equities or encumbrances.

 

5.2 Representations and Warranties of FFT. FFT hereby makes the following representations and warranties to IPSI (as regards the Warrant, the FFT Shares and the Fintech Shares):

 

5.2.1 Organization. FFT is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, and has the requisite corporate power and authority to own, lease and operate its assets and properties, and to carry on its business as it is now being conducted.

 

5

 

 

5.2.2 Power and Authority. FFT has all necessary corporate power and authority to execute and deliver this Agreement and to perform its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery by FFT of this Agreement and the consummation by FFT of the transactions contemplated hereby have been duly and validly authorized and approved by all necessary corporate action on the part of FFT, and no other corporate proceedings on the part of FFT are necessary to authorize and approve the execution and delivery of this Agreement by FFT or the consummation by FFT of the transactions contemplated hereby. This Agreement has been duly and validly executed by FFT and, assuming the execution and delivery of this Agreement by IPSI, constitutes legal and binding obligations of FFT, enforceable against FFT in accordance with its terms.

 

5.2.3 No Conflict; Required Filings and Consents. The execution and delivery of this Agreement does not, and the performance by FFT of its obligations hereunder will not, (i) conflict with or violate the Articles of Incorporation or Bylaws of FFT or equivalent organizational documents of FFT, or (ii) require any consent, approval, authorization or permit of, or registration, filing with or notification to any Governmental Entity.

 

5.2.4 Ownership of the Warrant. FFT is the record and beneficial owner of the Warrant free and clear of any and all taxes, charges, impositions, purchase rights, liens, claims, security interests, equities and encumbrances. FFT has not sold, transferred, hypothecated or assigned all or any portion of or any interest in the Warrant.

 

ARTICLE VI

INDEMNIFICATION

 

6.1 Indemnification of FFT by IPSI. IPSI shall indemnify, defend from any third party claim and hold FFT, as the case may be, harmless from and against any and all losses (including, without limitation, any loss caused by the diminution in value of any asset purchased or acquired by FFT hereunder), damages, liabilities, fees (including, without limitation, expert witness fees, court reporter’s fees and reasonable attorneys’ fees), out of pocket unaffiliated third party costs and expenses FFT shall have suffered, sustained or incurred as a result of, related to or in connection with any breach of representation and warranty by IPSI, or a breach of any covenant or agreement hereunder by IPSI. Any defense of FFT shall be by highly qualified counsel which shall first be approved in writing by FFT. If IPSI shall fail to retain FFT approved counsel within 21 days after the date upon which IPSI receives written notice of a third party claim against FFT, then FFT shall have the right to retain counsel and conduct and control directly the defense against any such third party claim, and IPSI shall remain obligated for the fees, costs and expenses of such counsel pursuant to this indemnification as well as the other obligations imposed by this Section 6.1. No settlement of any third party claim against FFT may be made by IPSI unless (i) it is solely for cash and payable solely by IPSI, and (ii) FFT receives a full general release from the person or entity asserting such third party claim. Any amount owing to FFT by IPSI pursuant to this Section 6.1 shall be payable to FFT within 10 Business Days after the date upon which FFT makes demand therefor in writing, accompanied by a copy of all receipts, invoices and other evidence of obligation or payment reasonably necessary to support such demand for payment. Any amount payable to FFT pursuant to this indemnification which is not paid when due shall bear interest at the rate of 10% per annum until it is paid in full along with any accrued but unpaid interest.

 

6.2 Indemnification of IPSI by FFT. FFT shall indemnify, defend from any third party claim and hold IPSI, as the case may be, harmless from and against any and all losses, damages, liabilities, fees (including, without limitation, expert witness fees, court reporters’ fees and reasonable attorneys’ fees), unaffiliated third party costs and expenses IPSI shall have suffered, sustained or incurred as a result of, related to or in connection with any breach of representation and warranty by FFT hereunder or any breach by FFT of any covenant or agreement by FFT hereunder. The provisions of Section 6.1 respecting third party claims, the payment of any indemnification obligation and interest upon any unpaid indemnification obligation shall be fully applicable pursuant to this Section 6.2, substituting only IPSI for FFT, where applicable.

 

6

 

 

ARTICLE VII

CLOSING DELIVERIES

 

7.1 Closing Deliveries of IPSI. At the Closing on the Closing Date, and as a condition to the effectiveness of the transactions contemplated by this Agreement, IPSI shall deliver to FFT each of the following:

 

7.1.1 A certificate evidencing the FFT Shares, duly registered in the name of IPSI;

 

7.1.2 An Assignment of the FFT Shares to FFT, duly executed and dated by an officer of IPSI, in the form of Exhibit 1 attached hereto;

 

7.1.3 A certificate evidencing the Fintech Shares, duly registered in the name of IPSI,; and

 

7.1.4. An Assignment of the Fintech Shares to FFT, duly executed and dated by an officer of IPSI, in the form of Exhibit 1 hereto; and

 

7.1.5 A complete copy of resolutions or unanimous written consent to adopted by the Board of Directors of IPSI authorizing and approving the execution and delivery of this Agreement to FFT and the performance of all of IPSI’s obligations set forth herein, accompanied by a Secretary’s Certificate of IPSI, dated as of the Closing Date and duly executed by the Secretary of IPSI, certifying to FFT that such resolutions were duly adopted by the Board of Directors of IPSI, are in full force and effect on the Closing Date and have not been modified since the date of adoption.

 

7.2 Closing Deliveries of FFT. At the Closing on the Closing Date, and as a condition to the effectiveness of the transactions contemplated by this Agreement, FFT shall deliver to IPSI a complete copy of resolutions adopted by the Board of Directors of FFT authoring and approving the execution and delivery of this Agreement to IPSI and the performance of all of FFT’s obligations set forth herein, accompanied by a Secretary’s Certificate of FFT, dated as of the Closing Date and duly executed by the Secretary of FFT, certifying to IPSI that such resolutions were duly adopted by the Board of Directors of FFT are in full force and effect on the Closing Date and have not been modified since the date of adoption.

 

ARTICLE VIII

GENERAL PROVISIONS

 

8.1 Expenses. All costs and expenses, including fees and disbursements of counsel, financial advisors, and accountants, incurred in connection with the preparation and execution of this Agreement, or any amendment or waiver hereof, and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

 

8.2 Further Assurances. In connection with this Agreement and the transactions contemplated hereby, each of IPSI and FFT agrees, at the request of the other party hereto to which an obligation is owed or an agreement or acknowledgement given hereunder, to execute and deliver such additional documents, instruments, and assurances and to take such further actions as may be required to carry out the provisions hereof and give effect to the transactions contemplated hereby.

 

7

 

 

8.3 Notices. All notices, requests, consents, claims, demands, waivers, and other communications hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or email of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the respective parties at the following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 8.3):

 

If to FFT:

Frictionless Financial Technologies, Inc.

50 Milk Street, Floor 16

Boston, MA. 02109

E-mail: s.harake@frictionlessft.com

Attention: Chief Executive Officer

 

with a copy to:

Law Office of Stephen A. Landsman

200 East Randolph Street, Suite 5100

Chicago, Illinois 60601

Facsimile: (312) 233-0063

E-mail: lands@landslawpc.com

Attention: Stephen A. Landsman

 

If to IPSI:

Innovative Payment Solutions, Inc.

56 B 5th Street, Lot 1, #AT

Carmel by the Sea, CA. 93921
E-mail: bill@ipsipay.com

Attention: William Corbett

 

with a copy to:

Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, NY 10105
Facsimile: (212) 370-7889
E-mail: lrosenbloom@egsllp.com
Attention: Lawrence A. Rosenbloom

 

Notice received by counsel to any party hereto shall not be deemed effective notice to that party hereunder.

 

8.4 Headings. The headings in this Agreement are inserted for convenience or reference only and are in no way intended to describe, interpret, define, or limit the scope, extent, or intent of this Agreement or any provision of this Agreement.

 

8

 

 

8.5 Severability. If any term or provision of this Agreement is held to be invalid, illegal, or unenforceable under applicable law in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.

 

8.6 Entire Agreement. This Agreement, together with all related Exhibits and Schedules, constitutes the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein and therein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, with respect to such subject matter.

 

8.7 Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs, executors, administrators, successors, and assigns.

 

8.8 No Third Party Beneficiaries . Except as provided in Sections 4.6 and 4.7 hereof, which shall be for the benefit of and enforceable by Persons as described therein, this Agreement is for the sole benefit of the parties hereto (and their respective heirs, executors, administrators, successors, and assigns) and nothing herein, express or implied, is intended to or shall confer upon any other Person, including any creditor of a party hereto, any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

 

8.9 Amendment. No provision of this Agreement may be amended or modified except by an instrument in writing executed by the parties affected by such amendment.

 

8.10 Waiver. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. No waiver by any party shall operate or be construed as a waiver in respect of any failure, breach, or default not expressly identified by such written waiver, whether of a similar or different character, and whether occurring before or after that waiver. No failure to exercise, or delay in exercising, any right, remedy, power, or privilege arising from this Agreement shall operate or be construed as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

 

8.11 Governing Law. All issues and questions concerning the application, construction, validity, interpretation, and enforcement of this Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of Delaware.

 

8.12 Submission to Jurisdiction. The parties hereby agree that any suit, action, or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby, whether in contract, tort, or otherwise, shall be brought in the United States District Court for the District of Delaware or in the Court of Chancery of the State of Delaware (or, if such court lacks subject matter jurisdiction, in the Superior Court of the State of Delaware), so long as one of such courts shall have subject-matter jurisdiction over such suit, action, or proceeding, and that any cause of action arising out of this Agreement shall be deemed to have arisen from a transaction of business in the State of Delaware. Each of the parties hereby irrevocably consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient form. Service of process, summons, notice, or other document by registered mail to the address set forth in Section 8.3 above shall be effective service of process for any suit, action, or other proceeding brought in any such court.

 

9

 

 

8.13 Waiver of Jury Trial. Each party hereto hereby acknowledges and agrees that any controversy which may arise under this Agreement is likely to involve complicated and difficult issues and, therefore, each such party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Agreement or the transactions contemplated hereby.

 

8.14 Equitable Remedies. Each party hereto acknowledges that a breach or threatened breach by such party of any of its obligations under this Agreement would give rise to irreparable harm to the other parties, for which monetary damages would not be an adequate remedy, and hereby agrees that in the event of a breach or a threatened breach by such party of any such obligations, each of the other parties hereto shall, in addition to any and all other rights and remedies that may be available to them in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance and any other relief that may be available from a court of competent jurisdiction (without any requirement to post bond).

 

8.15 Attorneys’ Fees. In the event that any party hereto institutes any legal suit, action, or proceeding against another party in respect of a matter arising out of or relating to this Agreement, the prevailing party in the suit, action, or proceeding shall be entitled to receive, in addition to all other damages to which it may be entitled, the costs incurred by such party in conducting the suit, action or proceeding, including reasonable attorneys’ fees and expenses, and court costs.

 

8.16 Remedies Cumulative. The rights and remedies under this Agreement are cumulative and are in addition to and not in substitution for any other rights and remedies available at law or in equity or otherwise.

 

8.17 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, email, or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

(Signature page follows-no further text)

 

10

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above.

 

  FFT:
   
  Frictionless Financial Technologies, Inc.
     
  By: /s/ Sarmad Harake
  Name:  Sarmad Harake
  Title: CEO
     
  IPSI:
   
  Innovative Payment Solutions, Inc.
     
  By: /s/ William Corbett
  Name: William Corbett
  Title: CEO

 

11

 

 

Exhibit 1

 

Form of Assignment

 

ASSIGNMENT OF SHARES

 

For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, effective immediately the undersigned hereby sells, transfers and assigns to Frictionless Financial Technologies, Inc., a Delaware corporation, __________ shares of common stock in ______________________________, a ________________corporation (“___________”), constituting the undersigned’s entire stock ownership in ____________.

 

IN WITNESS WHEREOF, the undersigned executes and delivers this Assignment of Shares this ___ day of May, 2023.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
     
  By:      
  Name:  
  Its (Title):  

 

ACCEPTED BY:  
   
FRICTIONLESS FINANCIAL TECHNOLOGIES, INC.  
     
By:    
Name: Sarmad Harake  
Its: CEO  

 

 

 

 

 

EX-31.1 3 f10q0323ex31-1_innovativepay.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION OF THE

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William D. Corbett, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15I and 15d-15I) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

  

Date: May 15, 2023 By: /s/ William D. Corbett
    William D. Corbett
   

Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 4 f10q0323ex31-2_innovativepay.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION OF THE

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 15, 2023 By: /s/ Richard Rosenblum
    Richard Rosenblum
   

Chief Financial Officer

(Principal Financial Officer)

 

EX-32.1 5 f10q0323ex32-1_innovativepay.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION OF THE

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc. (the “Company”) for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William D. Corbett, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: May 15, 2023 By: /s/ William D. Corbett
    William D. Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

EX-32.2 6 f10q0323ex32-2_innovativepay.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION OF THE

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc. (the “Company”) for the quarterly period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: May 15, 2023 By: /s/ Richard Rosenblum
    Richard Rosenblum
    Chief Financial Officer
    (Principal Financial Officer)

EX-101.SCH 7 qpag-20230331.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization and Description of Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Accounting Policies and Estimates link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Liquidity Matters and Going Concern link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Intangibles link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Investments link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Federal Relief Loans link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Convertible Notes Payable link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Derivative Liability link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Stockholders’ Equity link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Accounting Policies and Estimates (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Intangibles (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Derivative Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Accounting Policies and Estimates (Details) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Liquidity Matters and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Intangibles (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Investments (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Investments (Details) - Schedule of investment link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Leases (Details) - Schedule of total lease cost link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Leases (Details) - Schedule of other lease information link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Federal Relief Loans (Details) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Notes Payable (Details) - Schedule of notes payable link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Convertible Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Convertible Notes Payable (Details) - Schedule of convertible notes payable link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Derivative Liability (Details) link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Derivative Liability (Details) - Schedule of movement in derivative liability link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Stockholders’ Equity (Details) link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Stockholders’ Equity (Details) - Schedule of restricted stock activity link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Stockholders’ Equity (Details) - Schedule of restricted stock granted and exercisable link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Stockholders’ Equity (Details) - Schedule of warrant activity link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Stockholders’ Equity (Details) - Schedule of warrants outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Stockholders’ Equity (Details) - Schedule of option activity link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Stockholders’ Equity (Details) - Schedule of options outstanding and exercisable link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - Net Loss Per Share (Details) - Schedule of dilutive shares link:presentationLink link:definitionLink link:calculationLink 060 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 061 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 qpag-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 qpag-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 qpag-20230331_lab.xml XBRL LABEL FILE EX-101.PRE 11 qpag-20230331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2023
May 10, 2023
Document Information Line Items    
Entity Registrant Name Innovative Payment Solutions, Inc.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   376,901,679
Amendment Flag false  
Entity Central Index Key 0001591913  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55648  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 33-1230229  
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
City Area Code (866)  
Local Phone Number 477-4729  
Entity Interactive Data Current Yes  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash $ 155,868 $ 374,765
Other current assets 75,085 97,042
Total Current Assets 230,953 471,807
Non-current assets    
Plant and equipment 25,528 40,362
Intangible assets 1,631,739 1,692,811
Security deposit 47,592 47,592
Investment 500,000 500,000
Total Non-Current Assets 2,204,859 2,280,765
Total Assets 2,435,812 2,752,572
Current Liabilities    
Accounts payable 889,042 761,732
Federal relief loans – current portion 3,217
Notes payable 988,368 964,268
Convertible debt, net of unamortized discount of $228,888 and $0, respectively 2,632,451 2,266,602
Derivative liability 1,609,892 2,550,642
Total Current Liabilities 6,122,970 6,543,244
Non-Current Liabilities    
Federal relief loans 159,952 163,978
Total Non-Current Liabilities 159,952 163,978
Total Liabilities 6,282,922 6,707,222
Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 376,901,679 shares issued and outstanding as of March 31, 2023 and December 31, 2022. 37,690 37,690
Additional paid-in-capital 48,788,448 48,405,921
Accumulated deficit (52,673,248) (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders (3,847,110) (3,956,247)
Non-controlling interest 1,597
Total Equity (Deficit) (3,847,110) (3,954,650)
Total Liabilities and Equity (Deficit) $ 2,435,812 $ 2,752,572
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 228,888 $ 0
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares issued 376,901,679 376,901,679
Common stock, shares outstanding 376,901,679 376,901,679
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net Revenue $ 433
Cost of Goods Sold 2,085
Gross loss (1,652)
General and administrative 965,207 869,387
Depreciation and amortization 140,690 4,496
Total Expense 1,105,897 873,883
Loss from Operations (1,107,549) (873,883)
Penalty on convertible notes (719,558)
Interest expense (85,221) (45,766)
Amortization of debt discount (22,967) (263,200)
Derivative liability movements 940,750 92,161
Loss before Income Taxes (274,987) (1,810,246)
Income Taxes
Net Loss (274,987) (1,810,246)
Net loss attributable to non-controlling interest 1,597 8,752
Net loss attributable to Innovative Payment Solutions, Inc. stockholders $ (273,390) $ (1,801,494)
Basic and diluted loss per share (in Dollars per share) $ 0 $ 0
Weighted Average Number of Shares Outstanding - Basic (in Shares) 376,901,679 367,901,679
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Diluted loss per share $ 0.00 $ 0.00
Weighted Average Number of Shares Outstanding – Diluted 376,901,679 376,901,679
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2021 $ 36,790 $ 45,771,012 $ (42,111,701) $ 35,211 $ 3,731,312
Balance (in Shares) at Dec. 31, 2021 367,901,679        
Stock based option expense 94,466 94,466
Restricted stock awards 62,766 62,766
Net loss (1,801,494) (8,752) (1,810,246)
Balance at Mar. 31, 2022 $ 36,790 45,928,244 (43,913,195) 26,459 2,078,298
Balance (in Shares) at Mar. 31, 2022 367,901,679        
Balance at Dec. 31, 2022 $ 37,690 48,405,921 (52,399,858) 1,597 (3,954,650)
Balance (in Shares) at Dec. 31, 2022 376,901,679        
Fair value of warrants issued 251,856 251,856
Stock based option expense 130,671 130,671
Net loss (273,390) (1,597) (274,987)
Balance at Mar. 31, 2023 $ 37,690 $ 48,788,448 $ (52,673,248) $ (3,847,110)
Balance (in Shares) at Mar. 31, 2023 376,901,679        
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (274,987) $ (1,810,246)
Adjustments to reconcile net loss to net cash used in operating activities:    
Derivative liability movements (940,750) (92,161)
Depreciation 140,690 4,496
Amortization of debt discount 22,967 263,200
Penalty on convertible debt 719,558
Stock based compensation 130,671 157,232
Changes in Assets and Liabilities    
Other current assets 21,957 45,708
Accounts payable and accrued expenses 127,311 (6,221)
Interest accruals 83,837 (42,484)
CASH USED IN OPERATING ACTIVITIES (688,304) (760,918)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in intangibles (64,783) (179,030)
NET CASH USED IN INVESTING ACTIVITIES (64,783) (179,030)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from convertible notes 535,000
Repayment of convertible notes (1,147,063)
Repayment of federal relief loans (809)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 534,191 (1,147,063)
NET DECREASE IN CASH (218,896) (2,087,011)
CASH AT BEGINNING OF PERIOD 374,765 5,449,751
CASH AT END OF PERIOD 155,869 3,362,740
CASH PAID FOR INTEREST AND TAXES:    
Cash paid for income taxes
Cash paid for interest 1,384 88,250
NON CASH INVESTING AND FINANCING ACTIVITIES    
Fair value of warrants issued with convertible notes $ 251,856
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business
3 Months Ended
Mar. 31, 2023
ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

a)Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

b)Description of current business

 

The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was fully launched in July 2022 after a soft launch in December 2021. Previously the Company intended to invest in physical kiosks where any payment processing could be undertaken by customers in person. The Company has shifted its business to focus solely on downloadable apps used via smartphones and other online payment processing solutions..

 

The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies and Estimates
3 Months Ended
Mar. 31, 2023
Organization and Description of Business [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2 ACCOUNTING POLICIES AND ESTIMATES

 

a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech.

 

c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

h)Reporting by Segment

 

No segmental information is required as the Company only has one operating segment.

 

i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

 

j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022.

 

k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

i.identify the contract with a customer;

 

ii.identify the performance obligations in the contract;

 

iii.determine the transaction price;

 

iv.allocate the transaction price to performance obligations in the contract; and

 

v.recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. 

 

o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Liquidity Matters and Going Concern
3 Months Ended
Mar. 31, 2023
Liquidity Matters [Abstract]  
LIQUIDITY MATTERS AND GOING CONCERN
  3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2023 and the year ended December 31, 2022, the Company had a net loss of $274,987 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the three months ended March 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Intangibles
3 Months Ended
Mar. 31, 2023
Intangibles [Abstract]  
INTANGIBLES
4INTANGIBLES

 

On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $41,320  and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $1,127,400 and $28,893, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.

 

    March 31,
2023
    December 31, 
2022
 
     Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchase Technology – Beyond Wallet   $ 327,211     $
-
    $ 327,211     $ 291,320  
Purchased Technology - IPSIPay     1,531,293       (226,765 )     1,304,528       1,401,491  
    $ 1,858,504     $ (226,765 )   $ 1,631,739     $ 1,692,811  

 

Amortization expense was $125,856 and $0 for the three months ended March 31, 2023 and 2022, respectively.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
3 Months Ended
Mar. 31, 2023
Investments, All Other Investments [Abstract]  
INVESTMENTS
5INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.

 

The shares in Frictionless are unlisted as of March 31, 2023.

 

   

March 31,

2023

    December 31,
2022
 
Investment in Frictionless Financial Technologies, Inc.   $ 500,000     $ 500,000  
    $ 500,000     $ 500,000  
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
3 Months Ended
Mar. 31, 2023
Disclosure Text Block [Abstract]  
LEASES
6LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Operating lease expense  $15,264   $14,400 

 

Other lease information:

 

   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(15,264)  $(14,400)
           
Remaining lease term – operating lease   Monthly    Monthly 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Federal Relief Loans
3 Months Ended
Mar. 31, 2023
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
7FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company.

 

The Company has repaid an aggregate principal amount of $809 and interest of $1,384 as of March 31, 2023. The loan balance outstanding as of March 31, 2023, consists of principal of $149,191 and accrued interest thereon of $13,978, of which $3,217 is disclosed as current.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable
3 Months Ended
Mar. 31, 2023
Notes Payable [Abstract]  
NOTES PAYABLE
8NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    March 31, 2023
Amount, net
    December 31, 2022
Amount, net
 
Cavalry Fund I LP     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Total convertible notes payable               $ 964,000     $ 24,368     $ 988,368     $ 964,268  

  

Interest expense totaled $24,100 and $0 for the three months ended March 31, 2023 and 2022, respectively.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable
3 Months Ended
Mar. 31, 2023
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
9CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

On February 16, 2021, we entered into separate SPAs with each of Cavalry and Mercer, pursuant to which we received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.24 per share. Cavalry and Mercer are Selling Stockholders listed in this prospectus.

 

The Original Warrants are discussed in note 8 above.

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under their respective Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

(1)The conversion price of the Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Notes). As a result of this change in conversion price, under the existing terms of the Notes, the 3,000,000 shares of common stock underlying the Extension Warrants was increased to 39,130,435 shares;

 

(2)The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

  

(3)Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Notes until after March 30, 2023 and (ii) waive any events of default under the Notes and the SPAs;

 

(4)Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the common stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and

 

(5)The company was obligated to register the shares of common stock underlying the Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our common stock underlying the Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to the filed registration statement.

 

The amendments to the convertible debt were evaluated in terms of ASC470, Debt, to determine if the amendments to the convertible debt were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the convertible notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the convertible note holders valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (Note 8 above) and the value of full rachet provisions of certain of the warrants issued to the convertible note holders amounting to $841,003, see note 12 below, the amendment of the convertible notes was determined to be a debt extinguishment.

 

Convertible notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    March 31, 2023 Amount, net     December 31, 2022 Amount, net  
Cavalry Fund I LP     10 %   December 30, 
2023
    1,091,754       68,841      
          -
      1,160,595       1,133,301  
                                                     
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 
2023
    1,091,754       68,841      
-
      1,160,595       1,133,301  
                                                     
February 2023 convertible notes     8 %   February 13, 2024
to February 23, 2024
    535,000       5,149       (228,888 )     311,261      
-
 
                                                     
Total convertible notes payable               $ 2,718,508     $ 142,831     $ (228,888 )   $ 2,632,451     $ 2,266,602  

 

Interest expense totaled $59,737 and $44,379 for the three months ended March 31, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $22,967 and $263,200 for the three months ended March 31, 2023 and 2022, respectively.

 

The Cavalry and Mercer convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the common stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

The balance of the Cavalry Note plus accrued interest at March 31, 2023 was $1,160,595.

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

The balance of the Mercer Note plus accrued interest at March 31, 2023 was $1,160,595.

  

February 2023 convertible notes

 

Between February 13, 2023 and February 23, 2023, the Company, entered into Securities Purchase Agreements (the “Securities Purchase Agreement”) with 11 accredited investors, pursuant to which the Company received an aggregate of $535,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

Convertible Notes Promissory (the “Notes” and each a “Note”); and

 

five-year warrants (the “Warrants”) to purchase an aggregate 46,521,739 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

The Notes and the Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

The balance of the February 2023 Notes plus accrued interest at March 31, 2023 was $311,261, net of unamortized debt discount of $228,888.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE LIABILITY
10DERIVATIVE LIABILITY

 

Certain of the short-term convertible notes disclosed in note 9 above and certain warrants disclosed in note 11 below, have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 9 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

The net movement on the derivative liability for the three months ended March 31, 2023 was a net mark-to-market release of derivative liability of $940,750, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Three months ended March 31, 2023       Year ended December 31, 2022 
Conversion price  $0.0115   $0.0115 to $0.15  
Risk free interest rate   3.60 to 4.79%   0.79 to 4.73 %
Expected life of derivative liability   9 to 53 months    1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 192.53%    120.49 to 258.3 %
Expected dividend rate   0%   0%

 

The movement in derivative liability is as follows:

 

  

March 31,
2023

  

December 31,
2022

 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   
-
    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (940,750)   (411,752)
   $1,609,892   $2,550,642 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY
11STOCKHOLDERS’ EQUITY

 

a.Common Stock

 

The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 shares of Common Stock issued and outstanding as of March 31, 2023 and December 31, 2022, respectively.

 

b.Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2022   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding December 31, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2023   23,495,000   $0.050    -   $0.049    23,495,000   $0.050 

 

The restricted stock granted, issued and exercisable at March 31, 2023 is as follows:

 

   Restricted Stock Granted and Vested 
Grant date Price  Number Granted   Weighted Average Fair Value per Share 
$ 0.049   20,495,000   $0.049 
$ 0.050   1,000,000    0.050 
$ 0.055   2,000,000    0.055 
    23,495,000   $0.050 

 

The Company has recorded an expense of $0 and $62,766 for the three months March 31, 2023 and 2022, respectively. 

 

c.Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2023 and December 31, 2022.

 

d.Warrants

  

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of common stock in the Company at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. Subsequent to March 31, 2023, the Company entered into an agreement to cancel this warrant (see Note 15).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:

 

  The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;

 

  The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

  An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

Between February 13, 2023 and February 23, 2023, the Company entered into Securities Purchase Agreements with 11 accredited investors, as disclosed in Note 9 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 46,521,739 shares of the Company’s common stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.

 

The Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

    Three months
ended
March 31,
2023
 
Exercise price   $ 0.0115  
Risk free interest rate     3.93 to 4.16 %
Expected life     5 years   
Expected volatility of underlying stock     189.15 to 189.37 %
Expected dividend rate     0 %

 

A summary of warrant activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

    Shares
Underlying
Warrants
    Exercise
price per
share
    Weighted
average
exercise price
 
Outstanding January 1, 2022     37,304,105     $ 0.05 – 0.1875     $ 0.12  
Granted     51,000,000        0.0115 – 0.0345       0.01826  
Increase in warrants due to debt amendment full rachet trigger     72,260,870       0.0115       0.0115  
Cancelled on debt amendment     (4,973,914 )     0.15       0.1500  
Exercised     -       -       -  
Outstanding December 31, 2022     155,591,061     $  0.0115 – 0.1875     $ 0.0300  
Granted     46,521,739        0.0115       0.0115  
Forfeited     (1,000,000 )     0.05       0.05  
Cancelled on debt amendment     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     201,112,800     $  0.0115 – 0.1875     $ 0.0256  

 

The warrants outstanding and exercisable at March 31, 2023 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0115    168,519,466    4.48         168,519,466         4.48 
$0.0345    15,000,000    2.27         10,312,500         2.27 
$0.15    15,166,667    2.96         15,166,667         2.96 
$0.1875    2,426,667    2.96         2,426,667         2.96 
      201,112,800    4.18   $0.0256    196,425,300   $0.0256    4.23 

 

The warrants outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.

 

e.Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.

 

Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

A summary of option activity during the period January 1, 2022 to March 31, 2023 is as follows:

 

    Shares
Underlying
options
    Exercise
price per
share
    Weighted
average
exercise
price
 
Outstanding January 1, 2022     30,516,666     $ 0.15 to 0.40     $ 0.15  
Granted     15,800,000        0.04 – 0.15       0.14  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding December 31, 2022     46,316,666     0.04 to 0.40     $ 0.15  
Granted     -       -       -  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     46,316,666     0.04 to 0.40     $ 0.15  

 

The options outstanding and exercisable at March 31, 2023 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise  Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.04    800,000    9.46         800,000         9.46 
$0.15    45,208,333    8.69         38,125,000         8.74 
$0.24    208,333    7.90         208,333         7.90 
$0.40    100,000    5.75         100,000         5.75 
      46,316,666    8.69   $0.15    39,233,333   $0.15    8.75 

 

The options outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.

 

The option expense was $94,464 and $94,466 for the three months ended March 31, 2023 and 2022, respectively. 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2023
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE
12NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2023 and 2022 are as follows:

 

   Three months ended
March 31,
2023
(Shares)
   Three months ended
March 31,
2022
(Shares)
 
Convertible debt   248,812,128    11,687,855 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   201,112,800    37,304,104 
    496,241,594    79,508,625 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
13RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.

 

The option expense for Mr. Corbett was $66,587 and $1,090,201  for the three months ended March 31, 2023 and the year ended December 31, 20221, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

 

Madisson Corbett

 

On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Corbett was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

  

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $27,879 and $111,514 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES
14COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under note 8 and 9 above, which mature between December 30, 2023 and February 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
15SUBSEQUENT EVENTS

 

On April 28, 2023, the Company formed a new Delaware limited liability company called IPSIPay Express LLC. This entity was formed as a three-way joint venture with two other entities to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. As of the date of issuance of these financial statements, definitive documentation memorializing the joint venture are being finalized.

 

On May 10, 2023, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which the Company issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to the Company of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. The Company is required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies, by Policy (Policies)
3 Months Ended
Mar. 31, 2023
Organization and Description of Business [Abstract]  
Basis of Presentation
a)Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

Principles of Consolidation
b)Principles of Consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:

 

Innovative Payment Solutions, Inc. - Parent Company

Beyond Fintech Inc., 51% owned. 

 

See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech.

 

Use of Estimates
c)Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
d)Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

Fair Value of Financial Instruments
e)Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

Risks and Uncertainties
f)Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.

 

The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.

 

Recent accounting pronouncements
g)Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.

 

Reporting by Segment
h)Reporting by Segment

 

No segmental information is required as the Company only has one operating segment.

 

Cash and Cash Equivalents
i)Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.

 

Accounts Receivable and Allowance for Doubtful Accounts
j)Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022.

 

Investments
k)Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

Plant and Equipment
l)Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

Long-Term Assets
m)Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

Revenue Recognition
n)Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue Recognition.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

i.identify the contract with a customer;

 

ii.identify the performance obligations in the contract;

 

iii.determine the transaction price;

 

iv.allocate the transaction price to performance obligations in the contract; and

 

v.recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. 

 

Share-Based Payment Arrangements
o)Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

Derivative Liabilities
p)Derivative Liabilities

 

ASC Topic 815, Derivatives and hedging (“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

Income Taxes
q)Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
r)Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies and Estimates (Tables)
3 Months Ended
Mar. 31, 2023
Organization and Description of Business [Abstract]  
Schedule of estimated useful lives of the assets
Description   Estimated Useful Life
     
Kiosks (not used in the Company’s current business)   7 years
     
Computer equipment   3 years
     
Office equipment   10 years

 

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Intangibles (Tables)
3 Months Ended
Mar. 31, 2023
Intangibles Table [Abstract]  
Schedule of facilitate the functioning of the IPSIPay software
    March 31,
2023
    December 31, 
2022
 
     Cost     Accumulated
amortization
    Net Book
Value
    Net book
value
 
Purchase Technology – Beyond Wallet   $ 327,211     $
-
    $ 327,211     $ 291,320  
Purchased Technology - IPSIPay     1,531,293       (226,765 )     1,304,528       1,401,491  
    $ 1,858,504     $ (226,765 )   $ 1,631,739     $ 1,692,811  

 

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
3 Months Ended
Mar. 31, 2023
Investments, All Other Investments [Abstract]  
Schedule of investment
   

March 31,

2023

    December 31,
2022
 
Investment in Frictionless Financial Technologies, Inc.   $ 500,000     $ 500,000  
    $ 500,000     $ 500,000  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Tables)
3 Months Ended
Mar. 31, 2023
Disclosure Text Block [Abstract]  
Schedule of total lease cost
   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Operating lease expense  $15,264   $14,400 

 

Schedule of other lease information
   Three months
ended
March 31,
2023
   Three months
ended
March 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(15,264)  $(14,400)
           
Remaining lease term – operating lease   Monthly    Monthly 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Tables)
3 Months Ended
Mar. 31, 2023
Notes Payable [Abstract]  
Schedule of notes payable
Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    March 31, 2023
Amount, net
    December 31, 2022
Amount, net
 
Cavalry Fund I LP     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 2023     482,000       12,184       494,184       482,134  
Total convertible notes payable               $ 964,000     $ 24,368     $ 988,368     $ 964,268  

  

XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Tables)
3 Months Ended
Mar. 31, 2023
Convertible Notes Payable [Abstract]  
Schedule of convertible notes payable
Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    March 31, 2023 Amount, net     December 31, 2022 Amount, net  
Cavalry Fund I LP     10 %   December 30, 
2023
    1,091,754       68,841      
          -
      1,160,595       1,133,301  
                                                     
Mercer Street Global Opportunity Fund, LLC     10 %   December 30, 
2023
    1,091,754       68,841      
-
      1,160,595       1,133,301  
                                                     
February 2023 convertible notes     8 %   February 13, 2024
to February 23, 2024
    535,000       5,149       (228,888 )     311,261      
-
 
                                                     
Total convertible notes payable               $ 2,718,508     $ 142,831     $ (228,888 )   $ 2,632,451     $ 2,266,602  

 

XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Tables)
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of assumptions were used in the black-scholes valuation model
   Three months ended March 31, 2023       Year ended December 31, 2022 
Conversion price  $0.0115   $0.0115 to $0.15  
Risk free interest rate   3.60 to 4.79%   0.79 to 4.73 %
Expected life of derivative liability   9 to 53 months    1.5 to 59 months  
Expected volatility of underlying stock     158.72 to 192.53%    120.49 to 258.3 %
Expected dividend rate   0%   0%

 

Schedule of movement in derivative liability
  

March 31,
2023

  

December 31,
2022

 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   
-
    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (940,750)   (411,752)
   $1,609,892   $2,550,642 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of restricted stock activity
   Total
restricted
shares
   Weighted
average
fair market
value per
share
   Total
unvested
restricted
shares
   Weighted
average
fair market
value per
share
   Total vested
restricted
shares
   Weighted
average
fair market
value per share
 
Outstanding January 1, 2022   21,495,000   $0.049    10,247,500   $0.049    11,247,500   $0.049 
Granted and issued   2,000,000    0.055    
-
    
-
    2,000,000    0.055 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding December 31, 2022   23,495,000   $0.050    5,123,750   $0.049    18,371,250   $0.050 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (5,123,750)   (0.049)   5,123,750    0.049 
Outstanding March 31, 2023   23,495,000   $0.050    -   $0.049    23,495,000   $0.050 

 

Schedule of restricted stock granted and exercisable
   Restricted Stock Granted and Vested 
Grant date Price  Number Granted   Weighted Average Fair Value per Share 
$ 0.049   20,495,000   $0.049 
$ 0.050   1,000,000    0.050 
$ 0.055   2,000,000    0.055 
    23,495,000   $0.050 

 

Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model
    Three months
ended
March 31,
2023
 
Exercise price   $ 0.0115  
Risk free interest rate     3.93 to 4.16 %
Expected life     5 years   
Expected volatility of underlying stock     189.15 to 189.37 %
Expected dividend rate     0 %

 

Schedule of warrant activity
    Shares
Underlying
Warrants
    Exercise
price per
share
    Weighted
average
exercise price
 
Outstanding January 1, 2022     37,304,105     $ 0.05 – 0.1875     $ 0.12  
Granted     51,000,000        0.0115 – 0.0345       0.01826  
Increase in warrants due to debt amendment full rachet trigger     72,260,870       0.0115       0.0115  
Cancelled on debt amendment     (4,973,914 )     0.15       0.1500  
Exercised     -       -       -  
Outstanding December 31, 2022     155,591,061     $  0.0115 – 0.1875     $ 0.0300  
Granted     46,521,739        0.0115       0.0115  
Forfeited     (1,000,000 )     0.05       0.05  
Cancelled on debt amendment     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     201,112,800     $  0.0115 – 0.1875     $ 0.0256  

 

Schedule of warrants outstanding and exercisable
    Warrants Outstanding   Warrants Exercisable 
Exercise Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.0115    168,519,466    4.48         168,519,466         4.48 
$0.0345    15,000,000    2.27         10,312,500         2.27 
$0.15    15,166,667    2.96         15,166,667         2.96 
$0.1875    2,426,667    2.96         2,426,667         2.96 
      201,112,800    4.18   $0.0256    196,425,300   $0.0256    4.23 

 

Schedule of option activity
    Shares
Underlying
options
    Exercise
price per
share
    Weighted
average
exercise
price
 
Outstanding January 1, 2022     30,516,666     $ 0.15 to 0.40     $ 0.15  
Granted     15,800,000        0.04 – 0.15       0.14  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding December 31, 2022     46,316,666     0.04 to 0.40     $ 0.15  
Granted     -       -       -  
Forfeited/Cancelled     -       -       -  
Exercised     -       -       -  
Outstanding March 31, 2023     46,316,666     0.04 to 0.40     $ 0.15  

 

Schedule of options outstanding and exercisable
    Options Outstanding   Options Exercisable 
Exercise  Price   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.04    800,000    9.46         800,000         9.46 
$0.15    45,208,333    8.69         38,125,000         8.74 
$0.24    208,333    7.90         208,333         7.90 
$0.40    100,000    5.75         100,000         5.75 
      46,316,666    8.69   $0.15    39,233,333   $0.15    8.75 

 

XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Net Loss Per Share [Abstract]  
Schedule of dilutive shares
   Three months ended
March 31,
2023
(Shares)
   Three months ended
March 31,
2022
(Shares)
 
Convertible debt   248,812,128    11,687,855 
Stock options   46,316,666    30,516,666 
Warrants to purchase shares of Common Stock   201,112,800    37,304,104 
    496,241,594    79,508,625 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Description of Business (Details) - USD ($)
1 Months Ended 3 Months Ended
Dec. 31, 2019
Aug. 26, 2021
Mar. 31, 2023
Aug. 30, 2022
Jun. 22, 2021
Feb. 16, 2021
Nov. 01, 2019
Organization and Description of Business (Textual)              
Shares of Common Stock (in Shares)     621,920        
Aggregate shares of Common Stock (in Shares)     2,500     51,901,711  
Retained shares of Common Stock (in Dollars)     $ 500,000        
Outstanding shares of Common Stock (in Shares)             32,047,817
Exchange shares (in Shares) 2,250,000            
Stock purchase agreement (in Shares) 2,250,000            
Shares of vivi 9.00%            
Percentage of remaining shares owned   49.00%          
Beyond Fintech [Member]              
Organization and Description of Business (Textual)              
Stake owned percentage   51.00%          
Common Stock [Member]              
Organization and Description of Business (Textual)              
Common stock, par value (in Dollars per share)     $ 0.0001        
Shares of Common Stock (in Shares)     500,000        
Aggregate shares of Common Stock (in Shares)       3,000,000      
Outstanding Common Stock percentage     91.00%        
Outstanding shares of Common Stock (in Shares)             320,477,867
Frictionless Financial Technologies, Inc. [Member]              
Organization and Description of Business (Textual)              
Acquired percentage     1.00%        
Frictionless [Member]              
Organization and Description of Business (Textual)              
Strategic interest         10.00%    
Common stock outstanding percentage     41.00%        
Purchase price (in Dollars)     $ 300,000        
Qpagos Corporation’s Capital Stock [Member]              
Organization and Description of Business (Textual)              
Shares of Common Stock (in Shares)     4,992,900        
Qpagos Corporation’s Capital Stock [Member] | Common Stock [Member]              
Organization and Description of Business (Textual)              
Shares of Common Stock (in Shares)     497,500        
Gaston Pereira [Member]              
Organization and Description of Business (Textual)              
Shares of vivi 5.00%            
Andrey Novikov [Member]              
Organization and Description of Business (Textual)              
Shares of vivi 2.50%            
Joseph Abrams [Member]              
Organization and Description of Business (Textual)              
Shares of vivi 1.50%            
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies and Estimates (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Accounting Policies and Estimates (Textual)      
Ownership percentage 20.00%    
Operating segment 1    
Federally insured limit $ 0   $ 120,580
Plant and equipment costs 1,000    
Revenues $ 433 $ 0  
Beyond Fintech Inc. [Member]      
Accounting Policies and Estimates (Textual)      
Ownership percentage 51.00%    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets
Mar. 31, 2023
Kiosks [Member]  
Estimated useful lives 7 years
Computer equipment [Member]  
Estimated useful lives 3 years
Office equipment [Member]  
Estimated useful lives 10 years
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Liquidity Matters and Going Concern (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Liquidity Matters (Textual)    
Net loss $ 274,987 $ 10,331,424
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Intangibles (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 26, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]          
Gross proceeds $ 250,000       $ 375,000
Beyond fintech percentage 51.00%        
Owned frictionless percentage 49.00%        
Additional amount of software   $ 35,891   $ 41,320  
IPSIPay software amount   28,893   $ 1,127,400  
Amortization expense   $ 125,856 $ 0    
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Schedule of facilitate the functioning of the IPSIPay software [Abstract]    
Cost $ 1,858,504  
Accumulated amortization (226,765)  
Net Book Value 1,631,739 $ 1,692,811
Purchase Technology – Beyond Wallet [Member]    
Schedule of facilitate the functioning of the IPSIPay software [Abstract]    
Cost 327,211  
Accumulated amortization  
Net Book Value 327,211 291,320
Purchased Technology - IPSIPay [Member]    
Schedule of facilitate the functioning of the IPSIPay software [Abstract]    
Cost 1,531,293  
Accumulated amortization (226,765)  
Net Book Value $ 1,304,528 $ 1,401,491
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
Investment (Textual)  
Right to acquire percentage 1.00%
Frictionless Financial Technologies, Inc.[Member]  
Investment (Textual)  
Right to acquire percentage 41.00%
Purchase price (in Dollars) $ 300,000
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - Schedule of investment - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Investments (Details) - Schedule of investment [Line Items]    
Investment $ 500,000 $ 500,000
Investment in Frictionless Financial Technologies, Inc. [Member]    
Investments (Details) - Schedule of investment [Line Items]    
Investment $ 500,000 $ 500,000
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Details) - USD ($)
3 Months Ended
Jan. 01, 2023
Mar. 31, 2023
Leases (Textual)    
Lease, description   The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022.
Lease amount   $ 4,800
Monthly rent $ 5,088  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Details) - Schedule of total lease cost - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule of total lease cost [Abstract]    
Operating lease expense $ 15,264 $ 14,400
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Details) - Schedule of other lease information - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (15,264) $ (14,400)
Remaining lease term – operating lease Monthly Monthly
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Federal Relief Loans (Details) - USD ($)
1 Months Ended 3 Months Ended
Jul. 07, 2020
Feb. 16, 2021
Mar. 31, 2023
Federal Relief Loans [Abstract]      
Disaster loan amount $ 150,000    
Bearing interest, percentage 3.75%    
Repayable installments $ 731    
Aggregate principal amount   $ 572,000 $ 809
Aggregate principal amount interest     1,384
Loan balance outstanding     149,191
Accrued interest     13,978
Disclosed amount of accrued interest     $ 3,217
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Details) - USD ($)
3 Months Ended
Feb. 16, 2021
Mar. 31, 2023
Mar. 31, 2022
Notes Payable (Details) [Line Items]      
Company received $ 500,500    
Interest rate 12.50%    
Common stock, shares (in Shares) 2,486,957    
Exercise price per share (in Dollars per share) $ 0.24    
Promissory note $ 482,000    
Notes issued 964,000    
Fair value of the warrants 43,608    
Convertible debt $ 920,392    
Interest expense   $ 24,100 $ 0
December 30, 2022 Note [Member]      
Notes Payable (Details) [Line Items]      
Interest rate 10.00%    
Common stock, shares (in Shares) 51,901,711    
Promissory note $ 482,000    
Maturity date Dec. 30, 2023    
Cavalry and Mercer [Member]      
Notes Payable (Details) [Line Items]      
Company received $ 500,500    
Principal amount $ 572,000    
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Notes Payable (Details) - Schedule of notes payable - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Notes Payable (Details) - Schedule of notes payable [Line Items]    
Principal $ 964,000  
Accrued Interest 24,368  
Amount, net $ 988,368 $ 964,268
Cavalry Fund I LP [Member]    
Notes Payable (Details) - Schedule of notes payable [Line Items]    
Interest Rate 10.00%  
Maturity date December 30, 2023  
Principal $ 482,000  
Accrued Interest 12,184  
Amount, net $ 494,184 482,134
Mercer Street Global Opportunity Fund, LLC [Member]    
Notes Payable (Details) - Schedule of notes payable [Line Items]    
Interest Rate 10.00%  
Maturity date December 30, 2023  
Principal $ 482,000  
Accrued Interest 12,184  
Amount, net $ 494,184 $ 482,134
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 03, 2022
Feb. 23, 2023
Feb. 13, 2023
Dec. 28, 2022
Nov. 16, 2022
Feb. 16, 2021
Mar. 31, 2023
Dec. 31, 2022
Convertible Notes Payable (Textual)                
Net proceeds           $ 500,500    
Principal amount           $ 572,000 $ 809  
Common stock shares (in Shares)           2,486,957 3,000,000  
Exercise price per share (in Dollars per share)       $ 0.0115   $ 0.24 $ 0.0115  
Maturity date Aug. 16, 2022         Dec. 30, 2023    
Interest rate           10.00% 8.00%  
Purchase of additional shares (in Shares) 3,000,000              
Warrant exercisable (in Shares)             39,130,435  
Non-convertible promissory notes           $ 482,000    
Common stock shares issued (in Shares)           51,901,711 2,500  
Common stock price per share (in Dollars per share)             $ 0.06  
Aggregate amount       $ 2,264,784        
Convertible notes             $ 836,414  
Black-scholes valuation model             1,499,577  
Convertible note holders             238,182  
Additional charge             920,392  
Warrant cost             43,608  
Value of notes             964,000  
Holders amount             841,003  
Interest expense             59,737 $ 44,379
Amortization of debt discount             22,967 263,200
Accrued interest and penalty interest             311,261  
Gross proceeds   $ 535,000 $ 535,000          
Purchase of aggregate shares             $ 46,521,739  
Conversion price of per share (in Dollars per share)             $ 0.0115  
Beneficially own of percentage             4.99%  
Limitation exceeds of percentage             9.99%  
Net of unamortized debt discount             $ 228,888 $ 0
Cavalry Fund I LP [Member]                
Convertible Notes Payable (Textual)                
Net proceeds           $ 500,500    
Original issue discount           $ 71,500    
Exercise price per share (in Dollars per share)         $ 0.15 $ 0.24    
Interest rate         20.00% 10.00%    
Warrant exercisable (in Shares)           2,486,957    
Senior secured convertible note           $ 572,000    
Initial conversion price per share (in Dollars per share)           $ 0.23    
Purchase an additional shares (in Shares)         3,000,000      
Conversion price (in Dollars per share)             $ 1,160,595  
Mercer Street Global Opportunity Fund, LLC [Member]                
Convertible Notes Payable (Textual)                
Net proceeds           $ 500,500    
Original issue discount           $ 572,000    
Exercise price per share (in Dollars per share)         $ 0.15 $ 0.24    
Interest rate         20.00%      
Warrant exercisable (in Shares)           2,486,957    
Senior secured convertible note           $ 71,500    
Purchase an additional shares (in Shares)         3,000,000      
Conversion price (in Dollars per share)           $ 0.23    
Original issue discount rate           10.00%    
Accrued interest and penalty interest             $ 1,160,595  
Minimum [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)             $ 0.15  
Minimum [Member] | Cavalry Fund I LP [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)         $ 0.15      
Minimum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)         0.15      
Maximum [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)             0.0115  
Maximum [Member] | Cavalry Fund I LP [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)         0.0115      
Maximum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)         $ 0.0115      
Cavalry and Mercer [Member]                
Convertible Notes Payable (Textual)                
Net proceeds           $ 500,500    
Original issue discount           $ 12.5    
Exercise price per share (in Dollars per share) $ 0.15           0.04  
Interest rate 20.00%              
Aggregate amount       $ 1,132,392        
Cavalry and Mercer [Member] | Minimum [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)             0.15  
Cavalry and Mercer [Member] | Maximum [Member]                
Convertible Notes Payable (Textual)                
Conversion price, per share (in Dollars per share)             $ 0.0115  
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Convertible Notes Payable (Details) - Schedule of convertible notes payable - Construction Loan Payable [Member] - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Principal $ 2,718,508  
Accrued Interest 142,831  
Unamortized debt discount (228,888)  
Convertible notes payable $ 2,632,451 $ 2,266,602
Cavalry Fund I LP [Member]    
Interest Rate 10.00%  
Maturity date December 30,  2023  
Principal $ 1,091,754  
Accrued Interest 68,841  
Unamortized debt discount  
Convertible notes payable $ 1,160,595 1,133,301
Mercer Street Global Opportunity Fund, LLC [Member]    
Interest Rate 10.00%  
Maturity date December 30,  2023  
Principal $ 1,091,754  
Accrued Interest 68,841  
Unamortized debt discount  
Convertible notes payable $ 1,160,595 1,133,301
February 2023 convertible notes [Member]    
Interest Rate 8.00%  
Maturity date February 13, 2024 to February 23, 2024  
Principal $ 535,000  
Accrued Interest 5,149  
Unamortized debt discount (228,888)  
Convertible notes payable $ 311,261
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Details)
3 Months Ended
Mar. 31, 2023
USD ($)
Derivative Liability (Textual)  
Rachet provision $ 474,614
Derivative liability 940,750
Cavalry and Mercer [Member]  
Derivative Liability (Textual)  
Derivative liability $ 2,317,051
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Conversion price (in Dollars per share) $ 0.0115  
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Conversion price (in Dollars per share)   $ 0.0115
Risk free interest rate 3.60% 0.79%
Expected life of derivative liability 9 years 1 year 6 months
Expected volatility of underlying stock 158.72% 120.49%
Maximum [Member]    
Conversion price (in Dollars per share)   $ 0.15
Risk free interest rate 4.79% 4.73%
Expected life of derivative liability 53 years 59 years
Expected volatility of underlying stock 192.53% 258.30%
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Liability (Details) - Schedule of movement in derivative liability - USD ($)
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Opening balance $ 2,550,642 $ 407,161
Derivative financial liability arising from convertible note and warrants 238,182
Derivative financial liability arising on note amendment included in loss on convertible notes 2,317,051
Fair value adjustment to derivative liability (940,750) (411,752)
Total $ 1,609,892 $ 2,550,642
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 13, 2022
Jul. 11, 2022
Dec. 31, 2019
Dec. 30, 2022
Aug. 30, 2022
Aug. 30, 2022
Feb. 23, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Feb. 16, 2021
Stockholders' Equity (Textual)                      
Common Stock, Shares Authorized               750,000,000   750,000,000  
Common Stock, Par or Stated Value Per Share (in Dollars per share)               $ 0.0001   $ 0.0001  
Common Stock, Shares, Issued               376,901,679   376,901,679  
Common Stock, Shares, Outstanding               376,901,679   376,901,679  
Other Tax Expense (Benefit) (in Dollars)               $ 0 $ 62,766    
Preferred stock, authorized               25,000,000   25,000,000  
Preferred stock, par value (in Dollars per share)               $ 0.0001   $ 0.0001  
Description of compensation service                   (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date.  
Shares of Common Stock               2,500     51,901,711
Expiration Date         Aug. 30, 2027            
Purchased shares     2,250,000                
Exercise price (in Dollars per share) $ 0.04                    
Note amendment transaction description       the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:   ● The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;     ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.     ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.                
Limitation exceeds percentage               9.99%      
Warrants outstanding an intrinsic value (in Dollars)               $ 0 0    
Incentive stock options               201,112,800      
Amount of immediate expense (in Dollars)                   $ 31,970  
Options exercisable shares 200,000                    
Intrinsic value outstanding options (in Dollars)               $ 0 0    
Option expense (in Dollars)               $ 94,464 $ 94,466    
Common Stock [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock         3,000,000 3,000,000          
Exercise price (in Dollars per share)           $ 0.15          
Exercise price (in Dollars per share)       $ 0.0115              
Options exercisable shares 800,000                    
Warrant [Member]                      
Stockholders' Equity (Textual)                      
Purchased shares       30,000,000              
Fair value of warrants (in Dollars)       $ 348,938              
Maximum [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock               800,000      
Maximum [Member] | Common Stock [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock               100,000      
Maximum [Member]                      
Stockholders' Equity (Textual)                      
Warrants beneficially percentage               4.99%      
Chief Executive Officer [Member]                      
Stockholders' Equity (Textual)                      
Incentive stock options   15,000,000                  
Stock option exercise price (in Dollars per share)   $ 0.15                  
Amount of immediate expense (in Dollars)                   $ 823,854  
Debt Conversion Notices [Member]                      
Stockholders' Equity (Textual)                      
Aggregate shares of common stock             46,521,739        
Convertible debt amount (in Dollars)             $ 0.0115        
2021 Stock Incentive Plan [Member] | Maximum [Member]                      
Stockholders' Equity (Textual)                      
Shares of Common Stock               53,000,000      
2018 Stock Incentive Plan [Member]                      
Stockholders' Equity (Textual)                      
Terminates period               10 years      
2021 Stock Incentive Plan [Member]                      
Stockholders' Equity (Textual)                      
Terminates period               10 years      
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of restricted stock activity - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Total restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Total restricted shares, Outstanding at beginning (in Shares) 23,495,000 21,495,000
Total restricted shares, Outstanding at beginning (in Shares) 23,495,000 23,495,000
Total restricted shares, Granted and issued (in Shares) 2,000,000
Total restricted shares, Forfeited/Cancelled (in Shares)
Total restricted shares, Vested (in Shares)
Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at ending $ 0.05 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.05 0.05
Weighted average fair market value per share, Granted and issued 0.055
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested
Total unvested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Total unvested restricted shares, Outstanding at ending (in Shares) 5,123,750 10,247,500
Total unvested restricted shares, Outstanding at ending (in Shares)   5,123,750
Total unvested restricted shares, Granted and issued (in Shares)
Total unvested restricted shares, Forfeited/Cancelled (in Shares)
Total unvested restricted shares, Vested (in Shares) (5,123,750) (5,123,750)
Unvested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at ending $ 0.049 $ 0.049
Weighted average fair market value per share, Outstanding at ending 0.049 0.049
Weighted average fair market value per share, Granted and issued
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested (0.049) (0.049)
Total vested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Total vested restricted shares, Outstanding at ending 18,371,250 11,247,500
Total vested restricted shares, Outstanding at ending 23,495,000 18,371,250
Total vested restricted shares, Granted and issued 2,000,000
Total vested restricted shares, Forfeited/Cancelled
Total vested restricted shares, Vested 5,123,750 5,123,750
Vested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of restricted stock activity [Line Items]    
Weighted average fair market value per share, Outstanding at ending 0.05 0.049
Weighted average fair market value per share, Outstanding at ending 0.05 0.05
Weighted average fair market value per share, Granted and issued 0.055
Weighted average fair market value per share, Forfeited/Cancelled
Weighted average fair market value per share, Vested $ 0.049 $ 0.049
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of restricted stock granted and exercisable
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Restricted stock granted, number granted | shares 23,495,000
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares $ 0.05
Grant date Price 0.049 [Member]  
Restricted stock granted, number granted | shares 20,495,000
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares $ 0.049
Grant date Price 0.050 [Member]  
Restricted stock granted, number granted | shares 1,000,000
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares $ 0.05
Grant date Price 0.055 [Member]  
Restricted stock granted, number granted | shares 2,000,000
Restricted stock granted, weighted average fair value per share (in Dollars per share) | $ / shares $ 0.055
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model - Warrants [Member]
3 Months Ended
Mar. 31, 2023
$ / shares
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Exercise price (in Dollars per share) $ 0.0115
Expected life 5 years
Expected dividend rate 0.00%
Minimum [Member]  
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Risk free interest rate 3.93%
Expected volatility of underlying stock 189.15%
Maximum [Member]  
Stockholders’ Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]  
Risk free interest rate 4.16%
Expected volatility of underlying stock 189.37%
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of warrant activity - Warrant [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Product Warranty Liability [Line Items]    
Shares Underlying Warrants, Outstanding at beginning (in Shares) 155,591,061 37,304,105
Weighted average exercise price, Outstanding at ending $ 0.03 $ 0.12
Shares Underlying Warrants, Outstanding at beginning (in Shares) 201,112,800 155,591,061
Weighted average exercise price, Outstanding at ending $ 0.0256 $ 0.03
Shares Underlying Warrants, Granted (in Shares) 46,521,739 51,000,000
Exercise price per share, Granted $ 0.0115  
Weighted average exercise price, Granted $ 0.0115 $ 0.01826
Shares Underlying Warrants, Forfeited (in Shares) (1,000,000)  
Exercise price per share, Forfeited $ 0.05  
Weighted average exercise price, Forfeited $ 0.05  
Shares Underlying Warrants, Increase in warrants due to debt amendment full rachet trigger (in Shares)   72,260,870
Exercise price per share, Increase in warrants due to debt amendment full rachet trigger   $ 0.0115
Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger   $ 0.0115
Shares Underlying Warrants, Cancelled on debt amendment (in Shares) (4,973,914)
Exercise price per share, Cancelled on debt amendment $ 0.15
Weighted average exercise price, Cancelled on debt amendment $ 0.15
Shares Underlying Warrants, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]    
Product Warranty Liability [Line Items]    
Exercise price per share, Outstanding at ending 0.0115 0.05
Exercise price per share, Outstanding at ending 0.0115 0.0115
Exercise price per share, Granted   0.0115
Maximum [Member]    
Product Warranty Liability [Line Items]    
Exercise price per share, Outstanding at ending 0.1875 0.1875
Exercise price per share, Outstanding at ending $ 0.1875 0.1875
Exercise price per share, Granted   $ 0.0345
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of warrants outstanding and exercisable
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Warrants Outstanding, Number Outstanding 201,112,800
Warrants Outstanding, Weighted Average Remaining Contractual life in years 4 years 2 months 4 days
Warrants Outstanding, Weighted Average Exercise Price | $ / shares $ 0.0256
Warrants Exercisable, Number Exercisable 196,425,300
Warrants Exercisable ,Weighted Average Exercise Price | $ / shares $ 0.0256
Warrants Exercisable, Weighted Average Remaining Contractual life in years 4 years 2 months 23 days
Exercise Price 0.0115 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.0115
Warrants Outstanding, Number Outstanding 168,519,466
Warrants Outstanding, Weighted Average Remaining Contractual life in years 4 years 5 months 23 days
Warrants Exercisable, Number Exercisable 168,519,466
Warrants Exercisable, Weighted Average Remaining Contractual life in years 4 years 5 months 23 days
Exercise Price 0.0345 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.0345
Warrants Outstanding, Number Outstanding 15,000,000
Warrants Outstanding, Weighted Average Remaining Contractual life in years 2 years 3 months 7 days
Warrants Exercisable, Number Exercisable 10,312,500
Warrants Exercisable, Weighted Average Remaining Contractual life in years 2 years 3 months 7 days
Exercise Price 0.15 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.15
Warrants Outstanding, Number Outstanding 15,166,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years 2 years 11 months 15 days
Warrants Exercisable, Number Exercisable 15,166,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years 2 years 11 months 15 days
Exercise Price 0.1875 [Member]  
Warrants Outstanding, Exercise Price | $ / shares $ 0.1875
Warrants Outstanding, Number Outstanding 2,426,667
Warrants Outstanding, Weighted Average Remaining Contractual life in years 2 years 11 months 15 days
Warrants Exercisable, Number Exercisable 2,426,667
Warrants Exercisable, Weighted Average Remaining Contractual life in years 2 years 11 months 15 days
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of option activity - Stock Options [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Shares Underlying options, Outstanding at beginning (in Shares) 46,316,666 30,516,666
Weighted average exercise price, Outstanding at beginning $ 0.15 $ 0.15
Shares Underlying options, Outstanding at ending (in Shares) 46,316,666 46,316,666
Weighted average exercise price, Outstanding at ending $ 0.15 $ 0.15
Shares Underlying options, Granted (in Shares) 15,800,000
Exercise price per share, Granted
Weighted average exercise price, Granted $ 0.14
Shares Underlying options, Forfeited/Cancelled (in Shares)
Exercise price per share, Forfeited/Cancelled
Weighted average exercise price, Forfeited/Cancelled
Shares Underlying options, Exercised (in Shares)
Exercise price per share, Exercised
Weighted average exercise price, Exercised
Minimum [Member]    
Exercise price per share, Outstanding at beginning   0.15
Exercise price per share, Outstanding at ending 0.04 0.04
Exercise price per share, Granted   0.04
Maximum [Member]    
Exercise price per share, Outstanding at beginning   0.4
Exercise price per share, Outstanding at ending $ 0.4 0.4
Exercise price per share, Granted   $ 0.15
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Equity (Details) - Schedule of options outstanding and exercisable
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Options Outstanding, Number Outstanding 46,316,666
Options Outstanding, Weighted Average Remaining Contractual life in years 8 years 8 months 8 days
Options Outstanding, Weighted Average Exercise Price | $ / shares $ 0.15
Options Exercisable, Number Exercisable 39,233,333
Options Exercisable ,Weighted Average Exercise Price | $ / shares $ 0.15
Options Exercisable, Weighted Average Remaining Contractual life in years 8 years 9 months
Exercise Price 0.04 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.04
Options Outstanding, Number Outstanding 800,000
Options Outstanding, Weighted Average Remaining Contractual life in years 9 years 5 months 15 days
Options Exercisable, Number Exercisable 800,000
Options Exercisable, Weighted Average Remaining Contractual life in years 9 years 5 months 15 days
Exercise Price 0.15 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.15
Options Outstanding, Number Outstanding 45,208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 8 years 8 months 8 days
Options Exercisable, Number Exercisable 38,125,000
Options Exercisable, Weighted Average Remaining Contractual life in years 8 years 8 months 26 days
Exercise Price 0.24 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.24
Options Outstanding, Number Outstanding 208,333
Options Outstanding, Weighted Average Remaining Contractual life in years 7 years 10 months 24 days
Options Exercisable, Number Exercisable 208,333
Options Exercisable, Weighted Average Remaining Contractual life in years 7 years 10 months 24 days
Exercise Price 0.40 [Member]  
Options Outstanding, Exercise Price | $ / shares $ 0.4
Options Outstanding, Number Outstanding 100,000
Options Outstanding, Weighted Average Remaining Contractual life in years 5 years 9 months
Options Exercisable, Number Exercisable 100,000
Options Exercisable, Weighted Average Remaining Contractual life in years 5 years 9 months
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss Per Share (Details) - Schedule of dilutive shares - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Anti-dilutive shares 496,241,594 79,508,625
Convertible debt [Member]    
Anti-dilutive shares 248,812,128 11,687,855
Stock options [Member]    
Anti-dilutive shares 46,316,666 30,516,666
Warrants to purchase shares of common stock [Member]    
Anti-dilutive shares 201,112,800 37,304,104
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 13, 2022
Jul. 11, 2022
Mar. 31, 2023
Dec. 31, 2022
James Fuller [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares) 200,000      
Exercise price (in Dollars per share) $ 0.04      
Option expense     $ 0 $ 7,993
William Corbett [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares)   15,000,000    
Exercise price (in Dollars per share)   $ 0.15    
Option expense     66,587 1,090,201
Clifford Henry [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares) 200,000      
Exercise price (in Dollars per share) $ 0.04      
Option expense     0 7,993
Financial and capital markets advice     3,500  
Common stock, value $ 7,993      
Madisson Corbett [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares) 200,000      
Exercise price (in Dollars per share) $ 0.04      
Option expense     0 7,993
Common stock, value $ 7,993      
David Rios [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares) 200,000      
Exercise price (in Dollars per share) $ 0.04      
Option expense     0 7,993
Common stock, value $ 7,993      
Richard Rosenblum [Member]        
Related Party Transactions (Textual)        
Shares of common stock (in Shares)   2,000,000    
Option expense     $ 27,879 $ 111,514
Common stock, value   $ 110,000    
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details) - USD ($)
1 Months Ended
May 11, 2023
Jun. 15, 2023
May 10, 2023
Subsequent Event [Member]      
Subsequent Events (Details) [Line Items]      
Aggregate principal amount     $ 117,320
Original issue discount     12,570
Gross proceeds     $ 104,750
Interest charge     13.00%
Maturity date     May 10, 2024
Frictionless agreement description the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless    
Forecast [Member]      
Subsequent Events (Details) [Line Items]      
Interest charge   60.00%  
Repayments amount   $ 13,257.1  
XML 74 f10q0323_innovativepay_htm.xml IDEA: XBRL DOCUMENT 0001591913 2023-01-01 2023-03-31 0001591913 2023-05-10 0001591913 2023-03-31 0001591913 2022-12-31 0001591913 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001591913 us-gaap:PreferredStockMember 2022-03-31 0001591913 us-gaap:CommonStockMember 2022-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001591913 us-gaap:RetainedEarningsMember 2022-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-03-31 0001591913 2022-03-31 0001591913 qpag:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 qpag:QpagosCorporationsCapitalStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2019-11-01 0001591913 2019-11-01 0001591913 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 qpag:GastonPereiraMember 2019-12-31 0001591913 qpag:AndreyNovikovMember 2019-12-31 0001591913 qpag:JosephAbramsMember 2019-12-31 0001591913 qpag:FrictionlessMember 2021-06-22 0001591913 qpag:FrictionlessMember 2023-03-31 0001591913 qpag:FrictionlessMember 2023-01-01 2023-03-31 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2023-03-31 0001591913 qpag:BeyondFintechMember 2021-08-01 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 qpag:BeyondFintechIncMember 2023-03-31 0001591913 qpag:KiosksMember 2023-03-31 0001591913 us-gaap:ComputerEquipmentMember 2023-03-31 0001591913 us-gaap:OfficeEquipmentMember 2023-03-31 0001591913 2022-01-01 2022-12-31 0001591913 2021-01-01 2021-12-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2023-01-01 2023-03-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2023-03-31 0001591913 qpag:PurchaseTechnologyBeyondWalletMember 2022-12-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2023-01-01 2023-03-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2023-03-31 0001591913 qpag:PurchasedTechnologyIPSIPayMember 2022-12-31 0001591913 qpag:FrictionlessFinancialTechnologiesIncMember 2023-01-01 2023-03-31 0001591913 qpag:InvestmentInFrictionlessFinancialTechnologiesIncMember 2023-03-31 0001591913 qpag:InvestmentInFrictionlessFinancialTechnologiesIncMember 2022-12-31 0001591913 2023-01-01 2023-01-01 0001591913 2020-07-01 2020-07-07 0001591913 2021-02-10 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-16 0001591913 2021-02-16 0001591913 qpag:December302022NoteMember 2021-02-16 0001591913 qpag:December302022NoteMember 2021-02-10 2021-02-16 0001591913 qpag:CavalryFundILPMember 2023-03-31 0001591913 qpag:CavalryFundILPMember 2023-01-01 2023-03-31 0001591913 qpag:CavalryFundILPMember 2022-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 2021-02-01 2021-02-16 0001591913 qpag:CavalryAndMercerMember 2021-02-01 2021-02-16 0001591913 2022-02-01 2022-02-03 0001591913 qpag:CavalryAndMercerMember 2022-02-03 0001591913 2022-02-03 0001591913 qpag:CavalryAndMercerMember 2022-02-01 2022-02-03 0001591913 srt:MinimumMember qpag:CavalryAndMercerMember 2023-03-31 0001591913 srt:MaximumMember qpag:CavalryAndMercerMember 2023-03-31 0001591913 qpag:CavalryAndMercerMember 2023-01-01 2023-03-31 0001591913 2022-12-01 2022-12-28 0001591913 qpag:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 srt:MinimumMember 2023-03-31 0001591913 srt:MaximumMember 2023-03-31 0001591913 qpag:CavalryFundILPMember 2021-02-01 2021-02-16 0001591913 qpag:CavalryFundILPMember 2021-02-16 0001591913 qpag:CavalryFundILPMember 2022-11-16 0001591913 qpag:CavalryFundILPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember qpag:CavalryFundILPMember 2022-11-16 0001591913 srt:MaximumMember qpag:CavalryFundILPMember 2022-11-16 0001591913 qpag:CavalryFundILPMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-01 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 srt:MaximumMember qpag:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-03-31 0001591913 2023-02-01 2023-02-23 0001591913 2023-02-01 2023-02-13 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:CavalryFundILPMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:MercerStreetGlobalOpportunityFundLLCMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 qpag:February2023ConvertibleNotesMember us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 us-gaap:ConstructionLoanPayableMember 2023-03-31 0001591913 us-gaap:ConstructionLoanPayableMember 2023-01-01 2023-03-31 0001591913 us-gaap:ConstructionLoanPayableMember 2022-12-31 0001591913 qpag:CavalryAndMercerMember 2023-03-31 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember 2023-01-01 2023-03-31 0001591913 2022-10-01 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 us-gaap:CommonStockMember 2022-08-01 2022-08-30 0001591913 2022-08-02 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 2022-12-01 2022-12-30 0001591913 qpag:DebtConversionNoticesMember 2021-02-01 2021-02-23 0001591913 qpag:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember 2023-03-31 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember 2023-01-01 2023-03-31 0001591913 qpag:TwoThousandTwentyOnePlanMember srt:MaximumMember 2023-03-31 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-01 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-01 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-01 2022-09-13 0001591913 2022-09-13 0001591913 qpag:TotalRestrictedSharesMember 2021-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 qpag:TotalRestrictedSharesMember 2022-12-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 qpag:TotalRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2023-01-01 2023-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-03-31 0001591913 qpag:TotalRestrictedSharesMember 2023-03-31 0001591913 qpag:WeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:TotalVestedRestrictedSharesMember 2023-03-31 0001591913 qpag:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-03-31 0001591913 qpag:ExercisePrice0049Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePriceRange5Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice0055Member 2023-01-01 2023-03-31 0001591913 qpag:WarrantsMember 2023-03-31 0001591913 srt:MinimumMember qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 qpag:WarrantsMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2023-03-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-03-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-03-31 0001591913 qpag:ExercisePrice00115Member 2023-03-31 0001591913 qpag:ExercisePrice00115Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice00345Member 2023-03-31 0001591913 qpag:ExercisePrice00345Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice015Member 2023-03-31 0001591913 qpag:ExercisePrice015Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice0187Member 2023-03-31 0001591913 qpag:ExercisePrice0187Member 2023-01-01 2023-03-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 us-gaap:StockOptionMember 2023-03-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice004Member 2023-03-31 0001591913 qpag:ExercisePrice004Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice024Member 2023-03-31 0001591913 qpag:ExercisePrice024Member 2023-01-01 2023-03-31 0001591913 qpag:ExercisePrice040Member 2023-03-31 0001591913 qpag:ExercisePrice040Member 2023-01-01 2023-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-03-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-03-31 0001591913 qpag:StockOptionsMember 2023-01-01 2023-03-31 0001591913 qpag:StockOptionsMember 2022-01-01 2022-03-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-03-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-03-31 0001591913 qpag:JamesFullerMember 2022-09-01 2022-09-13 0001591913 qpag:JamesFullerMember 2023-01-01 2023-03-31 0001591913 qpag:JamesFullerMember 2022-01-01 2022-12-31 0001591913 qpag:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 qpag:WilliamCorbettMember 2023-01-01 2023-03-31 0001591913 qpag:WilliamCorbettMember 2022-01-01 2022-12-31 0001591913 qpag:CliffordHenryMember 2023-01-01 2023-03-31 0001591913 qpag:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-09-13 0001591913 qpag:CliffordHenryMember 2022-01-01 2022-12-31 0001591913 qpag:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 qpag:MadissonCorbettMember 2022-09-13 0001591913 qpag:MadissonCorbettMember 2023-01-01 2023-03-31 0001591913 qpag:MadissonCorbettMember 2022-01-01 2022-12-31 0001591913 qpag:DavidRiosMember 2022-09-01 2022-09-13 0001591913 qpag:DavidRiosMember 2022-09-13 0001591913 qpag:DavidRiosMember 2023-01-01 2023-03-31 0001591913 qpag:DavidRiosMember 2022-01-01 2022-12-31 0001591913 qpag:RichardRosenblumMember 2022-07-01 2022-07-11 0001591913 qpag:RichardRosenblumMember 2022-07-11 0001591913 qpag:RichardRosenblumMember 2023-01-01 2023-03-31 0001591913 qpag:RichardRosenblumMember 2022-01-01 2022-12-31 0001591913 us-gaap:SubsequentEventMember 2023-05-10 0001591913 srt:ScenarioForecastMember 2023-06-01 2023-06-15 0001591913 srt:ScenarioForecastMember 2023-06-15 0001591913 us-gaap:SubsequentEventMember 2023-05-01 2023-05-11 shares iso4217:USD iso4217:USD shares pure 10-Q true 2023-03-31 2023 false 000-55648 NV 33-1230229 56B 5th Avenue Lot 1 #AT Carmel By The Sea CA 93921 (866) 477-4729 Yes Yes Non-accelerated Filer true false false 376901679 155868 374765 75085 97042 230953 471807 25528 40362 1631739 1692811 47592 47592 500000 500000 2204859 2280765 2435812 2752572 889042 761732 3217 988368 964268 228888 0 2632451 2266602 1609892 2550642 6122970 6543244 159952 163978 159952 163978 6282922 6707222 0.0001 0.0001 25000000 25000000 0 0 0 0 0.0001 0.0001 750000000 750000000 376901679 376901679 376901679 376901679 37690 37690 48788448 48405921 -52673248 -52399858 -3847110 -3956247 1597 -3847110 -3954650 2435812 2752572 433 2085 -1652 965207 869387 140690 4496 1105897 873883 -1107549 -873883 -719558 85221 45766 -22967 -263200 -940750 -92161 -274987 -1810246 -274987 -1810246 -1597 -8752 -273390 -1801494 0 0 376901679 367901679 376901679 37690 48405921 -52399858 1597 -3954650 251856 251856 130671 130671 -273390 -1597 -274987 376901679 37690 48788448 -52673248 -3847110 367901679 36790 45771012 -42111701 35211 3731312 94466 94466 62766 62766 -1801494 -8752 -1810246 367901679 36790 45928244 -43913195 26459 2078298 -274987 -1810246 -940750 -92161 140690 4496 22967 263200 -719558 130671 157232 -21957 -45708 127311 -6221 83837 -42484 -688304 -760918 64783 179030 -64783 -179030 535000 1147063 809 534191 -1147063 -218896 -2087011 374765 5449751 155869 3362740 1384 88250 251856 <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: white"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>1</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>ORGANIZATION AND DESCRIPTION OF BUSINESS</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Organizational History</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Description of current business</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is presently focused on operating and developing e-wallets that enable consumers to deposit cash, convert it into a digital form and remit the funds to Mexico and other countries quickly and securely. The Company’s first e-wallet, Beyond Wallet, is currently operational and is focused on business customers. The Company’s flagship e-wallet, IPSIPay, is also fully operational. IPSIPay, which is focused on individual customers, was fully launched in July 2022 after a soft launch in December 2021. Previously the Company intended to invest in physical kiosks where any payment processing could be undertaken by customers in person. The Company has shifted its business to focus solely on downloadable apps used via smartphones and other online payment processing solutions..</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”) on June 22, 2021. Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.</p> 0.0001 621920 500000 497500 2500 500000 4992900 0.91 320477867 32047817 2250000 2250000 0.09 0.05 0.025 0.015 0.10 0.41 300000 0.01 0.51 0.49 <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: white"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>2</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>ACCOUNTING POLICIES AND ESTIMATES</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Innovative Payment Solutions, Inc. - Parent Company</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Beyond Fintech Inc., 51% owned. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>d)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>e)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>f)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>g)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>h)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No segmental information is required as the Company only has one operating segment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>i)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>j)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>k)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>l)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>m)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>n)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">v.</span></td><td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>o)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>p)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC Topic 815, <i>Derivatives and hedging </i>(“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>q)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>r)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months ended March 31, 2023 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Quarterly Report on Form 10-Q (“Report”) should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2022, included in the Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiary in which it has a majority voting interest. All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The entities included in the accompanying unaudited condensed consolidated financial statements are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Innovative Payment Solutions, Inc. - Parent Company</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Beyond Fintech Inc., 51% owned. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">See Note 15 for subsequent event disclosure regarding the Company’s ownership interest in Beyond Fintech.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.51 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, estimates of the probability and potential magnitude of contingent liabilities, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>d)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Certain conditions may exist as of the date the financial statements are issued, which may result in the generation of continuing losses by the Company, but which will only be resolved when one or more future events occur or fail to occur.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>e)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>f)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. These risks include, without limitation, risks associated with (i) COVID-19 and its variants, (ii) launching and scaling the Company’s e-wallet and related products and the use by customers of such products, (iii) developing and implementing successful marketing campaigns and other strategic initiatives; (iv) competition, (iv) compliance with applicable laws, rules and regulations (including those related to fund remittance); (v) the Company’s outstanding indebtedness, including the Company’s ability to repay or extend the maturity of such indebtedness (see Note 8); (vi) inflation and other economic factors and (vii) the Company’s ability to obtain necessary financing. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s results may also be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things. Many of these risks are beyond the Company’s control and are unpredictable. The Company may be unable to adequately manage such risks and similar risks, which could impair the viability of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>g)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended March 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s condensed consolidated financial statements upon adoption.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>h)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">No segmental information is required as the Company only has one operating segment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> 1 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>i)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At March 31, 2023 and December 31, 2022, respectively, the Company had no cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At March 31, 2023 and December 31, 2022, the balance exceed the federally insured limit by $0 and $120,580, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 0 120580 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>j)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended March 31, 2023 and December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>k)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 0.20 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>l)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 2%"> </td> <td style="width: 49%; border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks (not used in the Company’s current business)</span></td> <td> </td> <td><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> P7Y P3Y P10Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>m)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>n)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, <i>Revenue Recognition</i>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">i.</span></td><td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">ii.</span></td><td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">iii.</span></td><td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">iv.</span></td><td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">v.</span></td><td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company had minimal revenues of $433 and $0 for the three months ended March 31, 2023 and 2022, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 433 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>o)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>p)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ASC Topic 815, <i>Derivatives and hedging </i>(“ASC 815”) generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>q)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of March 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>r)</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><b>3</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>LIQUIDITY MATTERS AND GOING CONCERN</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the three months ended March 31, 2023 and the year ended December 31, 2022, the Company had a net loss of $274,987 and $10,331,424, respectively. In connection with preparing the unaudited condensed consolidated financial statements for the three months ended March 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The accompanying financial statements for the three months ended March 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has determined that there is substantial doubt about their ability to continue as a going concern.</p> 274987 10331424 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>4</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>INTANGIBLES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On August 26, 2021, the Company formed a subsidiary, Beyond Fintech. to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owns 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $41,320  and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the three months ended March 31, 2023, an additional $1,127,400 and $28,893, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="10" style="text-align: center"><b>March 31, <br/> 2023</b></td> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31, <br/> 2022</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b> Cost</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/> amortization</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Book<br/> Value</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net book<br/> value</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Purchase Technology – Beyond Wallet</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">327,211</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">327,211</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">291,320</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Purchased Technology - IPSIPay</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,531,293</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(226,765</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,304,528</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,401,491</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,858,504</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(226,765</td> <td style="padding-bottom: 4pt; text-align: left">)</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,631,739</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,692,811</td> <td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Amortization expense was $125,856 and $0 for the three months ended March 31, 2023 and 2022, respectively.</p> 250000 0.51 0.49 41320 35891 375000 1127400 28893 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="10" style="text-align: center"><b>March 31, <br/> 2023</b></td> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31, <br/> 2022</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b> Cost</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accumulated<br/> amortization</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net Book<br/> Value</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net book<br/> value</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Purchase Technology – Beyond Wallet</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">327,211</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">327,211</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">291,320</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Purchased Technology - IPSIPay</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,531,293</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(226,765</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,304,528</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,401,491</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,858,504</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">(226,765</td> <td style="padding-bottom: 4pt; text-align: left">)</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,631,739</td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">1,692,811</td> <td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> 327211 327211 291320 1531293 -226765 1304528 1401491 1858504 -226765 1631739 1692811 125856 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>5</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>INVESTMENTS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Investment in Frictionless Financial Technologies Inc.</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired. See Note 15 for subsequent event disclosure regarding the Company’s relationship with Frictionless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The shares in Frictionless are unlisted as of March 31, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31,<br/> 2022</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 74%"><span style="font-size: 10pt">Investment in Frictionless Financial Technologies, Inc.</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right; width: 10%"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right; width: 10%"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table> 0.41 300000 0.01 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023</b></p></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31,<br/> 2022</b></span></td> <td style="white-space: nowrap; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 74%"><span style="font-size: 10pt">Investment in Frictionless Financial Technologies, Inc.</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right; width: 10%"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 1%"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right; width: 10%"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 1.5pt; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">500,000</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table> 500000 500000 500000 500000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>6</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>LEASES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5<sup>th</sup> Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90 day termination clause, for a monthly rental of $5,088.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Total Lease Cost</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Individual components of the total lease cost incurred by the Company is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,400</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Other lease information:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,264</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(14,400</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td></tr> </table> The lease commenced on April 1, 2021 and is for a twelve month period, terminating on April 1, 2022. 4800 5088 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15,264</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">14,400</td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> 15264 14400 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three months<br/> ended<br/> March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(15,264</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(14,400</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td></tr> </table> -15264 -14400 Monthly Monthly <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>7</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>FEDERAL RELIEF LOANS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><b>Small Business Administration Disaster Relief loan</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Company has repaid an aggregate principal amount of $809 and interest of $1,384 as of March 31, 2023. The loan balance outstanding as of March 31, 2023, consists of principal of $149,191 and accrued interest thereon of $13,978, of which $3,217 is disclosed as current.</p> 150000 0.0375 731 809 1384 149191 13978 3217 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>8</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>NOTES PAYABLE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Notes payable consists of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2023<br/> Amount, net</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022<br/> Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 29%; text-align: left">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">10</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: center">December 30, 2023</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">482,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">12,184</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">494,184</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">482,134</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Mercer Street Global Opportunity Fund, LLC</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right">10</td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">December 30, 2023</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">482,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,184</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">494,184</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">482,134</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,000</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">24,368</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">988,368</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,268</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Interest expense totaled $24,100 and $0 for the three months ended March 31, 2023 and 2022, respectively.</p> 500500 500500 0.125 572000 2486957 0.24 482000 964000 43608 920392 2023-12-30 0.10 51901711 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2023<br/> Amount, net</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022<br/> Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 29%; text-align: left">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">10</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: center">December 30, 2023</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">482,000</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">12,184</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">494,184</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 8%; text-align: right">482,134</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Mercer Street Global Opportunity Fund, LLC</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right">10</td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">December 30, 2023</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">482,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,184</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">494,184</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">482,134</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,000</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">24,368</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">988,368</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,268</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">  </p> 0.10 December 30, 2023 482000 12184 494184 482134 0.10 December 30, 2023 482000 12184 494184 482134 964000 24368 988368 964268 24100 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>9</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>CONVERTIBLE NOTES PAYABLE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><b>December 2022 Note Amendment Transaction</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">On February 16, 2021, we entered into separate SPAs with each of Cavalry and Mercer, pursuant to which we received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.24 per share. Cavalry and Mercer are Selling Stockholders listed in this prospectus.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Original Warrants are discussed in note 8 above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under their respective Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">On December 30, 2022, the Company again extended the maturity dates of each of the Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The conversion price of the Notes was reduced from $0.15 to $0.0115 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Notes). As a result of this change in conversion price, under the existing terms of the Notes, the 3,000,000 shares of common stock underlying the Extension Warrants was increased to 39,130,435 shares;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Notes until after March 30, 2023 and (ii) waive any events of default under the Notes and the SPAs;</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the common stock is $0.06 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $0.04 per share; and</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-size: 10pt">The company was obligated to register the shares of common stock underlying the Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The parties also acknowledged that the principal and accrued interest under the Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.0115 per share. All of the shares of our common stock underlying the Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to the filed registration statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The amendments to the convertible debt were evaluated in terms of ASC470, Debt, to determine if the amendments to the convertible debt were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the convertible notes from $0.15 to $0.0115 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the convertible note holders valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (Note 8 above) and the value of full rachet provisions of certain of the warrants issued to the convertible note holders amounting to $841,003, see note 12 below, the amendment of the convertible notes was determined to be a debt extinguishment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Convertible notes payable consists of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unamortized<br/> debt discount</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>March 31, 2023 Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022 Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 16%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 21%; text-align: center">December 30,  <br/>2023</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,091,754</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">68,841</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">          -</div></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,160,595</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,133,301</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: center">December 30,  <br/>2023</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,091,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">68,841</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,160,595</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,133,301</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: top">February 2023 convertible notes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right">8</td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">February 13, 2024 <br/>to February 23, 2024</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">535,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">5,149</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(228,888</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">311,261</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,718,508</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">142,831</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(228,888</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,632,451</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,266,602</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Interest expense totaled $59,737 and $44,379 for the three months ended March 31, 2023 and 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Amortization of debt discount totaled $22,967 and $263,200 for the three months ended March 31, 2023 and 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Cavalry and Mercer convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the common stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i>Cavalry Fund LLP</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On February 16, 2021, the Company closed a transaction with Cavalry, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The balance of the Cavalry Note plus accrued interest at March 31, 2023 was $1,160,595.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i>Mercer Street Global Opportunity Fund, LLC</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of common stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 2,486,957 shares of common stock at an initial exercise price of $0.24 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 3,000,000 shares of common stock at an exercise price of $0.15 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $0.15 to $0.0115 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of common stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The balance of the Mercer Note plus accrued interest at March 31, 2023 was $1,160,595.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i>February 2023 convertible notes</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Between February 13, 2023 and February 23, 2023, the Company, entered into Securities Purchase Agreements (the “Securities Purchase Agreement”) with 11 accredited investors, pursuant to which the Company received an aggregate of $535,000 in gross proceeds from the Investors through the initial closing of a private placement issuance of:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-size: 10pt">Convertible Notes Promissory (the “Notes” and each a “Note”); and</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-size: 10pt">five-year warrants (the “Warrants”) to purchase an aggregate 46,521,739 shares of the Company’s common stock (the “Common Stock”) at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Notes mature in 12 months, bears interest at a rate of 8% per annum, and are convertible into shares of Common Stock at a conversion price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Notes and the Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The balance of the February 2023 Notes plus accrued interest at March 31, 2023 was $311,261, net of unamortized debt discount of $228,888.</p> 500500 500500 12.5 572000 2486957 0.24 2022-08-16 0.20 3000000 0.15 0.15 0.0115 3000000 39130435 482000 2023-12-30 0.10 51901711 0.06 0.04 2264784 1132392 0.0115 836414 0.15 0.0115 1499577 238182 920392 43608 964000 841003 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; vertical-align: bottom">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Unamortized<br/> debt discount</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>March 31, 2023 Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><b>December 31, 2022 Amount, net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 16%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 21%; text-align: center">December 30,  <br/>2023</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,091,754</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">68,841</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">          -</div></td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,160,595</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 7%; text-align: right">1,133,301</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: center">December 30,  <br/>2023</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,091,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">68,841</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,160,595</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,133,301</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: top">February 2023 convertible notes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right">8</td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">February 13, 2024 <br/>to February 23, 2024</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">535,000</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">5,149</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(228,888</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">311,261</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: top"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,718,508</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">142,831</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(228,888</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,632,451</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,266,602</td> <td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.10 December 30,  2023 1091754 68841 1160595 1133301 0.10 December 30,  2023 1091754 68841 1160595 1133301 0.08 February 13, 2024 to February 23, 2024 535000 5149 228888 311261 2718508 142831 228888 2632451 2266602 59737 44379 22967 263200 500500 71500 572000 0.10 0.23 2486957 0.24 0.20 3000000 0.15 0.15 0.0115 1160595 500500 71500 572000 0.10 0.23 2486957 0.24 0.20 3000000 0.15 0.15 0.0115 1160595 535000 535000 46521739 0.0115 0.08 0.0115 0.0499 0.0999 311261 228888 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>10</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>DERIVATIVE LIABILITY</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Certain of the short-term convertible notes disclosed in note 9 above and certain warrants disclosed in note 11 below, have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 9 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The net movement on the derivative liability for the three months ended March 31, 2023 was a net mark-to-market release of derivative liability of $940,750, determined by using a Black-Scholes valuation model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following assumptions were used in the Black-Scholes valuation model:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended March 31, 2023</b>    </span></td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Conversion price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.0115</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0115 to $0.15 </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.60 to 4.79</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.79 to 4.73 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9 to 53 months</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  158.72 to 192.53</span></td><td style="text-align: left">%</td><td/> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  120.49 to 258.3 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The movement in derivative liability is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,<br/> 2023</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2022</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,550,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Derivative financial liability arising on note amendment included in loss on convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,317,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(940,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(411,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,609,892</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,550,642</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 474614 2317051 940750 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended March 31, 2023</b>    </span></td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended December 31, 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Conversion price</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.0115</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0115 to $0.15 </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.60 to 4.79</span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.79 to 4.73 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9 to 53 months</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  158.72 to 192.53</span></td><td style="text-align: left">%</td><td/> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  120.49 to 258.3 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.0115 0.0115 0.15 0.036 0.0479 0.0079 0.0473 P9Y P53Y P1Y6M P59Y 1.5872 1.9253 1.2049 2.583 0 0 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,<br/> 2023</b></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2022</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,550,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Derivative financial liability arising on note amendment included in loss on convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,317,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(940,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(411,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,609,892</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,550,642</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 2550642 407161 238182 2317051 -940750 -411752 1609892 2550642 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>11</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>STOCKHOLDERS’ EQUITY</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>a.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Common Stock</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has total authorized Common Stock of 750,000,000  shares with a par value of $0.0001 each. The Company had 376,901,679 shares of Common Stock issued and outstanding as of March 31, 2023 and December 31, 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>b.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Restricted stock awards</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A summary of restricted stock activity during the period January 1, 2022 to March 31, 2023 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> unvested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total vested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,247,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,247,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,495,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,123,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,371,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding March 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.049</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The restricted stock granted, issued and exercisable at March 31, 2023 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Granted and Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Grant date Price</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td> <td style="width: 75%; text-align: left">0.049</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td> <td style="text-align: left">0.050</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: left; padding-bottom: 1.5pt">0.055</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has recorded an expense of $0 and $62,766 for the three months March 31, 2023 and 2022, respectively. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>c.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Preferred Stock</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of March 31, 2023 and December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>d.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Warrants</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90<sup>th</sup> day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August 30, 2022, the Company extended the maturity date of convertible notes issued to Cavalry and Mercer and agreed to grant each note holder a warrant exercisable for 3,000,000 shares of Common Stock at an exercise price of $0.15 per share with an expiration date of August 30, 2027.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 30, 2022, the Company issued to Frictionless a 5 year warrant to purchase 30,000,000 shares of common stock in the Company at an exercise price of $0.0115 per share as disclosed in note 5 above. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. Subsequent to March 31, 2023, the Company entered into an agreement to cancel this warrant (see Note 15).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: top"> <td style="width: 7%"> </td> <td style="width: 3%"><span style="font-size: 10pt">●</span></td> <td style="width: 90%; text-align: justify"><span style="font-size: 10pt">The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%"> </td> <td style="width: 3%"><span style="font-size: 10pt">●</span></td> <td style="width: 90%; text-align: justify"><span style="font-size: 10pt">The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%"> </td> <td style="width: 3%"><span style="font-size: 10pt">●</span></td> <td style="width: 90%; text-align: justify"><span style="font-size: 10pt">An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">Between February 13, 2023 and February 23, 2023, the Company entered into Securities Purchase Agreements with 11 accredited investors, as disclosed in Note 9 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 46,521,739 shares of the Company’s common stock at an exercise price of $0.0115 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">The Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61<sup>st </sup>day after such notice.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Three months<br/> ended<br/> March 31,<br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 90%"><span style="font-size: 10pt">Exercise price</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 7%; text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">3.93 to 4.16</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Expected life</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">5 years </span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Expected volatility of underlying stock</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">189.15 to 189.37</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Expected dividend rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A summary of warrant activity during the period January 1, 2022 to March 31, 2023 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Shares<br/> Underlying<br/> Warrants</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> price per<br/> share</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Weighted<br/> average<br/> exercise price</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%"><span style="font-size: 10pt"><b>Outstanding January 1, 2022</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">37,304,105</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05 – 0.1875</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">0.12</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">51,000,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.0345</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.01826</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Increase in warrants due to debt amendment full rachet trigger</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">72,260,870</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Cancelled on debt amendment</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(4,973,914</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.1500</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-84">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt"><b>Outstanding December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">155,591,061</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.1875</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.0300</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">46,521,739</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Forfeited</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(1,000,000</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Cancelled on debt amendment</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-87">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-90">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-size: 10pt"><b>Outstanding March 31, 2023</b></span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">201,112,800</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.1875</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.0256</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The warrants outstanding and exercisable at March 31, 2023 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.0115</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">168,519,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">4.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">168,519,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">4.48</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td style="text-align: right">0.0345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,312,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.27</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.1875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">201,112,800</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4.18</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0256</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,425,300</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0256</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4.23</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The warrants outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>e.</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>Stock options</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The maximum number of securities available under the Plan is 800,000 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The maximum number of securities available under the 2021 Plan is 53,000,000 shares of Common Stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the 2021 Plan the company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> <b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On July 11, 2022, the Board approved, granted and issued 15,000,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $0.15 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 13, 2022, the Company granted ten-year options exercisable for 200,000 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 800,000 shares of Common Stock at an exercise price of $0.04 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A summary of option activity during the period January 1, 2022 to March 31, 2023 is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Shares<br/> Underlying<br/> options</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> price per<br/> share</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Weighted<br/> average<br/> exercise<br/> price</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%"><span style="font-size: 10pt"><b>Outstanding January 1, 2022</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">30,516,666</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.15 to 0.40</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">0.15</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">15,800,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.04 – 0.15</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.14</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-93">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-96">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><b>Outstanding December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">46,316,666</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$ </span></td> <td style="text-align: right"><span style="font-size: 10pt">0.04 to 0.40</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-98; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-99">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-102">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-105">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-size: 10pt"><b>Outstanding March 31, 2023</b></span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">46,316,666</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$ </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.04 to 0.40</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.15</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The options outstanding and exercisable at March 31, 2023 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Exercise  Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">9.46</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">9.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.74</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.40</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.75</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.75</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8.69</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">39,233,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8.75</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The options outstanding have an intrinsic value of $0 as of March 31, 2023 and March 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The option expense was $94,464 and $94,466 for the three months ended March 31, 2023 and 2022, respectively. </p> 750000000 0.0001 376901679 376901679 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<br/> unvested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per<br/> share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total vested<br/> restricted<br/> shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> average<br/> fair market<br/> value per share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10,247,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,247,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.055</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,495,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,123,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.049</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,371,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted and issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vested</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.049</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,123,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.049</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding March 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">-</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.049</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 21495000 0.049 10247500 0.049 11247500 0.049 2000000 0.055 2000000 0.055 -5123750 -0.049 5123750 0.049 23495000 0.05 5123750 0.049 18371250 0.05 -5123750 -0.049 5123750 0.049 23495000 0.05 0.049 23495000 0.05 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Restricted Stock Granted and Vested</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-weight: bold; border-bottom: Black 1.5pt solid">Grant date Price</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number Granted</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Fair Value per Share</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td> <td style="width: 75%; text-align: left">0.049</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,495,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.049</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td> <td style="text-align: left">0.050</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.050</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">$</td> <td style="text-align: left; padding-bottom: 1.5pt">0.055</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.055</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td colspan="2" style="text-align: left; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">23,495,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.050</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 20495000 0.049 1000000 0.05 2000000 0.055 23495000 0.05 0 62766 25000000 0.0001 (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. 3000000 0.15 2027-08-30 30000000 0.0115 348938 the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred:   ● The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above;     ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.     ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.   46521739 0.0115 0.0499 0.0999 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Three months<br/> ended<br/> March 31,<br/> 2023</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 90%"><span style="font-size: 10pt">Exercise price</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 7%; text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Risk free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">3.93 to 4.16</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Expected life</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">5 years </span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-size: 10pt">Expected volatility of underlying stock</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">189.15 to 189.37</span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Expected dividend rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0</span></td> <td><span style="font-size: 10pt">%</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.0115 0.0393 0.0416 P5Y 1.8915 1.8937 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Shares<br/> Underlying<br/> Warrants</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> price per<br/> share</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Weighted<br/> average<br/> exercise price</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 62%"><span style="font-size: 10pt"><b>Outstanding January 1, 2022</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">37,304,105</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-size: 10pt">0.05 – 0.1875</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">0.12</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">51,000,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.0345</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.01826</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Increase in warrants due to debt amendment full rachet trigger</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">72,260,870</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Cancelled on debt amendment</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(4,973,914</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.1500</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-83; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-84">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-85; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt"><b>Outstanding December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">155,591,061</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.1875</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.0300</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">46,521,739</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.0115</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.0115</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Forfeited</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">(1,000,000</span></td> <td><span style="font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.05</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Cancelled on debt amendment</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-86; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-87">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-88; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-89; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-90">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-size: 10pt"><b>Outstanding March 31, 2023</b></span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">201,112,800</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt"> 0.0115 – 0.1875</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.0256</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 37304105 0.05 0.1875 0.12 51000000 0.0115 0.0345 0.01826 72260870 0.0115 0.0115 -4973914 0.15 0.15 155591061 0.0115 0.1875 0.03 46521739 0.0115 0.0115 -1000000 0.05 0.05 201112800 0.0115 0.1875 0.0256 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Warrants Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.0115</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">168,519,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">4.48</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">168,519,466</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">4.48</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td style="text-align: right">0.0345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,312,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.27</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.96</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,166,667</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.96</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.1875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,426,667</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">201,112,800</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4.18</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0256</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">196,425,300</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.0256</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">4.23</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.0115 168519466 P4Y5M23D 168519466 P4Y5M23D 0.0345 15000000 P2Y3M7D 10312500 P2Y3M7D 0.15 15166667 P2Y11M15D 15166667 P2Y11M15D 0.1875 2426667 P2Y11M15D 2426667 P2Y11M15D 201112800 P4Y2M4D 0.0256 196425300 0.0256 P4Y2M23D 0 0 P10Y 800000 100000 P10Y 53000000 15000000 0.15 823854 200000 800000 0.04 31970 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Shares<br/> Underlying<br/> options</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Exercise<br/> price per<br/> share</b></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Weighted<br/> average<br/> exercise<br/> price</b></span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 65%"><span style="font-size: 10pt"><b>Outstanding January 1, 2022</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">30,516,666</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-size: 10pt">0.15 to 0.40</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$</span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">0.15</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">15,800,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"> 0.04 – 0.15</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">0.14</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-93">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-96">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-97; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt"><b>Outstanding December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">46,316,666</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$ </span></td> <td style="text-align: right"><span style="font-size: 10pt">0.04 to 0.40</span></td> <td> </td> <td> </td> <td><span style="font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-size: 10pt">0.15</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-98; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-99">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-100; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-size: 10pt">Forfeited/Cancelled</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-101; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-102">-</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-103; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-size: 10pt">Exercised</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-104; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: hidden-fact-105">-</span></span></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-106; font-size: 10pt">-</span></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-size: 10pt"><b>Outstanding March 31, 2023</b></span></td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">46,316,666</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$ </span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.04 to 0.40</span></td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">0.15</span></td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 30516666 0.15 0.4 0.15 15800000 0.04 0.15 0.14 46316666 0.04 0.4 0.15 46316666 0.04 0.4 0.15 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Options Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Exercise  Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number<br/> Exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.04</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">9.46</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">800,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">9.46</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td style="text-align: right">0.15</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.69</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,125,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8.74</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.90</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">208,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.40</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.75</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">100,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">5.75</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">46,316,666</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8.69</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">39,233,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.15</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8.75</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.04 800000 P9Y5M15D 800000 P9Y5M15D 0.15 45208333 P8Y8M8D 38125000 P8Y8M26D 0.24 208333 P7Y10M24D 208333 P7Y10M24D 0.4 100000 P5Y9M 100000 P5Y9M 46316666 P8Y8M8D 0.15 39233333 0.15 P8Y9M 0 0 94464 94466 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>12</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>NET LOSS PER SHARE</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2023 and 2022 all warrants, options and convertible debt securities were excluded from the computation of diluted net loss per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2023 and 2022 are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2023<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">248,812,128</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,687,855</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,316,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,112,800</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">496,241,594</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">79,508,625</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2023<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31,<br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">248,812,128</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">11,687,855</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,316,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,516,666</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">201,112,800</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,304,104</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">496,241,594</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">79,508,625</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 248812128 248812128 11687855 11687855 46316666 46316666 30516666 30516666 201112800 201112800 37304104 37304104 496241594 496241594 79508625 79508625 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>13</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following transactions were entered into with related parties:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>James Fuller</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Mr. Fuller was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>William Corbett</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 15,000,000 shares of Common Stock at an exercise price of $0.15 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Mr. Corbett was $66,587 and $1,090,201  for the three months ended March 31, 2023 and the year ended December 31, 20221, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Clifford Henry</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Mr. Henry was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Madisson Corbett</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 13, 2022, the Company granted Ms. Corbett, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Ms. Corbett was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>David Rios</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 200,000 shares of Common Stock at an exercise price of $0.04 per share, valued at $7,993 using a Black Scholes valuation model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Mr. Rios was $0 and $7,993 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Richard Rosenblum</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On July 11, 2022, the Company granted Mr. Rosenblum 2,000,000 restricted shares of Common Stock valued at $110,000, all of which are vested.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The option expense for Mr. Rosenblum was $27,879 and $111,514 for the three months ended March 31, 2023 and the year ended December 31, 2022, respectively.</p> 200000 0.04 0 7993 15000000 0.15 66587 1090201 3500 200000 0.04 7993 0 7993 200000 0.04 7993 0 7993 200000 0.04 7993 0 7993 2000000 110000 27879 111514 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>14</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>COMMITMENTS AND CONTINGENCIES</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has notes payable and convertible notes payable, disclosed under note 8 and 9 above, which mature between December 30, 2023 and February 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>15</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On April 28, 2023, the Company formed a new Delaware limited liability company called IPSIPay Express LLC. This entity was formed as a three-way joint venture with two other entities to develop and market <span style="background-color: white">a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. As of the date of issuance of these financial statements, definitive documentation memorializing the joint venture are being finalized.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On May 10, 2023, the Company entered into a Securities Purchase Agreement with 1800 Diagonal Lending LLC (“1800”) pursuant to which the Company issued a promissory note (the “1800 Note”) to 1800 in the aggregate principal amount of $117,320 (including $12,570 of original issue discount) for gross proceeds to the Company of $104,750. The 1800 Note carries a one-time interest charge equal to thirteen percent (13%) of the principal amount of the 1800 Note. The 1800 Note is unsecured, has a maturity date of May 10, 2024, carries a default interest rate of twenty-two percent (22%) per annum and contains customary events of default. The Company is required to begin mandatory monthly repayments of the 1800 Note beginning June 15, 2023 in the amount of $13,257.10 per month. Only following an event of default under the 1800 Note, the principal amount then outstanding under the 1800 Note (plus, at 1800’s option accrued interest thereon, including default interest if applicable) is convertible into shares of Common Stock at a price equal to sixty (60%) multiplied by the lowest trading price for the Common Stock during the twenty (20) trading days prior to the date of conversion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.</p> 117320 12570 104750 0.13 2024-05-10 13257.1 0.60 the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 30,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18 month period following the closing under the existing software services between the Company and Frictionless Innovative Payment Solutions, Inc. 0.00 0.00 376901679 376901679 false --12-31 Q1 0001591913 EXCEL 75 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 77 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 78 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 252 349 1 false 66 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://innovativepaymentssolu.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Sheet http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Sheet http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://innovativepaymentssolu.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Organization and Description of Business Sheet http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 8 false false R9.htm 008 - Disclosure - Accounting Policies and Estimates Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimates Accounting Policies and Estimates Notes 9 false false R10.htm 009 - Disclosure - Liquidity Matters and Going Concern Sheet http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcern Liquidity Matters and Going Concern Notes 10 false false R11.htm 010 - Disclosure - Intangibles Sheet http://innovativepaymentssolu.com/role/Intangibles Intangibles Notes 11 false false R12.htm 011 - Disclosure - Investments Sheet http://innovativepaymentssolu.com/role/Investments Investments Notes 12 false false R13.htm 012 - Disclosure - Leases Sheet http://innovativepaymentssolu.com/role/Leases Leases Notes 13 false false R14.htm 013 - Disclosure - Federal Relief Loans Sheet http://innovativepaymentssolu.com/role/FederalReliefLoans Federal Relief Loans Notes 14 false false R15.htm 014 - Disclosure - Notes Payable Notes http://innovativepaymentssolu.com/role/NotesPayable Notes Payable Notes 15 false false R16.htm 015 - Disclosure - Convertible Notes Payable Notes http://innovativepaymentssolu.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 16 false false R17.htm 016 - Disclosure - Derivative Liability Sheet http://innovativepaymentssolu.com/role/DerivativeLiability Derivative Liability Notes 17 false false R18.htm 017 - Disclosure - Stockholders??? Equity Sheet http://innovativepaymentssolu.com/role/StockholdersEquity Stockholders??? Equity Notes 18 false false R19.htm 018 - Disclosure - Net Loss Per Share Sheet http://innovativepaymentssolu.com/role/NetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 019 - Disclosure - Related Party Transactions Sheet http://innovativepaymentssolu.com/role/RelatedPartyTransactions Related Party Transactions Notes 20 false false R21.htm 020 - Disclosure - Commitments and Contingencies Sheet http://innovativepaymentssolu.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 21 false false R22.htm 021 - Disclosure - Subsequent Events Sheet http://innovativepaymentssolu.com/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 022 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimates 23 false false R24.htm 023 - Disclosure - Accounting Policies and Estimates (Tables) Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesTables Accounting Policies and Estimates (Tables) Tables http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimates 24 false false R25.htm 024 - Disclosure - Intangibles (Tables) Sheet http://innovativepaymentssolu.com/role/IntangiblesTables Intangibles (Tables) Tables http://innovativepaymentssolu.com/role/Intangibles 25 false false R26.htm 025 - Disclosure - Investments (Tables) Sheet http://innovativepaymentssolu.com/role/InvestmentsTables Investments (Tables) Tables http://innovativepaymentssolu.com/role/Investments 26 false false R27.htm 026 - Disclosure - Leases (Tables) Sheet http://innovativepaymentssolu.com/role/LeasesTables Leases (Tables) Tables http://innovativepaymentssolu.com/role/Leases 27 false false R28.htm 027 - Disclosure - Notes Payable (Tables) Notes http://innovativepaymentssolu.com/role/NotesPayableTables Notes Payable (Tables) Tables http://innovativepaymentssolu.com/role/NotesPayable 28 false false R29.htm 028 - Disclosure - Convertible Notes Payable (Tables) Notes http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://innovativepaymentssolu.com/role/ConvertibleNotesPayable 29 false false R30.htm 029 - Disclosure - Derivative Liability (Tables) Sheet http://innovativepaymentssolu.com/role/DerivativeLiabilityTables Derivative Liability (Tables) Tables http://innovativepaymentssolu.com/role/DerivativeLiability 30 false false R31.htm 030 - Disclosure - Stockholders??? Equity (Tables) Sheet http://innovativepaymentssolu.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://innovativepaymentssolu.com/role/StockholdersEquity 31 false false R32.htm 031 - Disclosure - Net Loss Per Share (Tables) Sheet http://innovativepaymentssolu.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://innovativepaymentssolu.com/role/NetLossPerShare 32 false false R33.htm 032 - Disclosure - Organization and Description of Business (Details) Sheet http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness 33 false false R34.htm 033 - Disclosure - Accounting Policies and Estimates (Details) Sheet http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails Accounting Policies and Estimates (Details) Details http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesTables 34 false false R35.htm 034 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets Sheet http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets Details http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesTables 35 false false R36.htm 035 - Disclosure - Liquidity Matters and Going Concern (Details) Sheet http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcernDetails Liquidity Matters and Going Concern (Details) Details http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcern 36 false false R37.htm 036 - Disclosure - Intangibles (Details) Sheet http://innovativepaymentssolu.com/role/IntangiblesDetails Intangibles (Details) Details http://innovativepaymentssolu.com/role/IntangiblesTables 37 false false R38.htm 037 - Disclosure - Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software Sheet http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software Details http://innovativepaymentssolu.com/role/IntangiblesTables 38 false false R39.htm 038 - Disclosure - Investments (Details) Sheet http://innovativepaymentssolu.com/role/InvestmentsDetails Investments (Details) Details http://innovativepaymentssolu.com/role/InvestmentsTables 39 false false R40.htm 039 - Disclosure - Investments (Details) - Schedule of investment Sheet http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable Investments (Details) - Schedule of investment Details http://innovativepaymentssolu.com/role/InvestmentsTables 40 false false R41.htm 040 - Disclosure - Leases (Details) Sheet http://innovativepaymentssolu.com/role/LeasesDetails Leases (Details) Details http://innovativepaymentssolu.com/role/LeasesTables 41 false false R42.htm 041 - Disclosure - Leases (Details) - Schedule of total lease cost Sheet http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable Leases (Details) - Schedule of total lease cost Details http://innovativepaymentssolu.com/role/LeasesTables 42 false false R43.htm 042 - Disclosure - Leases (Details) - Schedule of other lease information Sheet http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable Leases (Details) - Schedule of other lease information Details http://innovativepaymentssolu.com/role/LeasesTables 43 false false R44.htm 043 - Disclosure - Federal Relief Loans (Details) Sheet http://innovativepaymentssolu.com/role/FederalReliefLoansDetails Federal Relief Loans (Details) Details http://innovativepaymentssolu.com/role/FederalReliefLoans 44 false false R45.htm 044 - Disclosure - Notes Payable (Details) Notes http://innovativepaymentssolu.com/role/NotesPayableDetails Notes Payable (Details) Details http://innovativepaymentssolu.com/role/NotesPayableTables 45 false false R46.htm 045 - Disclosure - Notes Payable (Details) - Schedule of notes payable Notes http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable Notes Payable (Details) - Schedule of notes payable Details http://innovativepaymentssolu.com/role/NotesPayableTables 46 false false R47.htm 046 - Disclosure - Convertible Notes Payable (Details) Notes http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails Convertible Notes Payable (Details) Details http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables 47 false false R48.htm 047 - Disclosure - Convertible Notes Payable (Details) - Schedule of convertible notes payable Notes http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable Convertible Notes Payable (Details) - Schedule of convertible notes payable Details http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables 48 false false R49.htm 048 - Disclosure - Derivative Liability (Details) Sheet http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails Derivative Liability (Details) Details http://innovativepaymentssolu.com/role/DerivativeLiabilityTables 49 false false R50.htm 049 - Disclosure - Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model Sheet http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model Details http://innovativepaymentssolu.com/role/DerivativeLiabilityTables 50 false false R51.htm 050 - Disclosure - Derivative Liability (Details) - Schedule of movement in derivative liability Sheet http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable Derivative Liability (Details) - Schedule of movement in derivative liability Details http://innovativepaymentssolu.com/role/DerivativeLiabilityTables 51 false false R52.htm 051 - Disclosure - Stockholders??? Equity (Details) Sheet http://innovativepaymentssolu.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 52 false false R53.htm 052 - Disclosure - Stockholders??? Equity (Details) - Schedule of restricted stock activity Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable Stockholders??? Equity (Details) - Schedule of restricted stock activity Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 53 false false R54.htm 053 - Disclosure - Stockholders??? Equity (Details) - Schedule of restricted stock granted and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable Stockholders??? Equity (Details) - Schedule of restricted stock granted and exercisable Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 54 false false R55.htm 054 - Disclosure - Stockholders??? Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model Sheet http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable Stockholders??? Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 55 false false R56.htm 055 - Disclosure - Stockholders??? Equity (Details) - Schedule of warrant activity Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable Stockholders??? Equity (Details) - Schedule of warrant activity Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 56 false false R57.htm 056 - Disclosure - Stockholders??? Equity (Details) - Schedule of warrants outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable Stockholders??? Equity (Details) - Schedule of warrants outstanding and exercisable Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 57 false false R58.htm 057 - Disclosure - Stockholders??? Equity (Details) - Schedule of option activity Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable Stockholders??? Equity (Details) - Schedule of option activity Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 58 false false R59.htm 058 - Disclosure - Stockholders??? Equity (Details) - Schedule of options outstanding and exercisable Sheet http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable Stockholders??? Equity (Details) - Schedule of options outstanding and exercisable Details http://innovativepaymentssolu.com/role/StockholdersEquityTables 59 false false R60.htm 059 - Disclosure - Net Loss Per Share (Details) - Schedule of dilutive shares Sheet http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable Net Loss Per Share (Details) - Schedule of dilutive shares Details http://innovativepaymentssolu.com/role/NetLossPerShareTables 60 false false R61.htm 060 - Disclosure - Related Party Transactions (Details) Sheet http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://innovativepaymentssolu.com/role/RelatedPartyTransactions 61 false false R62.htm 061 - Disclosure - Subsequent Events (Details) Sheet http://innovativepaymentssolu.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://innovativepaymentssolu.com/role/SubsequentEvents 62 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:EarningsPerShareDiluted, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - f10q0323_innovativepay.htm 5579, 5590, 5591, 5592, 5593 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare - f10q0323_innovativepay.htm 5690 f10q0323_innovativepay.htm f10q0323ex10-1_innovativepay.htm f10q0323ex31-1_innovativepay.htm f10q0323ex31-2_innovativepay.htm f10q0323ex32-1_innovativepay.htm f10q0323ex32-2_innovativepay.htm qpag-20230331.xsd qpag-20230331_cal.xml qpag-20230331_def.xml qpag-20230331_lab.xml qpag-20230331_pre.xml http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 81 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0323_innovativepay.htm": { "axisCustom": 0, "axisStandard": 19, "baseTaxonomies": { "http://fasb.org/srt/2023": 1, "http://fasb.org/us-gaap/2023": 566, "http://xbrl.sec.gov/dei/2023": 27 }, "contextCount": 252, "dts": { "calculationLink": { "local": [ "qpag-20230331_cal.xml" ] }, "definitionLink": { "local": [ "qpag-20230331_def.xml" ] }, "inline": { "local": [ "f10q0323_innovativepay.htm" ] }, "labelLink": { "local": [ "qpag-20230331_lab.xml" ] }, "presentationLink": { "local": [ "qpag-20230331_pre.xml" ] }, "schema": { "local": [ "qpag-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd" ] } }, "elementCount": 543, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2023": 70, "http://innovativepaymentssolu.com/20230331": 37, "http://xbrl.sec.gov/dei/2023": 5, "total": 112 }, "keyCustom": 98, "keyStandard": 251, "memberCustom": 44, "memberStandard": 16, "nsprefix": "qpag", "nsuri": "http://innovativepaymentssolu.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMatterTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Liquidity Matters and Going Concern", "menuCat": "Notes", "order": "10", "role": "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcern", "shortName": "Liquidity Matters and Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:LiquidityMatterTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Intangibles", "menuCat": "Notes", "order": "11", "role": "http://innovativepaymentssolu.com/role/Intangibles", "shortName": "Intangibles", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Investments", "menuCat": "Notes", "order": "12", "role": "http://innovativepaymentssolu.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Leases", "menuCat": "Notes", "order": "13", "role": "http://innovativepaymentssolu.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Federal Relief Loans", "menuCat": "Notes", "order": "14", "role": "http://innovativepaymentssolu.com/role/FederalReliefLoans", "shortName": "Federal Relief Loans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:FederalReliefLoansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Notes Payable", "menuCat": "Notes", "order": "15", "role": "http://innovativepaymentssolu.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:NotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Convertible Notes Payable", "menuCat": "Notes", "order": "16", "role": "http://innovativepaymentssolu.com/role/ConvertibleNotesPayable", "shortName": "Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ConvertibleNotesPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Derivative Liability", "menuCat": "Notes", "order": "17", "role": "http://innovativepaymentssolu.com/role/DerivativeLiability", "shortName": "Derivative Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Stockholders\u2019 Equity", "menuCat": "Notes", "order": "18", "role": "http://innovativepaymentssolu.com/role/StockholdersEquity", "shortName": "Stockholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Net Loss Per Share", "menuCat": "Notes", "order": "19", "role": "http://innovativepaymentssolu.com/role/NetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "20", "role": "http://innovativepaymentssolu.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "21", "role": "http://innovativepaymentssolu.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://innovativepaymentssolu.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Accounting Policies, by Policy (Policies)", "menuCat": "Policies", "order": "23", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Accounting Policies and Estimates (Tables)", "menuCat": "Tables", "order": "24", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesTables", "shortName": "Accounting Policies and Estimates (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Intangibles (Tables)", "menuCat": "Tables", "order": "25", "role": "http://innovativepaymentssolu.com/role/IntangiblesTables", "shortName": "Intangibles (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "26", "role": "http://innovativepaymentssolu.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "27", "role": "http://innovativepaymentssolu.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfNotesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Notes Payable (Tables)", "menuCat": "Tables", "order": "28", "role": "http://innovativepaymentssolu.com/role/NotesPayableTables", "shortName": "Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "qpag:ScheduleOfNotesPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Convertible Notes Payable (Tables)", "menuCat": "Tables", "order": "29", "role": "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables", "shortName": "Convertible Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Derivative Liability (Tables)", "menuCat": "Tables", "order": "30", "role": "http://innovativepaymentssolu.com/role/DerivativeLiabilityTables", "shortName": "Derivative Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Stockholders\u2019 Equity (Tables)", "menuCat": "Tables", "order": "31", "role": "http://innovativepaymentssolu.com/role/StockholdersEquityTables", "shortName": "Stockholders\u2019 Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Net Loss Per Share (Tables)", "menuCat": "Tables", "order": "32", "role": "http://innovativepaymentssolu.com/role/NetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Organization and Description of Business (Details)", "menuCat": "Details", "order": "33", "role": "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "shortName": "Organization and Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "qpag:EquityMethodsInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Accounting Policies and Estimates (Details)", "menuCat": "Details", "order": "34", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails", "shortName": "Accounting Policies and Estimates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "2", "first": true, "lang": null, "name": "qpag:EquityMethodsInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c53", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets", "menuCat": "Details", "order": "35", "role": "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "shortName": "Accounting Policies and Estimates (Details) - Schedule of estimated useful lives of the assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "qpag:ScheduleOfEstimatedUsefulLivesOfAssets", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c53", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Liquidity Matters and Going Concern (Details)", "menuCat": "Details", "order": "36", "role": "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcernDetails", "shortName": "Liquidity Matters and Going Concern (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c51", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Intangibles (Details)", "menuCat": "Details", "order": "37", "role": "http://innovativepaymentssolu.com/role/IntangiblesDetails", "shortName": "Intangibles (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c51", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software", "menuCat": "Details", "order": "38", "role": "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "shortName": "Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfBeyondFintechIncTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "qpag:AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Investments (Details)", "menuCat": "Details", "order": "39", "role": "http://innovativepaymentssolu.com/role/InvestmentsDetails", "shortName": "Investments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "qpag:AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Investments (Details) - Schedule of investment", "menuCat": "Details", "order": "40", "role": "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable", "shortName": "Investments (Details) - Schedule of investment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:InvestmentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Investments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Leases (Details)", "menuCat": "Details", "order": "41", "role": "http://innovativepaymentssolu.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Leases (Details) - Schedule of total lease cost", "menuCat": "Details", "order": "42", "role": "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable", "shortName": "Leases (Details) - Schedule of total lease cost", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Leases (Details) - Schedule of other lease information", "menuCat": "Details", "order": "43", "role": "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable", "shortName": "Leases (Details) - Schedule of other lease information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOtherLeaseInformation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:OperatingCashFlowsFromOperatingLeases", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c68", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Federal Relief Loans (Details)", "menuCat": "Details", "order": "44", "role": "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails", "shortName": "Federal Relief Loans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c68", "decimals": "0", "first": true, "lang": null, "name": "qpag:DisasterLoanAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c69", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Notes Payable (Details)", "menuCat": "Details", "order": "45", "role": "http://innovativepaymentssolu.com/role/NotesPayableDetails", "shortName": "Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c69", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfNotesPayableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:DebtInstrumentsFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Notes Payable (Details) - Schedule of notes payable", "menuCat": "Details", "order": "46", "role": "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable", "shortName": "Notes Payable (Details) - Schedule of notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfNotesPayableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "qpag:DebtInstrumentsFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Convertible Notes Payable (Details)", "menuCat": "Details", "order": "47", "role": "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "shortName": "Convertible Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c81", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c119", "decimals": "0", "first": true, "lang": null, "name": "qpag:DebtInstrumentsFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Convertible Notes Payable (Details) - Schedule of convertible notes payable", "menuCat": "Details", "order": "48", "role": "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "shortName": "Convertible Notes Payable (Details) - Schedule of convertible notes payable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c119", "decimals": "0", "first": true, "lang": null, "name": "qpag:DebtInstrumentsFaceAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RachetProvision", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Derivative Liability (Details)", "menuCat": "Details", "order": "49", "role": "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails", "shortName": "Derivative Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RachetProvision", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "menuCat": "Statements", "order": "5", "role": "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals", "shortName": "Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPriceIncrease", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model", "menuCat": "Details", "order": "50", "role": "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "shortName": "Derivative Liability (Details) - Schedule of assumptions were used in the black-scholes valuation model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPriceIncrease", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeCashReceivedOnHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Derivative Liability (Details) - Schedule of movement in derivative liability", "menuCat": "Details", "order": "51", "role": "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable", "shortName": "Derivative Liability (Details) - Schedule of movement in derivative liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeCashReceivedOnHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Stockholders\u2019 Equity (Details)", "menuCat": "Details", "order": "52", "role": "http://innovativepaymentssolu.com/role/StockholdersEquityDetails", "shortName": "Stockholders\u2019 Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:OtherTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c158", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of restricted stock activity", "menuCat": "Details", "order": "53", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of restricted stock activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c146", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of restricted stock granted and exercisable", "menuCat": "Details", "order": "54", "role": "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of restricted stock granted and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:RestrictedStockGrantedShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c178", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model", "menuCat": "Details", "order": "55", "role": "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c178", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c188", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of warrant activity", "menuCat": "Details", "order": "56", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of warrant activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c182", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of warrants outstanding and exercisable", "menuCat": "Details", "order": "57", "role": "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of warrants outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c206", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of option activity", "menuCat": "Details", "order": "58", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of option activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c203", "decimals": "0", "lang": null, "name": "qpag:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of options outstanding and exercisable", "menuCat": "Details", "order": "59", "role": "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of options outstanding and exercisable", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "qpag:ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Stockholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "059 - Disclosure - Net Loss Per Share (Details) - Schedule of dilutive shares", "menuCat": "Details", "order": "60", "role": "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "shortName": "Net Loss Per Share (Details) - Schedule of dilutive shares", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c226", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060 - Disclosure - Related Party Transactions (Details)", "menuCat": "Details", "order": "61", "role": "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c226", "decimals": "0", "first": true, "lang": null, "name": "qpag:ShareOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c248", "decimals": "0", "first": true, "lang": null, "name": "qpag:AggregatesPrincipalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "62", "role": "http://innovativepaymentssolu.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c248", "decimals": "0", "first": true, "lang": null, "name": "qpag:AggregatesPrincipalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "7", "role": "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Organization and Description of Business", "menuCat": "Notes", "order": "8", "role": "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness", "shortName": "Organization and Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Accounting Policies and Estimates", "menuCat": "Notes", "order": "9", "role": "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimates", "shortName": "Accounting Policies and Estimates", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0323_innovativepay.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 66, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "qpag_AccountingPoliciesandEstimatesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates (Textual)" } } }, "localname": "AccountingPoliciesandEstimatesDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "stringItemType" }, "qpag_AccountingPoliciesandEstimatesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates (Details) [Table]" } } }, "localname": "AccountingPoliciesandEstimatesDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "stringItemType" }, "qpag_AdditionalAmountOfSoftware": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Additional amount of software.", "label": "Additional Amount Of Software", "terseLabel": "Additional amount of software" } } }, "localname": "AdditionalAmountOfSoftware", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of additional irrecvocable right to acquire percentage.", "label": "Additional Irrecvocable Right To Acquire Outstanding Common Stock Percentage", "terseLabel": "Right to acquire percentage" } } }, "localname": "AdditionalIrrecvocableRightToAcquireOutstandingCommonStockPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails" ], "xbrltype": "percentItemType" }, "qpag_AggregateAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Aggregate Amount means the sum of (i) the Purchase Price and (ii) the total consideration paid by Buyer's Affiliate to Seller under the Intellectual Property License Agreement.", "label": "Aggregate Amount", "terseLabel": "Aggregate amount" } } }, "localname": "AggregateAmount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AggregatesPrincipalAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of aggregate principal amount.", "label": "Aggregates Principal Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "AggregatesPrincipalAmount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AmortizationOfDebtDiscount": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_AmountOfImmediateExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of immediate expense.", "label": "Amount Of Immediate Expense", "terseLabel": "Amount of immediate expense (in Dollars)" } } }, "localname": "AmountOfImmediateExpense", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "qpag_AndreyNovikovMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Andrey Novikov Member", "terseLabel": "Andrey Novikov [Member]" } } }, "localname": "AndreyNovikovMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_BeneficiallyOwnOfPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beneficially Own Of Percentage", "terseLabel": "Beneficially own of percentage" } } }, "localname": "BeneficiallyOwnOfPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "percentItemType" }, "qpag_BeyondFintechIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beyond Fintech Inc Member", "terseLabel": "Beyond Fintech Inc. [Member]" } } }, "localname": "BeyondFintechIncMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "domainItemType" }, "qpag_BeyondFintechMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Beyond Fintech Member", "terseLabel": "Beyond Fintech [Member]" } } }, "localname": "BeyondFintechMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_BlackScholesValuationModel": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Black-Scholes valuation model.", "label": "Black Scholes Valuation Model", "terseLabel": "Black-scholes valuation model" } } }, "localname": "BlackScholesValuationModel", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Abstract", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "stringItemType" }, "qpag_CavalryAndMercerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cavalry And Mercer Member", "terseLabel": "Cavalry and Mercer [Member]", "verboseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]" } } }, "localname": "CavalryAndMercerMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails", "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "qpag_CavalryFundILPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cavalry Fund ILPMember", "terseLabel": "Cavalry Fund I LP [Member]" } } }, "localname": "CavalryFundILPMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_CliffordHenryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Clifford Henry Member", "terseLabel": "Clifford Henry [Member]" } } }, "localname": "CliffordHenryMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_ConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Abstract" } } }, "localname": "ConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Textual)" } } }, "localname": "ConvertibleNotesPayableDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Details) [Table]" } } }, "localname": "ConvertibleNotesPayableDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Abstract]" } } }, "localname": "ConvertibleNotesPayableLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayable" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Table]" } } }, "localname": "ConvertibleNotesPayableTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayable" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Tables Line Items", "terseLabel": "Convertible Notes Payable [Abstract]" } } }, "localname": "ConvertibleNotesPayableTablesLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Tables) [Table]" } } }, "localname": "ConvertibleNotesPayableTablesTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables" ], "xbrltype": "stringItemType" }, "qpag_ConvertibleNotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable Text Block", "terseLabel": "CONVERTIBLE NOTES PAYABLE" } } }, "localname": "ConvertibleNotesPayableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "qpag_DavidRiosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "David Rios Member", "terseLabel": "David Rios [Member]" } } }, "localname": "DavidRiosMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_DebtConversionNoticesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Conversion Notices Member", "terseLabel": "Debt Conversion Notices [Member]" } } }, "localname": "DebtConversionNoticesMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "qpag_DebtInstrumentAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of debt instrument accrued interest.", "label": "Debt Instrument Accrued Interest", "terseLabel": "Accrued interest and penalty interest" } } }, "localname": "DebtInstrumentAccruedInterest", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentOriginalIssueDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount paid to debt instrument original issue discount.", "label": "Debt Instrument Original Issue Discount", "terseLabel": "Original issue discount" } } }, "localname": "DebtInstrumentOriginalIssueDiscount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsConvertibleConversionPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instruments Convertible Conversion Price1", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentsConvertibleConversionPrice1", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "qpag_DebtInstrumentsFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instruments Face Amount", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentsFaceAmount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "qpag_DebtInstrumentsInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instruments Interest Rate Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentsInterestRateStatedPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "percentItemType" }, "qpag_December302022NoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December302022 Note Member", "terseLabel": "December 30, 2022 Note [Member]" } } }, "localname": "December302022NoteMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "qpag_DerivativeFinancialLiabilityArisingFromConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents as a derivative financial liability arising from convertible note.", "label": "Derivative Financial Liability Arising From Convertible Note", "terseLabel": "Derivative financial liability arising from convertible note and warrants" } } }, "localname": "DerivativeFinancialLiabilityArisingFromConvertibleNote", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_DerivativeLiabilityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability (Textual)" } } }, "localname": "DerivativeLiabilityDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "qpag_DerivativeLiabilityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Liability (Details) [Table]" } } }, "localname": "DerivativeLiabilityDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails" ], "xbrltype": "stringItemType" }, "qpag_DerivativeLiabilityMovement": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of derivative liability movements.", "label": "Derivative Liability Movement", "negatedLabel": "Derivative liability movements" } } }, "localname": "DerivativeLiabilityMovement", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_DisasterLoanAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disaster loan amount", "label": "Disaster Loan Amount", "terseLabel": "Disaster loan amount" } } }, "localname": "DisasterLoanAmount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "qpag_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_EquityMethodsInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Methods Investment Ownership Percentage", "terseLabel": "Ownership percentage" } } }, "localname": "EquityMethodsInvestmentOwnershipPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "percentItemType" }, "qpag_ExercisePrice00115Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price00115 Member", "terseLabel": "Exercise Price 0.0115 [Member]" } } }, "localname": "ExercisePrice00115Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice00345Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price00345 Member", "terseLabel": "Exercise Price\t0.0345 [Member]" } } }, "localname": "ExercisePrice00345Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0049Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0049 Member", "terseLabel": "Grant date Price 0.049 [Member]" } } }, "localname": "ExercisePrice0049Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice004Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price004 Member", "terseLabel": "Exercise Price 0.04 [Member]" } } }, "localname": "ExercisePrice004Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0055Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0055 Member", "terseLabel": "Grant date Price 0.055 [Member]" } } }, "localname": "ExercisePrice0055Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice015Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price015 Member", "terseLabel": "Exercise Price 0.15 [Member]" } } }, "localname": "ExercisePrice015Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice0187Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price0187 Member", "terseLabel": "Exercise Price 0.1875 [Member]" } } }, "localname": "ExercisePrice0187Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price024 Member", "terseLabel": "Exercise Price 0.24 [Member]" } } }, "localname": "ExercisePrice024Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePrice040Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price040 Member", "terseLabel": "Exercise Price 0.40 [Member]" } } }, "localname": "ExercisePrice040Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExercisePricePerShareCancelledOnDebtAmendment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of cancelled on debt amendment.", "label": "Exercise Price Per Share Cancelled On Debt Amendment", "terseLabel": "Exercise price per share, Cancelled on debt amendment" } } }, "localname": "ExercisePricePerShareCancelledOnDebtAmendment", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePricePerShareIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of increase in warrants due to debt amendment full rachet trigger.", "label": "Exercise Price Per Share Increase In Warrants Due To Debt Amendment Full Rachet Trigger", "terseLabel": "Exercise price per share, Increase in warrants due to debt amendment full rachet trigger" } } }, "localname": "ExercisePricePerShareIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ExercisePriceRange5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range5 Member", "terseLabel": "Grant date Price 0.050 [Member]" } } }, "localname": "ExercisePriceRange5Member", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "domainItemType" }, "qpag_ExpirationDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date.", "label": "Expiration Dates", "terseLabel": "Expiration Date" } } }, "localname": "ExpirationDates", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "dateItemType" }, "qpag_FairValueAdjustmentToDerivativeLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Fair Value Adjustment To Derivative Liability", "terseLabel": "Fair value adjustment to derivative liability" } } }, "localname": "FairValueAdjustmentToDerivativeLiability", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "qpag_FairValueAssumptionsExpectedTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Fair Value Assumptions Expected Term1", "terseLabel": "Expected life of derivative liability" } } }, "localname": "FairValueAssumptionsExpectedTerm1", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable" ], "xbrltype": "durationItemType" }, "qpag_February2023ConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "February2023 Convertible Notes Member", "terseLabel": "February 2023 convertible notes [Member]" } } }, "localname": "February2023ConvertibleNotesMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_FederalReliefLoansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Relief Loans [Abstract]" } } }, "localname": "FederalReliefLoansAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_FederalReliefLoansNonCurrent": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Federal relief loans portion of non current.", "label": "Federal Relief Loans Non Current", "terseLabel": "Federal relief loans" } } }, "localname": "FederalReliefLoansNonCurrent", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "qpag_FederalReliefLoansTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Relief Loans Text Block", "terseLabel": "FEDERAL RELIEF LOANS" } } }, "localname": "FederalReliefLoansTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoans" ], "xbrltype": "textBlockItemType" }, "qpag_FederallyInsuredLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of federally insured limit.", "label": "Federally Insured Limit", "terseLabel": "Federally insured limit" } } }, "localname": "FederallyInsuredLimit", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FinancialAndCapitalMarketsAdvice": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of financial and capital markets advice.", "label": "Financial And Capital Markets Advice", "terseLabel": "Financial and capital markets advice" } } }, "localname": "FinancialAndCapitalMarketsAdvice", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_FintechPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of fintech.", "label": "Fintech Percentage", "terseLabel": "Beyond fintech percentage" } } }, "localname": "FintechPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "percentItemType" }, "qpag_FrictionlessFinancialTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Frictionless Financial Technologies Inc Member", "terseLabel": "Frictionless Financial Technologies, Inc. [Member]", "verboseLabel": "Frictionless Financial Technologies, Inc.[Member]" } } }, "localname": "FrictionlessFinancialTechnologiesIncMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_FrictionlessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Frictionless Member", "terseLabel": "Frictionless [Member]" } } }, "localname": "FrictionlessMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_GastonPereiraMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gaston Pereira Member", "terseLabel": "Gaston Pereira [Member]" } } }, "localname": "GastonPereiraMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_GrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gross Proceeds", "terseLabel": "Gross proceeds" } } }, "localname": "GrossProceeds", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_GrossProceedsToCompany": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of gross proceeds", "label": "Gross Proceeds To Company", "terseLabel": "Gross proceeds" } } }, "localname": "GrossProceedsToCompany", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_HoldersAmounting": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Holders amounting.", "label": "Holders Amounting", "terseLabel": "Holders amount" } } }, "localname": "HoldersAmounting", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_IncreaseDecreaseInInterestAccruals": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of interest accruals.", "label": "Increase Decrease In Interest Accruals", "terseLabel": "Interest accruals" } } }, "localname": "IncreaseDecreaseInInterestAccruals", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "qpag_InitialConversionPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of initial conversion price.", "label": "Initial Conversion Price Per Share", "terseLabel": "Initial conversion price per share (in Dollars per share)" } } }, "localname": "InitialConversionPricePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "qpag_IntangiblesDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of facilitate the functioning of the IPSIPay software [Abstract]" } } }, "localname": "IntangiblesDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "stringItemType" }, "qpag_IntangiblesDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles (Details) - Schedule of facilitate the functioning of the IPSIPay software [Table]" } } }, "localname": "IntangiblesDetailsScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "stringItemType" }, "qpag_IntangiblesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles [Abstract]" } } }, "localname": "IntangiblesLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/Intangibles" ], "xbrltype": "stringItemType" }, "qpag_IntangiblesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles [Table]" } } }, "localname": "IntangiblesTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/Intangibles" ], "xbrltype": "stringItemType" }, "qpag_IntangiblesTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles Table [Abstract]" } } }, "localname": "IntangiblesTablesLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesTables" ], "xbrltype": "stringItemType" }, "qpag_IntangiblesTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intangibles (Tables) [Table]" } } }, "localname": "IntangiblesTablesTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesTables" ], "xbrltype": "stringItemType" }, "qpag_InterestChargeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest charge rate.", "label": "Interest Charge Rate", "terseLabel": "Interest charge" } } }, "localname": "InterestChargeRate", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "qpag_IntrinsicValueOutstandingOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Intrinsic Value Outstanding Options", "terseLabel": "Intrinsic value outstanding options (in Dollars)" } } }, "localname": "IntrinsicValueOutstandingOptions", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "qpag_InvestmentInFrictionlessFinancialTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment In Frictionless Financial Technologies Inc Member", "terseLabel": "Investment in Frictionless Financial Technologies, Inc. [Member]" } } }, "localname": "InvestmentInFrictionlessFinancialTechnologiesIncMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "domainItemType" }, "qpag_InvestmentsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment (Textual)" } } }, "localname": "InvestmentsDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "qpag_InvestmentsDetailsScheduleofinvestmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of investment [Line Items]" } } }, "localname": "InvestmentsDetailsScheduleofinvestmentLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_InvestmentsDetailsScheduleofinvestmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of investment [Table]" } } }, "localname": "InvestmentsDetailsScheduleofinvestmentTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "stringItemType" }, "qpag_InvestmentsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) [Table]" } } }, "localname": "InvestmentsDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails" ], "xbrltype": "stringItemType" }, "qpag_JamesFullerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "James Fuller Member", "terseLabel": "Mr. Fuller [Member]", "verboseLabel": "James Fuller [Member]" } } }, "localname": "JamesFullerMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_JosephAbramsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Joseph Abrams Member", "terseLabel": "Joseph Abrams [Member]" } } }, "localname": "JosephAbramsMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_KiosksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Kiosks Member", "terseLabel": "Kiosks [Member]" } } }, "localname": "KiosksMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "qpag_LeasesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Textual)" } } }, "localname": "LeasesDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "qpag_LeasesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases (Details) [Table]" } } }, "localname": "LeasesDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "qpag_LimitationExceedsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limitation exceeds percentage.", "label": "Limitation Exceeds Percentage", "terseLabel": "Limitation exceeds of percentage" } } }, "localname": "LimitationExceedsPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "percentItemType" }, "qpag_LiquidityMatterAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters [Abstract]" } } }, "localname": "LiquidityMatterAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_LiquidityMatterTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for liquidity matters.", "label": "Liquidity Matter Text Block", "terseLabel": "LIQUIDITY MATTERS AND GOING CONCERN" } } }, "localname": "LiquidityMatterTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcern" ], "xbrltype": "textBlockItemType" }, "qpag_LiquidityMattersandGoingConcernDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters (Textual)" } } }, "localname": "LiquidityMattersandGoingConcernDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "qpag_LiquidityMattersandGoingConcernDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity Matters and Going Concern (Details) [Table]" } } }, "localname": "LiquidityMattersandGoingConcernDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "qpag_LongtermAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents long term assets policy.", "label": "Longterm Assets Policy Text Block", "terseLabel": "Long-Term Assets" } } }, "localname": "LongtermAssetsPolicyTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "qpag_MadissonCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Madisson Corbett Member", "terseLabel": "Madisson Corbett [Member]" } } }, "localname": "MadissonCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_MercerStreetGlobalOpportunityFundLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mercer Street Global Opportunity Fund LLCMember", "terseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]", "verboseLabel": "Cavalry Fund I LP [Member]" } } }, "localname": "MercerStreetGlobalOpportunityFundLLCMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "qpag_MinorityInterestsOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interests Ownership Percentage By Parent", "terseLabel": "Stake owned percentage" } } }, "localname": "MinorityInterestsOwnershipPercentageByParent", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "qpag_MonthlyRent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monthly rent.", "label": "Monthly Rent", "terseLabel": "Monthly rent" } } }, "localname": "MonthlyRent", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "qpag_NetLossPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss Per Share [Abstract]" } } }, "localname": "NetLossPerShareLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShare" ], "xbrltype": "stringItemType" }, "qpag_NetLossPerShareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss Per Share [Table]" } } }, "localname": "NetLossPerShareTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShare" ], "xbrltype": "stringItemType" }, "qpag_NetLossPerShareTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss Per Share Tables Line Items", "terseLabel": "Net Loss Per Share [Abstract]" } } }, "localname": "NetLossPerShareTablesLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShareTables" ], "xbrltype": "stringItemType" }, "qpag_NetLossPerShareTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss Per Share (Tables) [Table]" } } }, "localname": "NetLossPerShareTablesTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShareTables" ], "xbrltype": "stringItemType" }, "qpag_NoteAmendmentTransactionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note amendment transaction description.", "label": "Note Amendment Transaction Description", "terseLabel": "Note amendment transaction description" } } }, "localname": "NoteAmendmentTransactionDescription", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "qpag_NotesPayableDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Line Items]" } } }, "localname": "NotesPayableDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "qpag_NotesPayableDetailsScheduleofnotespayableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) - Schedule of notes payable [Line Items]" } } }, "localname": "NotesPayableDetailsScheduleofnotespayableLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "qpag_NotesPayableDetailsScheduleofnotespayableTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) - Schedule of notes payable [Table]" } } }, "localname": "NotesPayableDetailsScheduleofnotespayableTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "qpag_NotesPayableDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Table]" } } }, "localname": "NotesPayableDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "qpag_NotesPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for notes payable.", "label": "Notes Payable Text Block", "terseLabel": "NOTES PAYABLE" } } }, "localname": "NotesPayableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "qpag_OperatingCashFlowsFromOperatingLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to operating cash flows from operating leases.", "label": "Operating Cash Flows From Operating Leases", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingCashFlowsFromOperatingLeases", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "monetaryItemType" }, "qpag_OptionsExercisableNumberExercisablein": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares options exercisable, number exercisable.", "label": "Options Exercisable Number Exercisablein", "terseLabel": "Options Exercisable, Number Exercisable" } } }, "localname": "OptionsExercisableNumberExercisablein", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_OptionsExercisableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options exercisable shares .", "label": "Options Exercisable Shares", "terseLabel": "Options exercisable shares" } } }, "localname": "OptionsExercisableShares", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "qpag_OptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "the per share of options exercisable ,weighted average exercise price.", "label": "Options Exercisable Weighted Average Exercise Price", "terseLabel": "Options Exercisable ,Weighted Average Exercise Price" } } }, "localname": "OptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_OrganizationandDescriptionofBusinessDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business (Textual)" } } }, "localname": "OrganizationandDescriptionofBusinessDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "qpag_OrganizationandDescriptionofBusinessDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business (Details) [Table]" } } }, "localname": "OrganizationandDescriptionofBusinessDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "qpag_OrganizationandDescriptionofBusinessLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract]" } } }, "localname": "OrganizationandDescriptionofBusinessLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness" ], "xbrltype": "stringItemType" }, "qpag_OrganizationandDescriptionofBusinessTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business [Table]" } } }, "localname": "OrganizationandDescriptionofBusinessTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness" ], "xbrltype": "stringItemType" }, "qpag_OriginalDiscountsRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of Original issue discount rate.", "label": "Original Discounts Rate Percentage", "terseLabel": "Original issue discount rate" } } }, "localname": "OriginalDiscountsRatePercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "percentItemType" }, "qpag_OriginalIssueDiscountAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Original issue discount amount.", "label": "Original Issue Discount Amount", "terseLabel": "Original issue discount" } } }, "localname": "OriginalIssueDiscountAmount", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_OwnedFrictionlessFinancialTechnologies": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of owned frictionless financial technologies.", "label": "Owned Frictionless Financial Technologies", "terseLabel": "Owned frictionless percentage" } } }, "localname": "OwnedFrictionlessFinancialTechnologies", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "percentItemType" }, "qpag_PenaltyOnConvertibleDebt": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Penalty on convertible debt.", "label": "Penalty On Convertible Debt", "negatedLabel": "Penalty on convertible debt", "terseLabel": "Penalty on convertible notes" } } }, "localname": "PenaltyOnConvertibleDebt", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "qpag_PercentageOfRemainingSharesOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of remaining shares owned.", "label": "Percentage Of Remaining Shares Owned", "terseLabel": "Percentage of remaining shares owned" } } }, "localname": "PercentageOfRemainingSharesOwned", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "qpag_PercentageOfSharesVivi": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage Of Shares Vivi", "terseLabel": "Shares of vivi" } } }, "localname": "PercentageOfSharesVivi", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "qpag_PurchaseOfAggregateShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Purchase Of Aggregate Shares", "terseLabel": "Purchase of aggregate shares" } } }, "localname": "PurchaseOfAggregateShares", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_PurchasePriceToAcquireOutstandingCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to purchase price to acquire outstanding common stock.", "label": "Purchase Price To Acquire Outstanding Common Stock", "terseLabel": "Purchase price (in Dollars)" } } }, "localname": "PurchasePriceToAcquireOutstandingCommonStock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_PurchaseTechnologyBeyondWalletMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase Technology Beyond Wallet Member", "terseLabel": "Purchase Technology \u2013 Beyond Wallet [Member]" } } }, "localname": "PurchaseTechnologyBeyondWalletMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "domainItemType" }, "qpag_PurchasedTechnologyIPSIPayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchased Technology IPSIPay Member", "terseLabel": "Purchased Technology - IPSIPay [Member]" } } }, "localname": "PurchasedTechnologyIPSIPayMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "domainItemType" }, "qpag_QpagosCorporationsCapitalStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Qpagos Corporations Capital Stock Member", "terseLabel": "Qpagos Corporation\u2019s Capital Stock [Member]" } } }, "localname": "QpagosCorporationsCapitalStockMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "qpag_RachetProvision": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A provision that provides an investor with down-round protection (i.e., where the company raises a subsequent round of financing, which can include IPO, at a lower price) by providing for the issuance of additional shares in the subsequent round.", "label": "Rachet Provision", "terseLabel": "Rachet provision" } } }, "localname": "RachetProvision", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "qpag_RelatedPartyTransactionsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Textual)" } } }, "localname": "RelatedPartyTransactionsDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "qpag_RelatedPartyTransactionsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "qpag_RemainingLeaseTermOperatingLease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The duration remaining lease term \u2013 operating lease.", "label": "Remaining Lease Term Operating Lease", "terseLabel": "Remaining lease term \u2013 operating lease" } } }, "localname": "RemainingLeaseTermOperatingLease", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofotherleaseinformationTable" ], "xbrltype": "stringItemType" }, "qpag_RepayableInstallments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rapayable installments", "label": "Repayable Installments", "terseLabel": "Repayable installments" } } }, "localname": "RepayableInstallments", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "qpag_RepaymentOfNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of including current and non current portion of notes payable repayments.", "label": "Repayment Of Notes Payable", "terseLabel": "Principal amount" } } }, "localname": "RepaymentOfNotesPayable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "qpag_RestrictedStockGrantedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock granted, number granted", "label": "Restricted Stock Granted Shares", "terseLabel": "Restricted stock granted, number granted" } } }, "localname": "RestrictedStockGrantedShares", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_RestrictedStockGrantedWeightedAverageFairValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The share of restricted stock granted, weighted.", "label": "Restricted Stock Granted Weighted Average Fair Value Per Share", "terseLabel": "Restricted stock granted, weighted average fair value per share (in Dollars per share)" } } }, "localname": "RestrictedStockGrantedWeightedAverageFairValuePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_RichardRosenblumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Richard Rosenblum Member", "terseLabel": "Mr. Rosenblum [Member]", "verboseLabel": "Richard Rosenblum [Member]" } } }, "localname": "RichardRosenblumMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Assumptions Were Used In The Black Scholes Valuation Model Abstract" } } }, "localname": "ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfBeyondFintechIncTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Beyond Fintech Inc Table Text Block", "terseLabel": "Schedule of facilitate the functioning of the IPSIPay software" } } }, "localname": "ScheduleOfBeyondFintechIncTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfConvertibleNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Convertible Notes Payable Abstract" } } }, "localname": "ScheduleOfConvertibleNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfDilutiveSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Dilutive Shares Abstract" } } }, "localname": "ScheduleOfDilutiveSharesAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents policy estimated useful lives of assets.", "label": "Schedule Of Estimated Useful Lives Of Assets", "terseLabel": "Schedule of estimated useful lives of the assets" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfAssets", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Estimated Useful Lives Of The Assets Abstract" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfFacilitateTheFunctioningOfTheIpsipaySoftwareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Facilitate The Functioning Of The Ipsipay Software Abstract" } } }, "localname": "ScheduleOfFacilitateTheFunctioningOfTheIpsipaySoftwareAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfFairValueOfTheWarrantsAndOptionsGrantedAndIssuedBlackScholesValuationModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of The Warrants And Options Granted And Issued Black Scholes Valuation Model Abstract" } } }, "localname": "ScheduleOfFairValueOfTheWarrantsAndOptionsGrantedAndIssuedBlackScholesValuationModelAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfNotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Notes Payable Abstract" } } }, "localname": "ScheduleOfNotesPayableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfNotesPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notes payable.", "label": "Schedule Of Notes Payable Table Text Block", "terseLabel": "Schedule of notes payable" } } }, "localname": "ScheduleOfNotesPayableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOptionActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Option Activity Abstract" } } }, "localname": "ScheduleOfOptionActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Options Outstanding And Exercisable Abstract" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfOptionsOutstandingAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of options outstanding and exercisable", "label": "Schedule Of Options Outstanding And Exercisable Table Text Block", "terseLabel": "Schedule of options outstanding and exercisable" } } }, "localname": "ScheduleOfOptionsOutstandingAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Lease Information", "terseLabel": "Schedule of other lease information" } } }, "localname": "ScheduleOfOtherLeaseInformation", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfOtherLeaseInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Lease Information Abstract" } } }, "localname": "ScheduleOfOtherLeaseInformationAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Activity Abstract" } } }, "localname": "ScheduleOfRestrictedStockActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Granted And Exercisable Abstract" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Granted And Exercisable Table Text Block", "terseLabel": "Schedule of restricted stock granted and exercisable" } } }, "localname": "ScheduleOfRestrictedStockGrantedAndExercisableTableTextBlock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "qpag_ScheduleOfTotalLeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of total lease cost [Abstract]" } } }, "localname": "ScheduleOfTotalLeaseCostAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfWarrantActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrant Activity Abstract" } } }, "localname": "ScheduleOfWarrantActivityAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ScheduleOfWarrantsOutstandingAndExercisableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding And Exercisable Abstract" } } }, "localname": "ScheduleOfWarrantsOutstandingAndExercisableAbstract", "nsuri": "http://innovativepaymentssolu.com/20230331", "xbrltype": "stringItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercised or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period", "terseLabel": "Shares Underlying Warrants, Exercised (in Shares)", "verboseLabel": "Shares Underlying options, Exercised (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which other than option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedWeightedAverageGrantDateFairValue", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercise Price Per Share", "periodEndLabel": "Exercise price per share, Outstanding at ending", "periodStartLabel": "Exercise price per share, Outstanding at ending", "terseLabel": "Exercise price per share, Outstanding at beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercise Price Per Share1", "terseLabel": "Exercise price per share, Outstanding at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisePricePerShare1", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercised Exercise Price Per Share", "terseLabel": "Exercise price per share, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercised Exercise Price Per Shares", "terseLabel": "Exercise price per share, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisedExercisePricePerShares", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Forfeited Exercise Price Per Share", "terseLabel": "Exercise price per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedForfeitedExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Grants Exercise Price Per Share", "terseLabel": "Exercise price per share, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedGrantsExercisePricePerShare", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Balance", "periodEndLabel": "Shares Underlying options, Outstanding at ending (in Shares)", "periodStartLabel": "Shares Underlying options, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBalance", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total restricted shares, vested.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Restricted Shares Vested", "terseLabel": "Total restricted shares, Vested (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of options outstanding, number outstanding.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Option Outstanding", "terseLabel": "Options Outstanding, Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionOutstanding", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "qpag_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The per share of weighted average fair market value per share, vested.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Vested Weighted Average Exercise Price", "terseLabel": "Weighted average fair market value per share, Vested" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_ShareOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares common stock.", "label": "Share Of Common Stock", "terseLabel": "Shares of common stock (in Shares)" } } }, "localname": "ShareOfCommonStock", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, forfeited.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Forfeited Cancelled", "negatedLabel": "Total unvested restricted shares, Forfeited/Cancelled (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, granted", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Granted", "terseLabel": "Total unvested restricted shares, Granted and issued (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesGranted", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total unvested restricted shares, vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Unvested Restricted Shares Vested", "terseLabel": "Total unvested restricted shares, Vested (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsUnvestedRestrictedSharesVested", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, forfeited/cancelled.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Forfeited Cancelled", "negatedLabel": "Total vested restricted shares, Forfeited/Cancelled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareForfeitedCancelled", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, granted", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Granted", "terseLabel": "Total vested restricted shares, Granted and issued" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareGranted", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares, vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Fair Market Value Per Share Vested", "terseLabel": "Total vested restricted shares, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageFairMarketValuePerShareVested", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term", "terseLabel": "Options Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "qpag_SharesUnderlyingWarrantsCancelledOnDebtAmendment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares underlying warrants, cancelled on debt amendment", "label": "Shares Underlying Warrants Cancelled On Debt Amendment", "terseLabel": "Shares Underlying Warrants, Cancelled on debt amendment\t(in Shares)" } } }, "localname": "SharesUnderlyingWarrantsCancelledOnDebtAmendment", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_SharesUnderlyingWarrantsIncreaseInWarrantsDueToDebtAmendmentFullRachetTriggerin": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares underlying warrants, Increase in warrants due to debt amendment full rachet trigger.", "label": "Shares Underlying Warrants Increase In Warrants Due To Debt Amendment Full Rachet Triggerin", "terseLabel": "Shares Underlying Warrants, Increase in warrants due to debt amendment full rachet trigger\t(in Shares)" } } }, "localname": "SharesUnderlyingWarrantsIncreaseInWarrantsDueToDebtAmendmentFullRachetTriggerin", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "qpag_StockIssuedDuringPeriodValueFairValueOfWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrants issued.", "label": "Stock Issued During Period Value Fair Value Of Warrants Issued", "terseLabel": "Fair value of warrants issued" } } }, "localname": "StockIssuedDuringPeriodValueFairValueOfWarrantsIssued", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "qpag_StockOptionExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option Exercise Price", "terseLabel": "Stock option exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "qpag_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents stock options.", "label": "Stock Options Member", "terseLabel": "Stock options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "qpag_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity (Textual)" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "qpag_StockholdersEquityDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "qpag_StockholdersEquityDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "qpag_StockholdersEquityDetailsScheduleofrestrictedstockactivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of restricted stock activity [Line Items]" } } }, "localname": "StockholdersEquityDetailsScheduleofrestrictedstockactivityLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_StockholdersEquityDetailsScheduleofrestrictedstockactivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of restricted stock activity [Table]" } } }, "localname": "StockholdersEquityDetailsScheduleofrestrictedstockactivityTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "stringItemType" }, "qpag_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "qpag_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "qpag_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "qpag_TotalRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Restricted Shares Member", "terseLabel": "Total restricted shares [Member]" } } }, "localname": "TotalRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalUnvestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Unvested Restricted Shares Member", "terseLabel": "Total unvested restricted shares [Member]" } } }, "localname": "TotalUnvestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalVestedRestrictedSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Vested Restricted Shares Member", "terseLabel": "Total vested restricted shares [Member]" } } }, "localname": "TotalVestedRestrictedSharesMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_TotalVestedRestrictedSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of total vested restricted shares.", "label": "Total Vested Restricted Shares Outstanding", "periodEndLabel": "Total vested restricted shares, Outstanding at ending", "periodStartLabel": "Total vested restricted shares, Outstanding at ending" } } }, "localname": "TotalVestedRestrictedSharesOutstanding", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_TwoThousandEighteenStockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Eighteen Stock Incentive Plan Member", "terseLabel": "2018 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandEighteenStockIncentivePlanMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "qpag_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One Plan Member", "terseLabel": "2021 Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "qpag_UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Restricted Weighted Average Fair Market Value Per Share Member", "terseLabel": "Unvested restricted Weighted average fair market value per share [Member]" } } }, "localname": "UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_VestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vested Restricted Weighted Average Fair Market Value Per Share Member", "terseLabel": "Vested restricted Weighted average fair market value per share [Member]" } } }, "localname": "VestedRestrictedWeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_WarrantsBeneficiallyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Beneficially Percentage", "terseLabel": "Warrants beneficially percentage" } } }, "localname": "WarrantsBeneficiallyPercentage", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "qpag_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Member", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "domainItemType" }, "qpag_WarrantsOutstandingExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The per share options outstanding, exercise price.", "label": "Warrants Outstanding Exercise Price", "terseLabel": "Warrants Outstanding, Exercise Price", "verboseLabel": "Options Outstanding, Exercise Price" } } }, "localname": "WarrantsOutstandingExercisePrice", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageExercisePriceCancelledOnDebtAmendment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at cancelled on debt amendment.", "label": "Weighted Average Exercise Price Cancelled On Debt Amendment", "terseLabel": "Weighted average exercise price, Cancelled on debt amendment" } } }, "localname": "WeightedAverageExercisePriceCancelledOnDebtAmendment", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageExercisePriceForfeitedinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Forfeitedin Shares", "terseLabel": "Weighted average exercise price, Forfeited" } } }, "localname": "WeightedAverageExercisePriceForfeitedinShares", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageExercisePriceIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at exercise price of increase in warrants due to debt amendment full rachet trigger.", "label": "Weighted Average Exercise Price Increase In Warrants Due To Debt Amendment Full Rachet Trigger", "terseLabel": "Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger" } } }, "localname": "WeightedAverageExercisePriceIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "qpag_WeightedAverageFairMarketValuePerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Fair Market Value Per Share Member", "terseLabel": "Weighted average fair market value per share [Member]" } } }, "localname": "WeightedAverageFairMarketValuePerShareMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "domainItemType" }, "qpag_WilliamCorbettMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "William Corbett Member", "terseLabel": "William Corbett [Member]" } } }, "localname": "WilliamCorbettMember", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "qpag_commonstockvalue1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount paid to Common stock value.", "label": "commonstockvalue1", "terseLabel": "Common stock, value" } } }, "localname": "commonstockvalue1", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "qpag_terminatesPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Terminates period.", "label": "terminates Period", "terseLabel": "Terminates period" } } }, "localname": "terminatesPeriod", "nsuri": "http://innovativepaymentssolu.com/20230331", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief executive officer.", "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [ "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_FinancingReceivableNonaccrualToOutstandingPercent": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Percentage of nonaccrual to total financing receivable outstanding.", "label": "Financing Receivable, Nonaccrual to Outstanding, Percent", "terseLabel": "Common stock outstanding percentage" } } }, "localname": "FinancingReceivableNonaccrualToOutstandingPercent", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "srt_MaximumMember": { "auth_ref": [ "r233", "r234", "r235", "r236", "r269", "r358", "r391", "r413", "r414", "r470", "r474", "r477", "r478", "r488", "r494", "r495", "r505", "r506", "r507", "r512", "r555", "r599", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r233", "r234", "r235", "r236", "r269", "r358", "r391", "r413", "r414", "r470", "r474", "r477", "r478", "r488", "r494", "r495", "r505", "r506", "r507", "r512", "r555", "r599", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r233", "r234", "r235", "r236", "r267", "r269", "r297", "r298", "r299", "r357", "r358", "r391", "r413", "r414", "r470", "r474", "r477", "r478", "r488", "r494", "r495", "r505", "r506", "r507", "r512", "r515", "r551", "r555", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r233", "r234", "r235", "r236", "r267", "r269", "r297", "r298", "r299", "r357", "r358", "r391", "r413", "r414", "r470", "r474", "r477", "r478", "r488", "r494", "r495", "r505", "r506", "r507", "r512", "r515", "r551", "r555", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r270", "r532", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r188", "r270", "r528", "r544" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.", "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r188", "r270", "r528", "r529", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r546", "r595" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization and Description of Business [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r16", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r88", "r511", "r607" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r301", "r302", "r303", "r410", "r541", "r542", "r543", "r589", "r608" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r10", "r49", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Additional charge" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r5", "r74", "r100", "r251" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r5", "r42", "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r122", "r151", "r172", "r202", "r215", "r219", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r320", "r324", "r336", "r376", "r434", "r511", "r523", "r553", "r554", "r597" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r146", "r153", "r172", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r320", "r324", "r336", "r511", "r553", "r554", "r597" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r172", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r320", "r324", "r336", "r553", "r554", "r597" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total Non-Current Assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Noncurrent [Abstract]", "terseLabel": "Non-current assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r272", "r273", "r274", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r296", "r297", "r298", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r30", "r148", "r497" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations": { "auth_ref": [ "r30", "r103", "r169" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations", "periodEndLabel": "CASH AT END OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r30", "r103", "r169" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r2", "r103" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET DECREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrant exercisable (in Shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r110", "r231", "r232", "r492", "r552" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r47", "r493" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockConvertibleConversionPriceDecrease": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Per share decrease in conversion price of convertible common stock. Excludes change due to standard antidilution provision.", "label": "Common Stock, Convertible, Conversion Price, Decrease", "terseLabel": "Conversion price of per share (in Dollars per share)" } } }, "localname": "CommonStockConvertibleConversionPriceDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Common stock price per share (in Dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r513", "r514", "r515", "r517", "r518", "r519", "r520", "r541", "r542", "r589", "r606", "r608" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Common Stock, Other Shares, Outstanding", "terseLabel": "Purchase of additional shares (in Shares)" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common Stock, Par or Stated Value Per Share (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r87", "r422" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "verboseLabel": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "verboseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r87", "r422", "r440", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common Stock, Shares Subscribed but Unissued", "terseLabel": "Common stock, shares (in Shares)" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r87", "r378", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 750,000,000 shares authorized, 376,901,679 shares issued and outstanding as of March 31, 2023 and December 31, 2022." } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r79", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Risks and Uncertainties" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r60", "r499" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionLoanPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A real estate loan to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan.", "label": "Construction Loan Payable [Member]", "terseLabel": "Construction Loan Payable [Member]" } } }, "localname": "ConstructionLoanPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockAmountIssued1": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Issued", "terseLabel": "Convertible notes" } } }, "localname": "ConversionOfStockAmountIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r15", "r124", "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r84" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible Debt, Current", "terseLabel": "Convertible debt, net of unamortized discount of $228,888 and $0, respectively" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Convertible debt [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of convertible notes payable" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Promissory note", "verboseLabel": "Non-convertible promissory notes" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r15", "r124", "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Convertible note holders" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r20" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current", "terseLabel": "Amount, net", "verboseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r97", "r359" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r33", "r35" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Aggregate shares of common stock" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r33", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Convertible debt amount (in Dollars)" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r111", "r248" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price, per share (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPriceIncrease": { "auth_ref": [ "r249", "r265" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in conversion price of debt instrument. Excludes change due to standard antidilution provision.", "label": "Debt Instrument, Convertible, Conversion Price, Increase", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPriceIncrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "auth_ref": [ "r539" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.", "label": "Debt Instrument, Decrease, Forgiveness", "terseLabel": "Disclosed amount of accrued interest" } } }, "localname": "DebtInstrumentDecreaseForgiveness", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFeeAmount": { "auth_ref": [ "r24" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.", "label": "Debt Instrument, Fee Amount", "terseLabel": "Loan balance outstanding" } } }, "localname": "DebtInstrumentFeeAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r539" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued Interest", "verboseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r22", "r75", "r250" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r22", "r247" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest Rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDateRangeEnd1": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Latest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date Range, End", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateRangeEnd1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateRangeStart1": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date Range, Start", "terseLabel": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateRangeStart1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "auth_ref": [ "r25" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to interest.", "label": "Debt Instrument, Periodic Payment, Interest", "terseLabel": "Aggregate principal amount interest" } } }, "localname": "DebtInstrumentPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r25" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Debt Instrument, Periodic Payment, Principal", "terseLabel": "Aggregate principal amount", "verboseLabel": "Principal amount" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r74", "r76", "r556" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedLabel": "Unamortized debt discount", "terseLabel": "Convertible debt, net of unamortized discount (in Dollars)", "verboseLabel": "Net of unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r5", "r46" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r5", "r205" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeCashReceivedOnHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash received during the period on settlement of a hedge.", "label": "Derivative, Cash Received on Hedge", "terseLabel": "Opening balance" } } }, "localname": "DerivativeCashReceivedOnHedge", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r67", "r68", "r69", "r70", "r412", "r414", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r450", "r451", "r452", "r453", "r456", "r457", "r458", "r459", "r479", "r481", "r485", "r487", "r498", "r513", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r154" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Current", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityNotionalAmount": { "auth_ref": [ "r480", "r482", "r484", "r486", "r586", "r587", "r588" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivative Liability, Notional Amount", "terseLabel": "Derivative liability" } } }, "localname": "DerivativeLiabilityNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r120", "r121" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "terseLabel": "DERIVATIVE LIABILITY" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r11", "r64", "r65", "r66", "r71", "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative Liabilities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r162", "r180", "r181", "r182", "r183", "r184", "r190", "r192", "r194", "r195", "r196", "r200", "r334", "r335", "r372", "r388", "r501" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic and diluted loss per share (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r162", "r180", "r181", "r182", "r183", "r184", "r192", "r194", "r195", "r196", "r200", "r334", "r335", "r372", "r388", "r501" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted loss per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r189", "r197", "r198", "r199" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET LOSS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r10", "r143", "r158", "r159", "r160", "r175", "r176", "r177", "r179", "r185", "r187", "r201", "r228", "r229", "r266", "r301", "r302", "r303", "r315", "r316", "r326", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r338", "r339", "r340", "r341", "r342", "r347", "r392", "r393", "r394", "r410", "r462" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityFairValueAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.", "label": "Equity, Fair Value Adjustment", "terseLabel": "Fair value of warrants (in Dollars)" } } }, "localname": "EquityFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Acquired percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ExcessStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders.", "label": "Excess Stock, Shares Issued", "netLabel": "Shares of Common Stock", "terseLabel": "Aggregate shares of Common Stock (in Shares)", "verboseLabel": "Common stock shares issued (in Shares)" } } }, "localname": "ExcessStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ExcessStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of excess stock held by shareholders.", "label": "Excess Stock, Shares Outstanding", "terseLabel": "Outstanding shares of Common Stock (in Shares)" } } }, "localname": "ExcessStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r1", "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Fair value of warrants issued with convertible notes" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Schedule of movement in derivative liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalHomeLoanBankAdvancesCurrent": { "auth_ref": [ "r7", "r48", "r84", "r123" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current portion of Federal Home Loan Bank borrowings initially due beyond one year or beyond the normal operating cycle if longer.", "label": "Long-Term Federal Home Loan Bank Advances, Current", "terseLabel": "Federal relief loans \u2013 current portion" } } }, "localname": "FederalHomeLoanBankAdvancesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r150", "r230" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend": { "auth_ref": [ "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset.", "label": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend", "terseLabel": "Cost" } } }, "localname": "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r98", "r444" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLES" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/Intangibles" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r95", "r172", "r202", "r214", "r218", "r220", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r336", "r503", "r553" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross loss" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r59", "r96", "r105", "r180", "r181", "r182", "r183", "r193", "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Net loss" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/LiquidityMattersandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r0", "r93", "r127", "r202", "r214", "r218", "r220", "r373", "r384", "r503" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r133", "r141", "r186", "r187", "r206", "r310", "r317", "r390" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r157", "r308", "r309", "r311", "r312", "r313", "r314", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r4" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeAssetsAndLiabilities": { "auth_ref": [ "r538" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Assets and Liabilities", "terseLabel": "Total" } } }, "localname": "IncreaseDecreaseInDerivativeAssetsAndLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r538" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Increase (Decrease) in Derivative Liabilities", "terseLabel": "Derivative liability movements" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r538" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r41", "r43" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r8" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Interest and Debt Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "terseLabel": "Amortization of debt discount" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r164", "r167", "r168" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentInterestRate": { "auth_ref": [ "r470", "r471", "r474", "r475", "r476", "r477", "r488", "r489", "r515", "r548", "r549" ], "lang": { "en-us": { "role": { "documentation": "Rate of interest on investment.", "label": "Investment Interest Rate", "terseLabel": "Strategic interest" } } }, "localname": "InvestmentInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r389", "r399", "r400", "r401", "r402", "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTableTextBlock": { "auth_ref": [ "r530", "r531", "r547" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of investment.", "label": "Investment [Table Text Block]", "terseLabel": "Schedule of investment" } } }, "localname": "InvestmentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r530", "r531", "r547" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_Investments": { "auth_ref": [ "r375" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.", "label": "Investments", "terseLabel": "Investment" } } }, "localname": "Investments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAllOtherInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, All Other Investments [Abstract]" } } }, "localname": "InvestmentsAllOtherInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsAndOtherNoncurrentAssets": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments, and noncurrent assets classified as other.", "label": "Investments and Other Noncurrent Assets", "terseLabel": "Investment" } } }, "localname": "InvestmentsAndOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r345", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Lease amount" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of total lease cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseDescription": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Description of lessor's operating lease.", "label": "Lessor, Operating Lease, Description", "terseLabel": "Lease, description" } } }, "localname": "LessorOperatingLeaseDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r172", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r321", "r324", "r325", "r336", "r421", "r502", "r523", "r553", "r597", "r598" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r92", "r126", "r381", "r511", "r540", "r550", "r591" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r147", "r172", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r321", "r324", "r325", "r336", "r511", "r553", "r597", "r598" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r15", "r81", "r82", "r83", "r85", "r172", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r321", "r324", "r325", "r336", "r553", "r597", "r598" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityIncreaseAccruedInterest": { "auth_ref": [ "r539" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the credit facility for the period.", "label": "Line of Credit Facility, Increase, Accrued Interest", "terseLabel": "Accrued Interest" } } }, "localname": "LineOfCreditFacilityIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturityDate": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Maturity date of long-term debt, in YYYY-MM-DD format.", "label": "Long-Term Debt, Maturity Date", "terseLabel": "Maturity date" } } }, "localname": "LongTermDebtMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r27", "r125", "r172", "r227", "r238", "r240", "r241", "r242", "r245", "r246", "r336", "r380", "r424" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.", "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r166" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r166" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r103", "r104", "r105" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r94", "r105", "r128", "r145", "r155", "r156", "r160", "r172", "r178", "r180", "r181", "r182", "r183", "r186", "r187", "r193", "r202", "r214", "r218", "r220", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r335", "r336", "r387", "r442", "r460", "r461", "r503", "r521", "r553" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to Innovative Payment Solutions, Inc. stockholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r63", "r119", "r155", "r156", "r186", "r187", "r386", "r534" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net loss attributable to non-controlling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "NON CASH INVESTING AND FINANCING ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r57", "r266", "r541", "r542", "r543", "r608" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling shareholders interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Notes Issued", "terseLabel": "Notes issued" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable [Abstract]" } } }, "localname": "NotesPayableAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r545" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Operating segment" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]", "terseLabel": "Office equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Expense" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r202", "r214", "r218", "r220", "r503" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r592" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoftotalleasecostTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r80", "r117", "r397", "r398" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r152", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r99" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses", "terseLabel": "Interest expense" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoninterestExpense": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noninterest expense classified as other.", "label": "Other Noninterest Expense", "terseLabel": "Interest expense" } } }, "localname": "OtherNoninterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r173", "r584", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Other Tax Expense (Benefit) (in Dollars)" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForSoftware": { "auth_ref": [ "r102" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments for Software", "terseLabel": "IPSIPay software amount" } } }, "localname": "PaymentsForSoftware", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r101" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Investment in intangibles" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r513", "r514", "r517", "r518", "r519", "r520", "r606", "r608" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r86", "r253" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r86", "r422" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r86", "r253" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r86", "r422", "r440", "r608", "r609" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r86", "r377", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022." } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r163" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Company received" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r536" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from Issuance of Debt", "terseLabel": "Net proceeds" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r3" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/IntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMinorityShareholders": { "auth_ref": [ "r28" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.", "label": "Proceeds from Noncontrolling Interests", "terseLabel": "Proceeds from convertible notes" } } }, "localname": "ProceedsFromMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Warrant cost" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyLiabilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Warranty Liability [Line Items]" } } }, "localname": "ProductWarrantyLiabilityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.", "label": "Product Warranty Liability [Table]" } } }, "localname": "ProductWarrantyLiabilityTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r145", "r155", "r156", "r165", "r172", "r178", "r186", "r187", "r202", "r214", "r218", "r220", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r319", "r322", "r323", "r335", "r336", "r373", "r385", "r409", "r442", "r460", "r461", "r503", "r508", "r509", "r522", "r534", "r553" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow", "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r109", "r149", "r383" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Plant and equipment costs" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r6", "r374", "r383", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r6", "r137", "r140", "r382" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r268", "r351", "r352", "r416", "r417", "r418", "r419", "r420", "r439", "r441", "r469" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails", "http://innovativepaymentssolu.com/role/NotesPayableDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r351", "r352", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/InvestmentsDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r268", "r351", "r352", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r416", "r417", "r418", "r419", "r420", "r439", "r441", "r469", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party, Type [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails", "http://innovativepaymentssolu.com/role/DerivativeLiabilityDetails", "http://innovativepaymentssolu.com/role/NotesPayableDetails", "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofinvestmentTable", "http://innovativepaymentssolu.com/role/ScheduleofnotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r348", "r349", "r350", "r352", "r353", "r405", "r406", "r407", "r445", "r446", "r447", "r466", "r468" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r537" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.", "label": "Repayments of Debt", "negatedLabel": "Repayment of federal relief loans" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r29" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayment of convertible notes" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "terseLabel": "Repayments amount" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Option expense (in Dollars)" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r89", "r113", "r379", "r395", "r396", "r404", "r423", "r511" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r143", "r175", "r176", "r177", "r179", "r185", "r187", "r228", "r229", "r301", "r302", "r303", "r315", "r316", "r326", "r328", "r329", "r331", "r333", "r392", "r394", "r410", "r608" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r443", "r496", "r500" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r161", "r172", "r203", "r204", "r213", "r216", "r217", "r221", "r222", "r223", "r227", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r336", "r373", "r553" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesNetOfInterestExpense": { "auth_ref": [ "r203", "r204", "r213", "r216", "r217", "r221", "r222", "r223" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income after deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues, Net of Interest Expense", "terseLabel": "Revenues" } } }, "localname": "RevenuesNetOfInterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionNetBookValue": { "auth_ref": [ "r130", "r131", "r132", "r594" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller.", "label": "Sale Leaseback Transaction, Net Book Value", "terseLabel": "Net Book Value" } } }, "localname": "SaleLeasebackTransactionNetBookValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r9", "r61", "r118" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of Stock, Description of Transaction", "terseLabel": "Description of compensation service" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction", "terseLabel": "Outstanding Common Stock percentage" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.", "label": "Sale of Stock, Percentage of Ownership before Transaction", "terseLabel": "Limitation exceeds percentage" } } }, "localname": "SaleOfStockPercentageOfOwnershipBeforeTransaction", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of dilutive shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "terseLabel": "Schedule of assumptions were used in the black-scholes valuation model" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/DerivativeLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of warrant activity" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of restricted stock activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "terseLabel": "Schedule of warrants outstanding and exercisable" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r13", "r14", "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of fair value of the warrants and options granted and issued Black Scholes valuation model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r15", "r124", "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Senior secured convertible note" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r533" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r207", "r208", "r209", "r210", "r211", "r212", "r222", "r504" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Reporting by Segment" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeniorNotes": { "auth_ref": [ "r78", "r605" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes", "terseLabel": "Value of notes" } } }, "localname": "SeniorNotes", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r4" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "terseLabel": "Shares Underlying options, Forfeited/Cancelled (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Shares Underlying Warrants, Granted (in Shares)", "verboseLabel": "Shares Underlying options, Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Shares Underlying Warrants, Outstanding at beginning (in Shares)", "periodStartLabel": "Shares Underlying Warrants, Outstanding at beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r284", "r285" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average exercise price, Outstanding at ending", "periodStartLabel": "Weighted average exercise price, Outstanding at ending", "terseLabel": "Weighted average exercise price, Outstanding at beginning", "verboseLabel": "Weighted average exercise price, Outstanding at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility of underlying stock" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Purchase an additional shares (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options Outstanding, Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Total restricted shares, Forfeited/Cancelled (in Shares)", "terseLabel": "Shares Underlying Warrants, Forfeited (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Total restricted shares, Granted and issued (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r50" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Warrants outstanding an intrinsic value (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Total restricted shares, Outstanding at beginning (in Shares)", "periodStartLabel": "Total restricted shares, Outstanding at beginning (in Shares)", "terseLabel": "Warrants Outstanding, Number Outstanding", "verboseLabel": "Incentive stock options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r276", "r277" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average fair market value per share, Outstanding at ending", "periodStartLabel": "Weighted average fair market value per share, Outstanding at ending" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r272", "r273", "r274", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r296", "r297", "r298", "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffacilitatethefunctioningoftheIPSIPaysoftwareTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r281" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted average fair market value per share, Forfeited/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted average fair market value per share, Granted and issued" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r271", "r275", "r294", "r295", "r296", "r297", "r300", "r304", "r305", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Payment Arrangements" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Warrants Exercisable, Number Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Total unvested restricted shares, Outstanding at ending (in Shares)", "periodStartLabel": "Total unvested restricted shares, Outstanding at ending (in Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "terseLabel": "Warrants Exercisable ,Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Exercisable, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Warrants Outstanding, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Warrants Outstanding, Weighted Average Remaining Contractual life in years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Common stock shares (in Shares)" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConvertibleNotesPayableDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtInterestRateIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage increase in the stated interest rate on a short-term debt instrument.", "label": "Short-Term Debt, Interest Rate Increase", "terseLabel": "Bearing interest, percentage" } } }, "localname": "ShortTermDebtInterestRateIncrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/FederalReliefLoansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r106", "r170" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "ACCOUNTING POLICIES AND ESTIMATES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesandEstimates" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r10", "r26", "r143", "r158", "r159", "r160", "r175", "r176", "r177", "r179", "r185", "r187", "r201", "r228", "r229", "r266", "r301", "r302", "r303", "r315", "r316", "r326", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r338", "r339", "r340", "r341", "r342", "r347", "r392", "r393", "r394", "r410", "r462" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r175", "r176", "r177", "r201", "r359", "r399", "r411", "r415", "r416", "r417", "r418", "r419", "r420", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r443", "r444", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r462", "r516" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r175", "r176", "r177", "r201", "r359", "r399", "r411", "r415", "r416", "r417", "r418", "r419", "r420", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r441", "r443", "r444", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r462", "r516" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofassumptionswereusedintheblackscholesvaluationmodelTable", "http://innovativepaymentssolu.com/role/ScheduleofconvertiblenotespayableTable", "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofestimatedusefullivesoftheassetsTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable", "http://innovativepaymentssolu.com/role/ScheduleofoptionsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofrestrictedstockgrantedandexercisableTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantsoutstandingandexercisableTable", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Retained shares of Common Stock (in Dollars)" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Exchange shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Shares of Common Stock (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Stock purchase agreement (in Shares)", "verboseLabel": "Purchased shares" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r10", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Restricted stock awards" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Stock based option expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionExercisePriceIncrease": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option, Exercise Price, Increase", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofoptionactivityTable" ], "xbrltype": "domainItemType" }, "us-gaap_StockOptionPlanExpense": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for option under share-based payment arrangement.", "label": "Stock or Unit Option Plan Expense", "terseLabel": "Option expense" } } }, "localname": "StockOptionPlanExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r87", "r90", "r91", "r107", "r424", "r440", "r463", "r464", "r511", "r523", "r540", "r550", "r591", "r608" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "totalLabel": "Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent [Abstract]", "terseLabel": "Equity (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r57", "r58", "r62", "r143", "r144", "r159", "r175", "r176", "r177", "r179", "r185", "r228", "r229", "r266", "r301", "r302", "r303", "r315", "r316", "r326", "r327", "r328", "r329", "r330", "r331", "r333", "r337", "r338", "r342", "r347", "r393", "r394", "r408", "r424", "r440", "r463", "r464", "r490", "r522", "r540", "r550", "r591", "r608" ], "calculation": { "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Equity (Deficit)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedBalanceSheet", "http://innovativepaymentssolu.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r112", "r171", "r252", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r266", "r332", "r465", "r467", "r491" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Equity [Text Block]", "terseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent Event, Description", "terseLabel": "Frictionless agreement description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r343", "r355" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r343", "r355" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r343", "r355" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r354", "r356" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleoffairvalueofthewarrantsandoptionsgrantedandissuedBlackScholesvaluationmodelTable" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "CASH PAID FOR INTEREST AND TAXES:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "Purchase price (in Dollars)" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/OrganizationandDescriptionofBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r5", "r456", "r457", "r458", "r459", "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "terseLabel": "Derivative financial liability arising on note amendment included in loss on convertible notes" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofmovementinderivativeliabilityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r37", "r38", "r39", "r134", "r135", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantExercisePriceIncrease": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.", "label": "Warrant, Exercise Price, Increase", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "WarrantExercisePriceIncrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r513", "r514", "r517", "r518", "r519", "r520" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]", "verboseLabel": "Warrants to purchase shares of common stock [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ScheduleofdilutivesharesTable", "http://innovativepaymentssolu.com/role/ScheduleofwarrantactivityTable", "http://innovativepaymentssolu.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": { "auth_ref": [ "r72" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of warrants not settleable in cash classified as equity.", "label": "Warrants Not Settleable in Cash, Fair Value Disclosure", "terseLabel": "Fair value of the warrants" } } }, "localname": "WarrantsNotSettleableInCashFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/NotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r191", "r196" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r190", "r196" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Number of Shares Outstanding - Basic (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://innovativepaymentssolu.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org//350/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org//810/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org//815/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org//820/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "50", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-50", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-51", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "840", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-52", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1405", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org//260/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(16))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(17))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(f)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(2)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column D))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13A(Column F))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column A))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column E))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "47", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r524": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r525": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r526": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r527": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org//321/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org//325/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org//320/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.16)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org//205/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 82 0001213900-23-039367-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-039367-xbrl.zip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